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There are many aspects of life which, when viewed retrospectively, 
fall into a pattern, although in their developing they seemed 
but a random play of accident and circumstance.
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Studies were undertaken to elucidate the in vivo immunochemical nature of the 
antigen revealed when autologous erythrocytes are treated with the proteolytic enzyme, 
bromelain. The primary aim of this thesis has been to identify the molecular form of 
the BrMRBC antigen normally found in vivo either on bromelain-treated mouse 
erythrocytes or in its naturally antigenically detectable form in the mouse 
gastrointestinal tract.
Carbonic anhydrase (CA) from mouse erythrocyte membranes is recognised 
and identified as an autoantigen in Western blotting experiments with FUB 1, a murine 
IgM monoclonal antibody that has binding reactivity towards both phosphatidylcholine 
and bromelain-treated mouse red blood cells (BrMRBC). Serum from mice stimulated 
with lipopolysaccharide (LPS-serum) also recognises CA from erythrocytes and the 
stomach. From SDS-PAGE and blotting experiments with whole mouse erythrocytes 
we found two closely spaced glycoprotein bands were found in the 30 kD region that 
reacted with both FUB 1 and LPS-serum; one of the molecular weight markers, 
bovine carbonic anhydrase, which ran in the same 30 kD region also reacted with these 
antibodies. Carbonic anhydrases from a range of mammalian species including rat, 
rabbit, dog, human, horse, sheep, and cow were found to be cross-reactive with FUB 
1 and LPS-serum by Western blotting, whereas human glycophorin A and human 
asialoglycophorin were not recognised by the antibodies. A doublet band occurred for 
mouse, rat and rabbit carbonic anhydrase, whereas a single band was evident for 
human, sheep and horse erythrocyte carbonic anhydrase. FUB 1 specifically 
recognises both native and denatured bovine carbonic anhydrase in ELISA assays. The 
serological identity of the determinants on CA and BrMRBC was confirmed by 
specific absorption of both FUB 1 and LPS-serum with BrMRBC and normal mouse 
erythrocytes.
Carbonic anhydrase was purified from mouse stomach and shown to be 
recognised by natural autoantibodies in western blotting experiments. In an attempt to 
define epitopes present on carbonic anhydrase, the glycoprotein was treated with 
specific enzymes to remove O-linked carbohydrates and was also treated with 
proteases to cleave CA into defineable fragments.When these forms of carbonic
x v i.
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anhydrase are western blotted, FUB 1 does not bind to deglycosylated carbonic 
anhydrase suggesting that FUB 1 recognises O-linked carbohydrates on carbonic 
anhydrase. In other preliminary experiments, where carbonic anhydrase has been 
proteolytically cleaved, LPS serum is capable of recognising all cleavage fragments, 
whereas FUB 1 appears to recognise a limited number of bands.
Thus, the autoantigenic epitope on erythrocytes that is revealed by the 
proteolytic action of bromelain is associated, at least in part, with carbonic anhydrase. 
The possible biological significance of natural autoantibodies binding to carbonic 
anhydrase is examined and a model of the functional importance of this interaction is 
presented.
CHAPTER ONE
IMM UNOCHEMICAL CHARACTERISATION OF ERYTHROCYTE 
ANTIGENS BY NATURAL AUTO ANTIBODIES
1.1. NATURAL AUTOANTIBODIES AND AUTOANTIGENS
Natural autoantibodies and the B lymphocytes from which they arise display 
many unusual and unique properties which will be examined briefly in this review. 
Natural antibodies are known to recognise a diverse range of autoantigens, of which a 
selection will be examined (Section 1.1.2.). It is difficult to make a clear distinction 
between pathological autoantibodies and natural non-pathogenic autoantibodies in 
normal and autoimmune animals due to the complexity, diversity and multifactorial 
nature of autoimmune disorders. Moreover, the function and origins of most natural 
antibodies or autoantibodies have not yet been ascertained (Section 1.2.) and thus the 
role of natural antibodies or autoantigens in the maintainence of self tolerance is 
currently open to question . The very idea that natural autoantibodies exist raises 
problems for how self tolerance and self recognition may operate, and the various 
models of self tolerance are examined from this perspective (Section 1.2.1.).
Throughout this literature review particular emphasis will be placed upon the 
determination of the in vivo immunochemical nature of a hidden autoantigen(s) on 
autologous mouse red blood cells (RBC) that are recognised by natural 
autoantibodies. In this model, a large proportion of the potential repertoire appears to 
be primed to respond to hidden antigens on autologous red blood cells treated with 
the proteolytic enzyme bromelain (BrMRBC; Cunningham 1974a, 1975,1976; Pages 
and Bussard 1975; Bussard and Pages 1976; Steele and Cunningham 1978). These 
studies and subsequent work by others on the elucidation of the BrMRBC-specific 
autoantibodies, BrMRBC antigen(s) and the regulation of this response will be 
reviewed (Sections 1.3. and 1.4.) and finally, vertebrate red blood cell antigens will 
be examined briefly (Section 1.5.) in order to provide background information on 
potential antigenic substances which may be involved in the BrMRBC epitope.
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CHAPTER ONE 2
1.1.1. Natural Autoantibodies
Natural antibodies have traditionally been defined as:
"any family o f molecules (probably always protein and, in mammals, probably always globulin) 
which are present in the body fluids o f normal animals and which have the capacity to combine 
specifically with potential antigens, but not with the immunologically acceptable molecules 
normally present in body fluids." (Boy den 1965).
Natural antibodies were once thought to appear in the serum either due to 
"unnoticed infections" with microorganisms or appear "spontaneously" with no 
apparent antigenic stimulation (Wiener 1951). The definition must now be modified 
to include the natural autoantibodies, principally of the IgM isotype, which display 
specificity for many self-antigens or autoantigens. Apart from the anti-BrMRBC-type 
of antibody, many natural autoantibodies have been demonstrated to occur in normal 
animals and they can recognise many native and denatured autoantigens (Karsenti et 
al. 1977; Guilbert et al. 1982; Dighiero etal. 1982, 1983,1985,1986,1987a 1987b). 
They form the "background" level of immunoglobulin present in normal, healthy 
animals but may be found in elevated levels in animals that have the genetic 
predisposition to develop "spontaneous" autoimmune diseases, such as the 
haemolytic anaemia which occurs in mice of the NZB inbred strain over the age of 
nine months (Warner 1973). Natural antibodies can also be elevated in animals with 
an increased antigenic load (Benner et al. 1982). Levels of natural antibody of the 
IgM isotype tend to decrease as organisms age, with a corresponding increase in the 
levels of autoantibodies of the IgG isotype (Kay and Makinodan 1976; Makinodan 
and Kay 1980).
Some natural antibodies may display "high idiotypic connectivity" (Freitas et al. 
1986; Holmberg et al. 1986) i.e. natural antibodies are capable of recognising the 
idiotope of other natural antibodies. With hybridoma collections prepared from the 
spleens of newborn mice, Holmberg et al. (1984a, 1984b, 1986) and Dighiero et al. 
(1985) have shown that many IgM natural autoantibodies recognise the idiotypes of 
other IgM natural autoantibodies. This high idiotypic connectivity is found to be 
prevalent in hybridomas prepared from newborn mice, but is not found in collection 
of hybridomas prepared from adult mice treated with B-cell mitogens. These highly
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connected natural autoantibodies appear to preferentially use two of the most 
D-proximal Vjj-gene families 7183 and QUPC 52 (Holmberg 1987).
Another feature of some natural autoantibodies is that they display 
cross-reactivity or "multispecificity" with many antigens and autoantigens (Dighiero 
et al. 1982; Guilbert et al. 1982; Rubin et al. 1984; Prabhakar et al. 1984; 
Underwood et al. 1985; Holmberg et al. 1986). In some of these studies it should 
be noted that xenogenic proteins are used so one should be cautious about the 
interpretations of cross-reactivity until it is demonstrated with targets prepared from 
the same species or that a close relationship can be established between the foreign 
and self antigen.
In the bromelain-modified mouse red blood cell (BrMRBC) model of 
autoreactivity, cross-reactivity has been demonstrated between the determinant on 
BrMRBC and Sheep RBC (Pages and Bussard 1975), isologous IgG (Fc) (Cunliffe 
and Cox 1980), and cross-reactivity between the BrMRBC determinant and 
trimethylammonium-containing compounds (Serban et al. 1981; Cox and Hardy 
1985) has also been established .
In normal strains of inbred mice which do not spontaneously develop 
autoimmune diseases, such as CBA/H, high levels of natural autoantibodies to 
erythrocyte antigens revealed by bromelain can be experimentally induced with 
anti-lymphocyte serum (Cunningham 1975,1976) and polyclonal B-cell activators or 
B-cell mitogens such as the lipopolysaccharides derived from many Gram negative 
microorganisms (Cunningham 1974a, 1975). In such mice, a large fraction of the 
potential Ig secreting repertoire (2% in spleen, 50-90% in peritoneum, 10% in bone 
marrow, 66% in pleural cells) has been shown to contain natural autoantibodies 
specific for bromelain-treated autologous erythrocytes (Steele and Cunningham 1978; 
Cunningham and Steele 1981). In a similar fashion, 35%-75% of the potential 
repertoire has also been reported to display rheumatoid factor activity (Dresser 1978), 
although Venn and Dresser (1987) have since detected an artefact in their haemolytic 
plaque assay for detecting rheumatoid factor cells in that contamination of target IgG 
by IgM results in the cross linking of target and effector IgM by the anti-IgM 
developing agents. Venn and Dresser have not reassessed the percentage of the
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potential repertoire that may be involved in the production of RF, however, Steele 
(1979) found that the level of anti-RF in cultured peritoneal cells was 1% when 
developing serum was not used.
The parallels between rheumatoid factors and anti-BrMRBC responses are 
striking (Table 1.1.). Cunliffe and Cox (1980) have demonstrated a cross-reaction 
between BrMRBC and isologous Fc (RF) through inhibition of haemolysis assays 
with isologous IgG (Fc) although the functional significance of this cross-reaction 
remains to be elucidated. However, there are fundamental differences in the V region 
genes employed in the anti-RF and anti-BrMRBC antibody responses (see Section 
1.3.6.) suggesting that that the responses are not identical. Shlomchik et al. (1986, 
1987a) examined the use of variable light chains used in the IgM anti-IgG response 
and showed a highly restricted use of light chain germline genes especially in the 
MRL-lprApr strain of mice where the rheumatoid factors appear to be a "monoclonal" 
response ( Shlomchik et al. 1987b).
1.1.2. Natural Antibodies and Development
There is increasing evidence for the internal activation of B-cells by 
self-antigens as first suggested by Jerne, in the context of idiotypic networks (Jeme 
1971,1984; Steele 1979; Steele and Cunnigham 1980; Cunningham and Steele 1981; 
Pereira et al. 1986; Portnoi et al. 1986), although a "spontaneous" appearance of 
natural autoantibodies due to "preprogrammed genetic expression" during 
development (Yancopoulous et al. 1984; Perlmutter et al. 1985) cannot be directly 
discounted. Perlmutter (1987) after reviewing preliminary data, is of the view that the 
develop mentally ordered expression of antibody Vjj  genes may be due to the 
progressive activation from telomere to centromere of the Vjj  locus. These authors 
however, have subsequently modified this idea of genetic predeterminantion in the 
face of evidence that gene segments from all Vjj  families are used in ontogney (Alt et 
al.. 1987, Malynn et al. 1987). As with other problems in development concerning 
ontogeny and phylogeny (Gould 1977), it is often difficult to determine the relative 
contributions of genetic potential as opposed to antigenic stimulation from internal 
and external environments.
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Table 1.1. The similarities between the anti-BrMRBC antibodies and 
Rheumatoid factors
Shlomchik (1986,1987a,1987b) summarised some features of rheumatoid factors:
1. They are not normally pathogenic (in contrast to IgG anti-IgG)
2. The production is regulated (with a peak in the response at d3 and a gradual subsidence in 
l-2wks.
3. The percentage o f B cells involved is high (3-15% of LPS-induced hybridomas)
4. There is little evidence o f somatic mutation in IgM anti-IgG,
5. Rheumatoid factors may be induced in normal mice by either LPS or repeated protein (tetanus 
toxin) injection but not by target IgG.
For anti-bromelain-treated mouse red blood cell antibodies:
1. Not normally pathogenic (mainly IgM) (Cunningham 1976)
2. Regulated production (peak response in PFC occurs at days 3-4 after LPS stimulation, with 
gradual subsidence by day 15; Cunningham 1975)
3. Percentage of B-cells involved is high (Steele and Cunningham 1978; or number of 
anti-BrMRBC peritoneal cell precursors was 1 in every 150-200 peritoneal cells or 1 in 50 for 
LPS-stimulated peritoneal cells (Cox et al. 1984)
4. No reported IgG anti-BrM as a result of class switching in vivo or in vitro (Cunningham 
1976) or almost always IgM except for IgG3 (Bussard et al. 1977). In the CH 12 lymphoma
line some isotype switching as well as simultaneous expression of two isotypes has been 
demonstrated to occur for IgA, IgG2b» IgG3 . (Arnold et al. 1988 )
5. Can elevate anti-BrM levels in mice with LPS, xenogenic erythrocytes but not with injection of 
NMRBC or BrMRBC (Cunningham 1974; Lord and Dutton 1975a; Cox et al 1977).
In addition, Heutz and Poncet (1989) have surveyed that anti-BrMRBC antibodies are of a 
restricted idiotype
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Cunningham and Steele have raised the possibility that autoantigens may be 
important educating in the development of immune diversity (Cunningham and Steele 
1979; Steele and Cunningham 1979, 1980). With the BrM-antigen, which they also 
found to occur at high levels in the gastrointestinal tract (Cunningham and Steele 
1981), they describe a relationship between appearance of BrM antigen in the gut and 
specific Ig-secreting cells in the spleen. Alternatively, natural autoantibodies may play 
a role in the recognition of other types of internal antigens and thus be crucial in the 
development of self tolerance (Avrameas 1986,1991).
The different views on how the antibody repertoire arises during development 
may be resolved as more information becomes available on different sub-population 
of lymphocytes in different immune system compartments. The Ly-1+ lymphocyte 
population from which natural antibodies are thought to arise may be of a different 
character to "conventional" B lymphocyte populations especially with regard to the 
ways in which Ly-1+ and conventional B celf arise (examined in 1.3.4). Separate 
pathways of development may operate for natural and acquired immunity and may 
depend upon the microenvironment that the B cell finds itself in (Rajewsky et al. 
1987; Kocks and Rajewsky 1989).
1.1.3. Natural Autoantibodies and Autoimmunity
Natural antibodies have been demonstrated to occur in normal animals and to 
recognize autoantigens without rampant autoimmunity being evident. So what 
distinguishes natural autoantibodies from pathological autoantibodies that occur in 
autoimmune diseases ? There is a great diversity in the types of diseases classified as 
autoimmune diseases, ranging from highly organ-specific thyroid disorders, such as 
Hasimoto's thyroiditis and thyrotoxicosis, to the non-organ speci^c disorders such as 
rheumatoid arthritis and systemic lupus erythematosus (reviewed in Roitt 1987; 
Theofilopoulos 1987). It has been proposed that there is multifactorial etiology for 
many autoimmune diseases (Table 1.2.) so it is feasible that natural antibodies may 
exist in normal animals, but the role that these natural antibodies may play in health 
and disease is not exactly clearcut (Smith and Steinberg 1983).
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Table 1.2. The m ultip licity  o f factors involved in autoim m une disorders
Genetic
Individual genes predispose to particular abnormalities 
Diseases can be polygenic 
Environmental Factors
Stimulate the immune system 
Interfere with normal immune regulation 
Hormonal Factors (modify disease manifestations)
Abnormal immune regulation
Disease results from quantitative abnormalities (e.g. amount of stem cell proliferation, amount of 
autoantibody, quantity of immune complexes.)
Modified from Smith and Steinberg (1983)
In human studies, specific anti-tubulin, thyroglobulin, actin, myoglobin and 
fetuin antibodies were found in a serum pool of 800 normal blood donors (Avrameas 
et al. 1983). Patients with multiple sclerosis had higher levels of natural IgG against 
myelin basic protein than normal controls or patients with other neurological diseases, 
whereas all patients and normal controls reacted to a panel of antigens including actin, 
myosin, tubulin, albumin, transferrin, peroxidase, thyroglobulin, DNA, prolactin, 
TNP and myelin basic protein (Matsiota et al. 1988). Anti-sperm natural antibodies 
have been demonstrated to occur in males and females aged 1 day to 40 years, but are 
significantly absent in patients with AIDS or AIDS-related complex (Rodman et al. 
1985,1986), although others have reported an overall increase in the levels of IgG, 
IgM and IgA in patients with AIDS or AIDS-related complex (Matsiota et a l  1987).
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1.1.4. Autoantigens
Autoantigens may be defined and identified by reference to a corresponding 
autoantibody, however, there seems to be an enormous range and diversity of 
substances that could be defined as autoantigens (see Table 1.3). The table is not 
comprehensive but aims to show the diversity of organs targeted or specific 
molecules that have recently been identified in rodent and human studies. The 
diversity of autoantigens raises many questions on what determines the antigenicity of 
autoantigens, the role of autoantigens in the pathogenesis and etiology of autoimmune 
disorders when compared to normal animals, and how do autoantigens, especially 
ones that could be considered "internal" and normally sequestered from the immune 
system by virtue of the cell membrane, become presented to the immune system ?
Autoantibodies can recognise many soluble autoantigens and cell-surface 
antigens which are readily accessible to the immune system (reviewed in Smith and 
Steinberg 1983), but they have also been found to recognise intracellular autoantigens 
and antigens "buried" in cell membranes. In a comprehensive study of autoimmunity 
in a human community, autoantibodies were found in 20% of the community (3492 
subjects tested) directed against rheumatoid factor (RF), smooth muscle antibody, 
nuclei, gastric parietal cells and thyroid epithelial cells in normal as well as humans 
with autoimmune disorders (Hooper et al. 1972). In the murine model of 
autoreactivity towards bromelain-modified mouse erythrocytes (see Sections 1.3 and 
1.4), a large proportion of natural autoantibodies have been found to be specific for 
the "buried" BrM autoantigen present on mouse erythrocytes and in the 
gastrointestinal tract (Cunningham and Steele 1981). Currently there is strong 
evidence that trim ethyl ammonium compounds and more specifically 
phosphatidylcholine is involved in the BrMRBC epitope (Serban et al. 1981; Pages et 
al. 1982; Cox and Hardy 1985; Mercolino et al. 1986, 1988, 1989; Kawaguchi 
1987b; Serban and Witz 1988) however, anti-BrM antibodies appear to recognise a 
diverse range of other erythrocytes and antigens isolated from the stomach (examined 
in detail in Section 1.4).
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Table 1.3 Target organs and auto-epitopes recognised by autoantibodies.
1. Rodent Studies (anti-BrM type) 
Sheep RBC in carboxy-methyl-cellulose 
Sheep RBC
Sheep RBC & anti HB antigen 





Low density lipoproteins, X and HB antigens
Low density lipoproteins (human and rat
but not chicken or mouse)
Phosphatidylcholine
Cholesterol particles coated with
phosphatidylcholine
Thrombin treated platelets




Murine interferon-a & interferon-^
Actin, tubulin,myosin,TNP-BSA 
DNA (ds and ss)
Bussard 1966
Pages and Bussard 1975, Bussard et al 1977
DeHeer, Pages and Bussard, 1980
Pages and Arnaud 1980
Pages and Arnaud 1980, Poncet et al. 1985
Cunliffe and Cox 1980
Poncet étal. 1985
Serban et al 1981, Pages et al. 1982, Serban and Witz 1988 
Linder and Edgington 1972,1973a,1973b 
Kawaguchi 1987b
Cox and Hardy 1985, Mercolino et al. 1986,1988,1989 
Kaushik et al. 1986 (comment only, no data)
Kawaguchi 1989
Arend and Nijssen 1977
Cerny-Provaznik et al. 1985, 1986, Ivanyi et al. 1978 
Martin&Martin 1975, Sandberg&Steinvinkel 1988 
De Maeyer-Guignard and De Maeyer 1986 
Dighiero et al. 1982,1983,19851986
Cholesterol
DNA,cell surface proteins




Liver, heart and brain















Calf thymus and cardiolipin, human 
thyroglobulin, human IgG and tetanus
Swartz, Jr et al. 1988
Jacob et al 1986 Muso and Jacob 1987
Laing et al. 1987, 1988
Steffanson et al. 1985
Daar and Fabre 1981
Lutz and Wipf 1982; Lutz et al. 1984
Winchester et al. 1975
Avrameas et.al. 1983; Dighiero et al. 
1982,1983; Guilbert et al. 1982
Tongio et al. 1985 
Wilson et al. 1970.
Jackson et al. 1987 
Dighiero et al. 1987 
Caruso et al. 1988 
Alvarez et al. 1987 
Rosenberg and Rogentine,Jr. 1972 
Alving et al. 1989 
Bucala et al. 1987 
Logtenberg et al. 1987 
toxin
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1 . 2 .  THE O RIG IN AND SIG N IF IC A N C E  OF NATURAL
AUTOANTIBODIES IN THE CONTEXT OF SELF-NONSELF
DISCRIM INATION.
1.2.1. Theories of self tolerance and self recognition.
How does the immune system deal with the potentially endless array of 
autoantigens and foreign antigens and still act in a non-aggresive way to the 
constituents of the body? How do the various theories of self tolerance deal with the 
existence of natural antibodies directed towards self antigens ? In this section, the aim 
is to examine the main theories proposed on how the immune system copes with the 
problem of self-recognition and tolerance in light of the fact that natural antibodies 
exist and recognise autoantigens (see Table 1.4.).
One basic requirement of self-recognition that is often overlooked is that 
self-antigen must be continually present, i.e. self-tolerance appears to be a learned or 
acquired response. This has been demonstrated by Owen (1945) with acquired 
tolerance to red blood cells in dizygotic cattle twins, by Triplett (1962) with Hyla 
regilla pituitary transplants and more recently McCullagh (1989) has demonstrated 
that self thyroid tissue needs to be present continuously for self tolerance to be 
maintained in lambs. Triplett's work has been extended by Rollins-Smith and Cohen 
(1982) in experiments where they show that allogeneic pituitary, but not self pituitary 
is rejected in Rana pipens, suggesting that perhaps self may be accepted at some later 
stage of development.There are many differences between these two amphibian 
studies which require further investigation to determine the exact role of different 
types of self antigens, and to determine if similar mechanisms operate in all animals.
In the clonal selection theory, Burnet provided a framework in which to view 
the capacity of the immune system to respond to a wide range of foreign antigens and 
yet not usually mount immune responses to tissues of the body. He proposed that 
antigen interacted with unique "receptors" on a single cell, and stimulated a cell to 
under go proliferation to produce descendants that preferentially produce one type of 
receptor specific to the antigenic determinants (Bumet 1959; reviewed by Ada and 
Nossal 1987; Steele 1991). The concept of clonal selection has remained intact,
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although it is now generally accepted that V-region diversification is completed after 
rather than before antigenic stimulation (Cunningham 1974b, 1977; Rajewsky etal. 
1987). Natural antibodies (e.g. red cell isoagglutinins such as anti-A , anti-B and the 
T-agglutinin) were thought by Burnet (1959), to be an "accidental and irrelevant 
circumstance" arising due to the purging of the appropriate clones by contact with 
antigen in the neonate. Later, it became obvious that many diseases could be viewed 
as an attack of the immune system on normal body constituents, and self reactive 
clones could exist. While Burnet's basic precepts on clonal selection have stood the 
test of time, his ideas of deletion of self reactive clones (1959) required modification 
to account for autoimmune disorders. Burnet later viewed autoimmunity as a result of 
the persistance of forbidden B-cell clones that had somehow escaped the purge of 
forbidden clones early in an animals' life, or arising as a result of failure of immune 
surveillance to deal with autoreactive clones that arise by somatic mutation (1961, 
1972).
Following along the same lines, clonal abortion and clonal anergy (reviewed by 
Nossal 1983) have been considered as mechanisms whereby tolerance is achieved by 
downregulation or killing of antigen-reactive clones, however, like the idea of 
forbidden self-reactive clones these methods of tolerance do not account for the 
existence of any self-reactive clones that may produce natural autoantibodies. Clonal 
deletion and anergy as models of tolerance are useful where large and frequent 
injections of foreign antigens are involved, but are not easily applicable to concepts of 
tolerance to self-antigens in normal animals. Evidence to support clonal anergy and 
clonal deletion has arisen from studies with transgenic animals. Goodnow et al. 
(1988, 1989,1990) have demonstrated in double-transgenic mice that "self-reactive" 
B-cells specific for a new self-antigen, hen egg lysozyme, are present but incapable 
of producing antibody suggesting some type of clonal anergy in operation. In another 
study, Nemazee and Burki (1989) have demonstrated clonal deletion of anti-MHC 
antibodies in transgenic mice.
In contrast to the theories of clonal anergy or deletion, the idea of effector cell 
blockade (Nossal and Schrader 1975), where the presence of self antigen can block 
membrane receptors for antigen, does not deny that self-reactive clones exist and may 
help explain some aspects of the regulation of the natural autoantibody response
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against BrM RBC. The production of large number*of anti-BrMRBC peritoneal cells 
in BrMRBC-free culture can be subsequently inhibited by the presence of BrMRBC 
in culture (Lord and Dutton 1975). As part of the process of effector cell blockade, 
natural autoantibodies may also act as blocking factors against cytotoxic lymphocytes 
in the serum (Hellstrôm and Hellstrom 1972).
Other mechanisms of tolerance such as suppression or idiotype-anti-idiotype 
regulation (Jeme 1984) may also have a role in the maintainence of self tolerance and 
the regulation of the anti-BrMRBC response in mice. Suppression as originally 
demonstrated by McCullagh (1970) and Gershon and Kondo (1971) may be an 
effective means whereby self tolerance is normally maintained. Cunningham (1975, 
1976) saw the regulation of self-reactive lymphoid cells specific for BrMRBC as a 
balance of continual antigenic stimulation by self antigens held in check by continual 
suppression. In normal CBA mice there was a 20-fold increase in anti-BrMRBC 
plaque forming cells in mice that received anti-lymphocyte serum, a treatment that 
specifically removes suppressor cells (Cunningham 1975). Thus, there is evidence 
that this potential "anti-self" response against a hidden epitope on autologous 
erythrocytes may be held in check by two different mechanisms of self-tolerance 
involving antigen blockade and suppression. Given the importance of recognising 
self antigens and maintaining self tolerance in different lymphoid compartments, 
where T-cells are clonal deleted in the thymus and B-cells appear to be functionally 
silenced (Basten 1989), it is highly likely that different mechanisms can operate 
concurrently.
In general natural autoantibodies and the B lymphocytes from which they arise 
do not fit neatly into theories of self tolerance involving deletion or anergy, but are 
not seen as a challenge to these theories because "natural autoantibodies apparently 
pose no threat to the host, presumably as a result of their low affinity and because 
their polyspecific nature may ensure that they do not bind and concentrate 
preferentially on any particular self-antigen target" (Goodnow 1989).
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Table 1.4. Theories of self tolerance and self recognition
Clonal Deletion Burnet (1959)
Clonal Abortion Burnet (1972) Nossal (1983)
Clonal Anergy Nossal (1983)
Suppression McCullagh (1970)
Gershon and Kondo (1971)
Effector cell blockade Nossal and Schrader (1975)
Blocking factors HeUstrom&Hellstrom (1972)
Antigen Blockade Lord and Dutton (1975)
Network Interactions Jeme (1971,1974,1984)
General references Theofilopoulos (1987) Roitt (1984)
CHAPTER ONE 14
One model of self-recognition as postulated by Jerne (1971, 1974, 1984) 
supports the presence of "autoantibodies" and contends that regulation of the immune 
system is achieved via an idiotypic network.In this scheme, the V region of an 
immunoglobulin or idiotype are immunogenic and may elicit other antibodies 
(anti-idiotypes). The anti-idiotype may in turn elicit another anti-idiotype and so on to 
form an idiotypic network. Evidence to support the importance of idiotypic networks 
in autoimmunity is increasing (Male 1986; Coutinho 1980; Kearney and Vakil 1986; 
Varela and Coutinho 1989; Pereira et al. 1986.). In one study of the role of idiotypic 
interactions amongst natural autoantibodies, Kearney and Vakil (1986) showed that 
idiotype-directed interactions during ontogeny play a major role in the establishment 
of the adult B cell repertoire. Suppression and or the manipulation of idiotypic 
networks may be achieved through injection of anti-idiotypic antibodies into neonate 
or via the maternal route. In agreement with Holmberg (1985) they found 
cross-reactivity amongst their panel of neonatal liver and spleen monoclonal 
antibodies. They state that anti- idiotype activity occurs mainly with lambda light 
chains, and provide evidence for the regulation and appearance of certain families in 
ontogeny. Idiotypic interactions between neonatal B cells appear to have a profound 
effect on the adult B cell repertoire.
In another study (Lundkvist et al. 1989) injected as little as 10 ng of IgM natural 
autoantibodies and showed chaotic perturbatuion of network interactions with each 
individual mouse appeared to have its own characteristic pattern. If anti-idiotypic 
antibodies are administered to newborn and pregnant mice, it has been found that the 
effect is negligible; in normal BALB/c mice, but that there is evidence for idiotypic 
suppression in autoimmune MRL-lpr/lpr mice and specific decreases in anti-DNA 
antibodies (Mahana et al. 1987). Neonatal animals appear to have the capacity to 
respond to self antigens which they cannot make responses to later in development. 
Neonatal mice can respond to syngeneic and xenogeneic actin and have higher 
antibody titres than adult mice of the same strain, but the results cannot be extended to 
other proteins such as myosin or albumin (Mahana et al. 1989). In a similar vein, if 
neonatal mice are injected with either of two different IgMK polyspecific natural 
autoantibodies the effect is that the adult mouse can produce altered amounts of IgG 
specific for myosin (increased) andTNP (decreased) (Mahana et al. 1988).
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There is a considerable amount of activity that occurs in the functioning immune 
systems of normal, and germ-free unmanipulated animals. In studies that examine the 
recruitment of cells into B-cell pools of the mouse (Osmond 1984) and the sheep 
(Reynolds 1987), it has been suggested that a percentage of these cells are recruited 
by internal stimulation. Similarly, in germ-free mice fed on antigen-free diets, normal 
levels of IgM may be maintained, although levels of IgG and IgA are decreased, 
suggesting that the immune system may operate despite the lack of external 
stimulation (Benner 1982). It has been demonstrated that antigenic challenge is 
required for the development of the peripheral lymphoid tissue since lymph nodes 
were not found to be present in antigen-free animals, however, there is considerable 
internal activation in spite of this e.g. normal levels of activated and effector B cells, 
and helper or suppressor T cells (Pereira et al. 1986).
1.2.2. Origins and Significance of Natural Autoantibodies.
It is difficult to discern how natural autoantibodies arise and what their exact 
functional role is in the immune system. Amongst the complexities are: a) that they 
are directed towards self-components; b) are found in normal as well as disease states 
and; c) apparently are of little consequence to the maintainence of self tolerance 
because of the low affinity for self antigens. Do these natural autoantibodies arise as a 
result of some kind of polyclonal activation or as a result of antigen induction or by 
some other process? Are they germ-line encoded or can they arise from somatic 
mutation? If little is certain about how they may arise, their function is less clear. 
Some of the proposed functions of natural autoantibodies have ranged from transport 
molecules to the precursors of pathogenic autoantibodies (Boyden 1965; Grabar 
1975, 1983).
Currently, there is evidence to support two main mechanisms for the appearance 
of autoantibodies, polyclonal activation and antigen induction (Table 1.5), but these 
mechanisms do not fully explain why autoantibodies should occur in normal animals 
unless they were germline encoded and served a vital physiological function such as 
increasing the clearance rate of antibody-antigen complexes by signalling to the 
reticuloendothelial system.
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TABLE 1.5. Comparison of polyclonal activiation and antigen induction.
POLYCLONAL ACTIVATION
1. B cell hyperresponsiveness
2. Poor response to further mitogenic 
stimulation (activation of autoreactive clones)
3. Normal animals mimic autoimmune 
states upon exposure to mitogens
4. B cell abnormalities
5. Germline encoded no real need for 
further somatic hypermutation
or antigen driven selection
(identical in autoimmune and normal animals)
6. Polyclonal activation causes an 
increased percentage of autoantibodies.
ANTIGEN INDUCTION
1. Increase in specific autoantibodies 
compared to the rest of the serum
2. Recognition of specific epitopes
3. Some evidence of somatic mutation 
implies antigen driven selection
Table modified from points raised by Dziarski (1988)
Currently, there is much debate on the role of somatic mutation of germline 
antibody sequences in autoimmunity. Autoantibodies are not thought to be derived 
from genes committed exclusively to autoantibody production as some pathological 
autoantibodies appear to use the same types of V-regions used in responses to 
exogenous antigens (Davidson et al. 1987; Kofler et al. 1987) . Diamond and 
collegues (Diamond and Scharff 1984; Davidson et al. 1986,1987) have 
demonstrated that somatic mutation of germline sequences may result in the types of 
pathological autoantibodies seen in autoimmune diseases i.e. the conversion of an 
anti-bacterial antibody to an anti-DNA antibody. On the contrary, it has been shown 
that germline encoded autoantibodies may ̂ mutate"upon antigenic stimulation to 
recognise foreign antigens (Naparstek 1986). Carroll et al. (1985) have demonstrated 
that bacterial phospholipid and whole bacteria (Streptococcus faecalis, Bacillus 
cereuSy Staphylococcus aureus, and Escherichia co li) were bound by autoantibodies 
derived from MRL-lpr/lpr mice. It had previously been demonstrated that a narrow
CHAPTER ONE 17
range of determinants, including cardiolipin, phosphatidic acid and double-stranded 
DNA, were recognised by unimmunised mice that develop systemic lupus 
erythematosus (Lafer et a l  1981). Phosphatidylserine, phosphatidylcholine and 
phosphatidylethanolamine failed to inhibit these autoantibodies and it was concluded 
that the common antigenic structure in the inhibitory molecules was the presence of 
phosphodiester linkages separated by three carbons. Schwartz (1986) is of the view 
that natural autoantibodies may serve no purpose and arise as the incidental 
by-products of the mechanism responsible for the generation of antibody diversity. 
Dighiero et a l . (1987a) have reviewed data on anti-BrMRBC responses in mice and 
because these antibodies appear quite early in ontogeny and in germ-free mice, there 
is evidence for a germline origin for anti-BrMRBC responses. Somatic mutation of 
anti-BrMRBC antibodies has not been generally demonstrated to occur, although 
IgG 3 has been demonstrated by one group (Bussard et al. 1977). In the CH 12 
lymphoma line that recognises BrMRBC, variants expressing IgA, IgG2^ and IgG3 
in addition to IgM, have been detected implying that some class switching and 
maturation of the response may occur (Arnold et al. 1988). In general though, 
anti-BrMRBC antibodies appear to be germline encoded (Reininger et al. 1987,1988; 
Pennell et al. 1989; Poncet et al. 1989).
The functional significance of natural autoantibodies remains to be conclusively 
demonstrated, although the patterns of cross-reactivity displayed by natural 
autoantibodies suggest that they may play important roles in the functioning of the 
immune system. It has been proposed that natural autoantibodies may function as 
carriers of metabolites or may function as opsonins in promoting phagocytosis of 
damaged cells (Boyden 1965; Grabar 1975,1983). Natural autoantibodies to 
erythrocyte antigens may also be essential for the removal of effete red blood cells 
from circulation (Cox , Baddams and Evans 1977), although this has been difficult to 
demonstrate mainly due to the low percentage of aged red blood cells in circulation 
(Cox and Cunliffe 1979).
It is known that red blood cells only have a limited lifespan (mouse 40-45 days; 
Cox and Cunliffe 1979), but what is not known is the exact mechanism whereby 
these cells are removed. Kay (1980) has shown that erythrophagocytosis of senescent 
RBC by mononuclear phagocytes of the liver and spleen remove* IgG-coated
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autologous RBC rather than some sort of osmotic lysis of old RBC. Most 
phagocytosis takes place in 1-2 hours after IgG attachment to RBC. The IgG that 
recognises RBC can recognise either autologous or allogeneic RBC suggesting that 
the antigenic site may be similar or identical for different individuals. The antigenic 
site may have been blocked by steric hindrance of neighbouring molecules, or 
alteration of "shielding" molecules with age (i.e. loss of subunits or loss of 
membrane fluidity allowing molecular drift) resulting in the exposure of different 
sugar, amino acids or a conformational change in structure.
1.3 NATURE OF B-LYM PHOCYTES AND ANTIBODIES THAT 
RECOGNISE BROMELAIN-TREATED MOUSE RED BLOOD CELLS.
In this section, different types of anti-BrMRBC B-cells and different ways of 
raising anti-BrM antibodies will be reviewed as there appears to be subtle but 
important differences between different populations of anti-mouse erythrocyte 
antibodies raised by different methods from normal and autoimmune strains of mice.
1.3.1. The Peritoneal Cell Phenomenon
Bussard (1966) demonstrated the de novo synthesis of anti-sheep red blood 
cell antibodies during the culture of peritoneal cells from non-immune mice in 
carboxymethyl-cellulose gum. Peritoneal cells (5 x 10^ cells) isolated from 8 week 
old CBA mice were cultured in 2.5.% carboxymethylcellulose containing 5 x 10^ 
sheep erythrocytes per ml and (10% fresh guinea pig semm) for three days at 37°C. 
Haemolytic antibodies were thought to arise de novo by antigenic stimulation. These 
antibody secreting cells were shown to be lymphocytes ( not macrophages) and to 
also be present in cells isolated from the pleural cavity (Bendinelli and Wedderbum 
1967). It was established that the peritoneal cell phenomenon could be demonstrated 
in germ-free mice and that enhancement of the response could be demonstrated in 
mice that had been pregnant (Nossal et al. 1970). Further, cell division was not 
involved in the response (Nossal et al. 1970) and the phenomenon appeared to be 
restricted principally to peritoneal cells (Bussard et al. 1970). This lack of cell
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division was later confirmed by Lord and Dutton (1975a) with a dramatic increase in 
PFC between 2-4 days in culture, so that the high numbers of cells engaged in the 
response do not arise due to enormous proliferation of a few autoreactive B-cells.
The in vitro phenomenon could also be induced in vivo . Thus Bussard and 
colleagues (Bussard et al. 1970; Nossal et al. 1970; Boris et al 1970) found that 
injections of sheep red blood cell could induce specific anti-SRBC lymphocytes but 
that injection of an extract of mouse food had no effect on the plaque formation of 
spleen cells against SRBC. These studies raised questions such as : What is the 
nature of the cross-reacting antigen which primes peritoneal cells against SRBC? 
What features of pregnancy cause the heightening of the phenomenon? Lord and 
Dutton (1975a) showed that the anti-SRBC response displays distinctly different 
kinetics to BrMRBC thus although the cross reactions between BrMRBC and Sheep 
RBC are similar, they are not thought to be identical. In a similar fashion, although 
injection of Rat RBC may elicit anti-BrMRBC the anti-Rat RBC response is not 
identical to anti-BrMRBC responses (section 1.3.3).
Heutz and Poncet (1989) have characterised the cellular populations present in 
the peritoneal cavity by FACS analysis and found that of the 3-7 x 10^ peritoneal 
cells recovered from an adult B ALB/c mouse, 25-30% were myeloid cells and 
65-70% were lymphoid cells. Of the lymphoid cells; 30-40% were Ly-1 B cells, 
45-50% were conventional B-cells and 5-15% were T cells. In the Lord and Dutton 
(1975a) study, they had difficulty in typing the cells responsible for plaques and 
ended up classifying them as large mononuclear cells. Cunningham (1976) also 
commented on these cells and classified them as basophillic mononuclear cells.
It was thought that these natural antibodies specific for sheep red blood cells 
may appear in the peritoneum of mice due to some mechanical irritation of the 
peritoneum or antigenic stimulation with foetal and placental antigens or due to an 
unidentified cross-reacting-environmental antigen (Boris et al. 1970; Bussard et al. 
1970; Nossal et al. 1970). These natural autoantibodies derived from peritoneal cells 
were later shown to recognise antigens revealed on mouse erythrocytes that had been 
pretreated with proteolytic enzymes (Section 1.4). The peritoneal cell phenomenon, 
therefore, appeared to represent a “spontaneous lifting of the natural tolerance
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towards self-antigens" (Bussard and Pages 1976).
In studies on the formation of antibodies produced by peritoneal cells and 
peritoneal cell hybridomas specific for sheep RBC and bromelain-treated mouse 
erythrocytes, a high number of peritoneal cells (up to 10% of PFC both anti-SRBC 
and anti-BrMRBCj with still higher numbers detected in NZB mice or retired breeder 
CB A) produced IgM and IgG3 antibodies that recognised a cross-reactive determinant 
on BrMRBC and SRBC (Bussard et al. 1977; Pages and Bussard 1978). BrMRBC 
ghosts could inhibit peritoneal cells in these assays suggesting that a specific epitope 
was present on the red blood cell membrane.
In the Steele and Cunningham (1978) study, the level of BrM plaque forming 
cells in the peritoneal cell population of CB A/H mice (pooled results from a number 
of studies with 1.5-5 month old male and female mice) in the absence of LPS was 
found to be approximately 15% of Ig-secreting cells, however, the potential 
anti-BrMRBC repertoire in the peritoneal cavity as revealed by LPS was found to 
increase to between 40% (6 week old female) and 95% (retired breeder female). 
Using the data from this study, if the numbers of anti-BrMRBC are reexpressed as 
numbers of anti-BrM per total PFC and numbers of anti-BrMRBC PFC per 
Ig-secreting cells (Table 1.6.) an estimate of the "precursor frequency" may be 
derived. The numbers of peritoneal cells secreting BrMRBC antibodies from the pool 
of male and female mice aged from 1.5-5 months is found to be 1 in 23809 (of total 
PFC) or 1 in 6 (of Ig-secreting PFC) for unstimulated peritoneal cells. Similarly, the 
numbers are found to be : 1 in 166 (of total PFC) or 1 in 3 (of Ig secreting PFC) for 
LPS-stimulated cells in 6 week old mice and ; 1 in 26 cells (of total PFC) and almost 
all of the Ig secreting cells for retired breeder females. Similar "precursor 
frequencies" may be obtained from the Cunningham and Steele (1981) study for cells 
before and after culture in LPS derived from 6-7 week old male mice.
Cox et al. (1984) have estimated the numbers of autoantibody precursors from 
untreated C3H mice by limiting dilution analysis because one criticism of the Steele 
and Cunningham (1978) data would be that spurious results may arise from relatively 
high cell densities of lofywell. In the Cox (1984) study, they could detect one 
autoantibody precursor for every 150-200 peritoneal cells cultured, and this could be
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increased to 1 in 50 in the presence of LPS or dextran sulphate. Thus, in the Steele 
and Cunningham study (1978) there may be an underestimation of the numbers of 
anti-BrMRBC secreting peritoneal cells in unstimulated mice due to the culture 
conditons, whereas the level of antibody precursors after LPS stimulation would 
appear to be in agreement
These limiting dilution analysis studies have been extended (Enington and Cox 
1986) to show that peritoneal cells cultured from mice less than 3 weeks old had few 
or no precursors but that adult levels were attained by 6 weeks of age. There was 
however a difference detected between males and females with females having a 
slightly elevated capacity for autoantibody producing precursors. This study hints that 
other cell populations (non-B, nonadherent) may be required for the anti-BrMRBC 
response. It has also been shown that cytokines may augment the levels of 
autoantibody precursors although it was found that B-cell growth factor may not be 
required since cell division was minimal (Cox et al. 1984). Autoantibody precursors 
may also be increased by irradiation, presumably because radiosensitive suppressor 
T cells are removed (Errington and Cox 1987). Accessory cells such as macrophages 
and cytokines may be essential for autoantibody production by peritoneal cells in vivo 
as they have been shown to be important in in vitro assays (Cox et al. 1984; Daenke 
and Cox 1986; Kawaguchi 1986).
In a study on the number of splenic precursors specific for either BrMRBC or 
sheep RBC in normal mice (Portnoi et al. 1986), it was found that most of the 
autoreactive clonal precursor B cells are more frequently found in large rather than 
small spleen cells, with the absolute frequencies of anti-BrMRBC for large and small 
cells stated as 1 in 150 and 1 in 1400 respectively as compared to the anti-sheep 
response of 1 in 33 (Large) and 1 in 230 (Small). For LPS stimulated mice, the anti 
BRMRBC response was 1 in 10 (Large) and 1 in 18 (Small) and the anti-SRBC 
response 1 in 30 (Large) and 1 in 15 (Small). In the Steele and Cunningham study 
(1978), it may be seen that the splenic levels are 1 in 11494 (anti-BrMRBC PFC per 
total cultured cells) or 1 in 66 (anti-BrM PFC per Ig-secreting cell) for unstimulated 
spleen cells or between 1 in 2000 (anti-BrMRBC PFC per total cultured cells) or 1 in 
130 (anti-BrM PFC per Ig-secreting cell) in 6 week old mice to 1 in 490
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Table 1.6. Re-evaluation of the levels of BrM plaque forming cells and determination of precusor frequencies 
from data presented by Steele and Cunningham (1978) and Cunningham and Steele (1981).
1. Unstimulated Mice - Pooled data from 1.5-5 months old male & female CBA/H 
Data from T^ble 1 (Steele and Cunningham 1978)
PFC per 10° cells Reexpressed data to determine"precursor frequency". 
Ig BrM %BrM BrM/PFC BrM/Ig
Peritoneal cells 250 42 15 42/10° = 1 in 23810 42/250 = 1 in 6
Spleen cells 5700 87 1.6 87/106 = 1 in 11494 87/5700 = 1 in 65
2. Cells cultured in presence of 10|ig LPS from female CBA mice of different ages
Data from Table 2 (Steele and Cunningham 1978)
PFC per 10° <:ells Reexpressed data
Ig BrM %BrM BrM/PFC BrM/Ig
a) 6 week old
Peritoneal cells 15000 6000 40 6000/106 = 1 in 166 6000/15000 = 1 in 2.5
Spleen cells 65000 500 0.8 500/106 = 1 in 2000 500/65000 = 1 in 130
b) 1 lweek old
Peritoneal cells 21000 15900 75.4 15900/106 = 1 in 63 15900/21000 = 1 in 1.3
Spleen cells 36900 580 1.6 580/106 = 1 in 1724 580/36900 = 1 in 63.6
c) 14 week old
Peritoneal cells 28200 24400 86.5 24400/106 = 1 in 41 24400/28200 = 1 in 1.2
Pleural cells 25600 1600 66.4 1600/106 = 1 in 625 1600/25600 = 1 in 16
d) Retired breeder female
Peritoneal cells 39140 37060 94.7 37060/106 = 1 in 27 37060/39140 = 1 in 1
Spleen cells 105600 2040 1.9 2040/106 = 1 in 490 2040/105600 = 1 in 52
3. Cells before and after culture in presence of 50p.g LPS from 
Data from Table 1 (Cunningham and Steele 1981) 
PFC per organ 
Ig BrM
6-7 week old CBA mice
Reexpressed data 
BrM/Ig
a)Day 0 results 
Peritoneal cells
uncultured 70 120 1 in 1
cultured 20000 19000 1 in 1
Spleen cells 220000 2900 l in  75
b) Day 3 culture 
Peritoneal cells
uncultured 2500 1800 1 in 1.3
cultured 9200 2900 1 in 3
Spleen cells 1100000 17400 1 in 63
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(anti-BrMRBC PFC per total cultured cells) or 1 in 52 (anti-BrM PFC per 
Ig-secreting cell) in retired breeder females in cultures containing LPS. Different mice 
also have different capabilities to respond to BrMRBC, with high responders 
{CBA/J, NZB, Biozzi (H), C3H, BXSB and C57BL/6} and low responders 
{BALB/c, DBA2 , SJL/J, CBA/N and Biozzi (L) mice} (Kaushik et al. 1986). The 
major point of these studies on the levels of anti-BrMRBC lymphocytes found in 
different immune compartments of mice of different ages and sex is that a large 
proportion of the immune system appears to be capable of responding to BrMRBC.
1.3.2. Lipopolysaccharide Stimulated Serum.
The actions of lipopolysaccharide isolated from the cell wall of many strains of 
bacteria on the immune system are numerous. In a recent review (Jacobs 1982), LPS 
acts as a T-independent antigen, B-cell mitogen and polyclonal B-cell activator and 
immunological adjuvant. The Lipid A portion of LPS is thought to account for most 
of its biological action. In normal mice, Cunningham (1974a) found that the spleen 
contained large numbers of plaque forming cells specific for components revealed on 
autologous erythrocytes that had been treated with bromelain. The level of plaques 
was elevated two to three days after injections with 50 jig lipopolysaccharide from 
Escherichia coli, whereas injections of the following did not increase PFC; injection 
of allogeneic red blood cells or spleen cells, injection of isologous erythrocytes in 
CFA, or a single injection of 10^ rat RBC (Cunningham 1974a) or injections of 
bromelain-treated mouse erythrocytes (Cunningham 1975). Levels of anti-BrMRBC 
were increased two to four days after injection of anti-lymphocyte serum 
(Cunningham 1975), thus it would appear that self tolerance may be a balance 
between continual antigenic stimulation and suppression because anti-lymphocyte 
serum was thought to remove suppressor cells. Further, Cunningham (1976) 
established that similar levels of anti-BrMRBC autoantibodies could be found in germ 
free mice, "specific pathogen free mice" and conventionally reared inbred mice.
Peritoneal cells from unimmunized mice where shown to produce in vitro, 
antibodies that recognised both sheep red blood cells and bromelain-modified mouse 
erythrocytes (Pages and Bussard 1975; Bussard and Pages 1976: Bussard, Vinit and
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Pages 1977), thus providing a link between the peritoneal cell phenomenon and the 
BrMRBC model of autoreactivity as demonstrated by Cunningham in the spleen. It 
appeared that some form of derepression occurred during in vitro culture of B-cells 
from  non-im m unized mice (Pages and Bussard 1975), thus releasing 
autoantibody-producing lymphocytes that were normally suppressed in vivo.
There have been a number of studies with LPS-stimulated cells that demonstrate 
a capacity of the immune system to react with autologous cells and proteins. 
Hammerstrom et al. (1976) used LPS to induce autoantibodies from cultured bovine 
spleen cells that could recognize untreated autologous red blood cells and Primi et a l  
(1977) also demonstrated that LPS-activated mouse B cells are capable of specifically 
recognising autologous spleen cells and autologous serum proteins. Ragimbeau and
■ fTrOtvx
Avrameas (1987) found natural autoantibodyA hybridomas prepared from 
LPS-stimulated mice specifically bound to DNA, TNP and cytoskeletal proteins (actin 
and tubulin). Single B cells producing these natural autoantibodies are polyspecific in 
that they react with more than a single autoantigen (20% of TNP reactive clones also 
react with actin, 14% with tubulin and 12% react with both actin and tubulin).
The age and sex of mice (Meredith, Kristie and Walford 1979; Errington and 
Cox 1986) also appears to have a significant influence on the levels of natural 
autoantibodies to erythrocyte antigens. Meredith and collegues (Meredith et al. 1979) 
have shown that 24 month old mice have 3-4 times the number of LPS plaque 
forming cells to autologous erythrocytes than 6 month old mice, but that the level of 
autoreactive cells in young mice approach* that of the old mice with the use of low 
doses of cyclophosphamide to selectively deplete suppressor cells.
1.3.3. Anti-rat Red Blood Cell Serum
Playfair and Marshall-Clarke (1973) were the first to demonstrate a loss of 
tolerance to autologous red blood cells in mice that had recieved repeated injections of 
rat RBC. The antigen was required continually (weekly intervals) for the mice to 
remain direct Coomb’s positive and anaemic (Cox and Keast 1973) and the type of
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anaemia induced was similar to the "warm-type" autoimmune haemolytic anaemia of 
humans (Cox and Keast 1974a; Cox and Howies 1981).
In a recent review on human autoimmune haemolytic anaemias (Gibson 1988) 
the main targets in warm-type autoimmune haemolytic anaemia are the blood group 
antigen systems Rh and hi, but these have not been directly demonstrated as targets in 
the mouse. There is, however, evidence for a cross reacting antigen on rat RBC able 
to break tolerance in the mouse that required whole rat RBC. The anti-MRBC 
response could not be induced with rat erythrocyte ghosts , heart, muscle, teste, brain 
or foetal material (Keast and Calegro 1977). Haemolytic anaemia induced by injection 
of rat RBC produces an anaemia in normal strains of mice which is self limiting 
(Cooke et al 1978).They found suppressive activity in cell transfer experiments in a 
population of cells derived from the spleen that had been B-cell depleted. Mice that 
have been treated with cyclosporin A do not develop anaemia associated with 
injections of Rat RBC and thi s shows unequivocally that T cells are involved in the 
response to rat RBC (Cox et al. 1983). Memory B cells as well as suppressor T cells 
have also been implicated in the regulation of the anaemia induced in mice to 
autologous RBC (Watt et al. 1986)
Different patterns of anti-Rat RBC and anti-Mouse RBC antibodies may be 
elicited with different immunisation protocols (Walker et al. 1987). In a protocol 
designed to promote T supressor cells (3x weekly injections of Rat RBC, 2 months 
rest,then 2x weekly injections of rat RBC) about 87% of the anti-Rat RBC 
monoclonal antibodies react with Rat RBC exclusively with 12% cross-reactive for 
mouse RBC, but in a protocol designed to promote T helper cells (5x weekly 
injections of Rat RBC) 96% of the anti-Rat RBC monoclonal antibodies are 
cross-reactive with only about 4% specifically anti-Rat RBC.
Recent studies have demonstrated that sialoglycophorins are recognised by 
mouse anti-rat RBC serum and hybridomas on Western blots (Laing et al. 1987,1988) 
They show that the major differences between rat and mouse RBC membranes 
resides in the sialoglycophorins.They have assumed that the antigen revealed on 
mouse and rat RBC is the same and that it is only present on the membrane and have 
demonstrated that mouse anti-Rat RBC serum and monoclonal antibodies recognise
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two major rat RBC glycoprotein bands at 81kD and 38kD, with a number of minor 
bands at 56kD, 31kD, 29kD and 23kD. These antibodies do not recognise mouse 
erythrocyte membranes, but this is not so surprising as the membrane profiles that 
they show for mouse and rat ghosts are different (i.e. mouse is missing many of the 
molecular weight bands below 45kD; Laing et al. 1987 Figure 6). Four of the six 
monoclonal antibodies specific for RRBC failed to react with rat membrane antigens 
(Laing et al. 1988) i.e. they may have recognised some component that had been 
removed during ghost preparation or alternatively epitopes that had been altered or 
destroyed during membrane preparation or western blotting. The other two 
monoclonal antibodies had reactivity resembling that of mouse anti rat RBC 
described in Laing et al. (1987) against the 38 and 81kD autoantigens. The minor 
bands were not characterised, however this group argued that because the two major 
bands were glycophorins, the minor bands must also be glycophorins. The reactivity 
of mouse anti-rat RBC serum or specific mouse anti-ratRBC hybridomas have not 
been assessed against phosphatidylcholine, nor have the V-regions that are used by 
these antibodies been characterised, so it is difficult to determine if antibodies used in 
the anti-Rat RBC and anti-BrM responses are identical.
1.3.4. L y-1+ B-cells
Ly-1+ B cells are a unique subpopulation of lymphocytes from which natural 
autoantibodies are thought to arise. They differ from conventional B cell populations 
in the surface markers expressed, the types of antigens recognised, the high levels 
expressed in the peritoneal cavity and the pathway of B cell differentiation followed 
(reviewed in Herzenberg et al. 1986; Stall et al. 1986; Kocks and Rajewsky 1989; 
Hayakawa and Hardy 1988). Hayakawa and colleagues (1983,1984,1985,1986) 
have shown that a subpopulation of B-cells delineated by the Ly-1 surface marker is 
present at high frequencies in NZB mice and is responsible for the high amounts of 
anti-erythrocyte autoantibodies produced. The Ly-1+ B-cell marker, which appears 
early in ontogeny, is also present in normal strains of mice and athymic mice 
(Hayakawa etal. 1983,1986a, 1986b; Hayakawa and Hardy 1988) but is absent from 
the immunodeficient xid  strains of mice (Stall et al. 1986). Ly-1+ B cells are 
characterised by FACS as being high IgM, low-intermediate IgD and they
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spontaneously secrete IgM in vitro in the absence of mitogens or antigens (Hayakawa 
et al. 1983). Injection of Sheep RBC does not increase the level of Ly-1+ B-cells 
(Hayakawa et al. 1983). Of the peritoneal B cell population, Ly-1+ B cells comprise 
30-60% whereas the level expressed in the spleen is about 2% (Hayakawa et al. 
1985,1986a, 1986b, Hayakawa and Hardy 1988 ). In humans, there is an equivalent 
type of B-cell known as Leu-1 or more correctly CD 5 B cells and these too form a 
major percentage of the B cells in humans that appear early in ontogeny, especially in 
foetal spleen and cord blood (reviewed by Kipps, 1989). Leu-1+ B cells secrete 
rheumatoid factor after stimulation with Staphylococcus aureus (Hardy et a l  1987) 
and antibodies to single-stranded DNA and rheumatoid factor after stimulation with 
Epstein-Barr virus (Casali et al. 1987).
Ly-1+ B cells from normal mice are responsible for most of the anti-BrMRBC 
response, whereas Ly-1*B cells from NZB mice also recognise DNA and thymocyte 
cell surface antigens, but have only minimal resonses to sheep RBC, 
2,4,6-trinitrophenyl-KLH and TNP-Ficoll (Hayakawa et al. 1984). The peritoneal 
cavity is an interesting lymphoid compartment because there is no identified organ 
that gives rise to Ly-1+ B cells, and it has been suggested that these cells may be 
"free-living" in the peritoneal cavity (Hayakawa et al. 1985).
Various organs have beji assessed for their ability to reconstitute the Ly-1 B cell 
lineage in lethally irradiated mice (Hayakawa et al. 1985). Adult allotype-congenic 
bone marrow and spleen are unable to reconstitue any Ly-1+ B lymphocytes, 
whereas adult peritoneal cells alone may reconstitute Ly-1 B cell populations. If 
however, adult peritoneal and bone marrow cells are transfered all B cell populations 
are restored. In contrast, bone marrow, spleen and liver from young mice are capable 
of restoring the Ly-1+ B cell population. Subsequently, it has been demonstrated that 
for reconstitution to occur, the Ly-1+ B cell populations must express surface IgM 
(Hayakawa et al. 1986b).
It has also been shown that many of the IgA secreting Ly-1+ B cells present in 
the lamina propria of murine gut are derived from Ly-1+ B cells in the peritoneal 
cavity (Kroese et al. 1989). IgM-, IgG- and IgA-secreting Ly-1+ B cells in lymphoid 
tissue and gut of lethally irradiated mice were derived from donor peritoneal B cells.
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About 50% of the IgA secreting B-cells found in the lamina propria are Ly-1+, with 
only a small proportion (estimated at less than 1%) of peritoneal cells capable of IgA 
secretion.
The similarity between Ly-1+ B-cells and those B-cells producing natural 
anti-erythrocyte autoantibodies is supported by the fact that both recognise BrMRBC 
(Hayakawa et al. 1984,1986a,1986b) and phosphatidylcholine (Mercolino et al. 
1986). Some Ly-1+ B cells have also been shown to bind to bacterial polysaccharides 
and haptens such as TNP-BSA, phosphorylcholine-BSA, BSA, dextran, type 3 
pneumococcal polysaccharide and BrMRBC but the majorityAthe interactions were of 
low affinty and multireactive (Lalor and Morahan 1990). In limiting dilution assays, 
there was a high ffequencey of Ly-1+ peritoneal B cells reactive with TNP-BSA (1 in 
8), phosphorylcholine-BSA (1 in 10) and BrMRBC (1 in 17). For germ-free mice, 
these figures were TNP-BSA (1 in 7), phosphorylcholine-BSA (1 in 3) and 
BrMRBC (1 in 5). Lalor and Morahan (1990) have shown that anti-BRMRBC 
antibody producing B cells are present in conventional spleen and bone marrow, but 
at a reduced level (1 in 1700 spleen, 1 in 630 for Ly-1" spleen cells and 1 in 740 for 
virgin B cells derived from bone marrow).
In recent studies, a minor splenic subpopulation of CD5-negative B cells (i.e. 
similar characteristics to CD5 B cells but lack expression of CD5 molecule) from BW 
and CBA mice has been shown by FACS analysis to produce anti-BrMRBC 
antibodies (Andrew et al. 1990) and it has been demonstrated that Ly-1" cells may 
arise from the same precursors that give rise to Ly-1+ cells (Palacios et al. 1989) so 
there may be subtle differences between different populations of anti-BrMRBC B 
lymphocytes that are still to be resolved.
While Ly-1+ B cells only form a minor part of the adult B cell population they 
are prevalent early in development and may be responsible for nearly half of the 
serum IgM (Forster and Rajewsky 1987). Donor peritoneal cells survived the transfer 
into allotype-congenic newborn recipients whereas donor bone marrow cells did not. 
At 20 weeks, donor-derived Ly-1"*" B-cells were found at a level of 2% in the spleen, 
suggesting some type of migration from the peritoneal cavity to the spleen and there is 
an increase in the number of donor cells after 20 weeks to 15 times greater than the
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level injected. It would appear that this lineage may be important in the establishment 
of the repertoire during ontogeny.
The importance of subtle changes to the Ly-1+ B cell population in the neonate 
and the subsequent effects on adult repertoires has been examined in companion 
studies (Lalor et al. 1989a, 1989b). In the first study (Lalor et al. 1989a), 
anti-allotype IgM antibodies have been used to selectively deplete the paternal allotype 
of conventional and Ly-1 B cell lineages (i.e. half the population) in allotype 
heterozygote mice. The conventional B cell lineage gradually replenishes itself , 
however, the Ly-1 lineage (Ly-1+ and its sister population) will not replenish itself 
once the long-lived precursor cells are depleted. They also report that the level of 
nucleated erythrocye precursor cells is elevated in treated mice (up to 50% from the 
5%-10% normally found in control mice), however as they did not assess other 
haematological parameters it is difficult to assess the significance of their observation 
in relation to erythropoietic activity or haemolytic anaemia. In contrast, in the second 
study (Lalor et al. 1989b), if allotype homozygous animals are used, all Ly-1 B cells 
are depleted, but reappear after the treatment antibody disappears. This study shows 
that there may be a feedback loop operating during development, because addition of 
mature Ly-1 B cells appears to block the development of immature precursors.
In addition to these subtle changes that occur to Ly-1+B cells in the internal 
mileu, Ogura (1989) has shown that Ly-1+ Bcells may also be sensitive to external 
factors. In several strains of autoimmune-disease prone mice there was a reduction in 
the numbers of Ly-1+ B cells when these animals were maintained on a chronic 
energy-intake restriction diet (high carbohydrate, low fat). The nature of the 
inhibitory factors elicited by dietary manipulation was not specificed.
Ly-1+ B cells also display a remarkable ability to withstand long periods of in 
vitro culture (Braun et al. 1986; Citri et al. 1987). Spleen cultures were permitted to 
establish growth over an extended period (up to three years culture) and after an initial 
"crisis period" they gave rise to an immortal Ly-1+ B cell line. It has subsequently 
been shown that an elevated level of c-myc oncogene expression occurs in these cell 
lines (Citri et al. 1987) signifying an elevated potential for lymphoid neoplasia.
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It had been previously established that B cell lymphomas could be induced in 
mice by hyperimmunisation with sheep erythrocytes (Lanier et al. 1978), but these 
CH series of lymphomas have been subsequently been found to bear the Ly-1 B cell 
marker (Lanier et al 1981).The CH series of lymphomas bind specifically to 
BrMRBC, Sheep RBC and Escherichia coli (Pennell et al. 1985; Haughton et al 
1986) or phosphorylcholine (Mercolino 1986,1988). Recent studies on the V regions 
of these cell lines are reviewed in section 1.3.6..
In recent work Haughton and coworkers (Mercolino et al. 1986, 1988,1989) 
have em ployed liposomal probes of diasterolphosphatidyl choline or 
diasterolphosphatidyl glycerol impregnated with fluorocein conjugates to allow 
detection and isolation of BrMRBC specific peritoneal B cells using the fluorescence 
activated cell sorter. In one study (Mercolino et al. 1986) it was demonstrated that 
most of phosphatidylcholine-binding B cells could be classed as belonging to the 
Ly-1+ B cell lineage and that six CH lymphomas (CH12, CH27, CH28, CH32, 
CH34 and CH35) that specifically bound to both SRBC and BRMRBC also bound to 
phosphatidylcholine-containing liposomes. Two other anti-BRM specific CH 
lymphomas (CH9 and CH I5) examined did not show binding to either SRBC or 
liposomes.Originally, these cells were derived from the CH series of murine 
lymphomas (Lanier et a l . 1978, 1981; Pennell 1985). In studies on the ontogeny of 
cells that bind to PC-liposomes, none were found in 1 or 4 day liver or speen, while 
at day 12 there is approx 4 xlO^ and adult levels are attained by 3 weeks (Mercolino 
et a l . 1988).
1.3.5. Antibodies and hybridomas from unstimulated animals
Various groups have demonstrated in normal unimmunised animals the 
occurrence of natural antibodies that bind to other natural antibodies (Holmberg et al. 
1984a, 1984b, 1986; Lymberi et al. 1985) or to cytoskeletal proteins such as tubulin 
(Karsenti et al. 1977) or actin, tubulin, myosin (reviewed in Dighiero et al. 1987a) or 
intracellular components of mouse fibroblasts (Underwood et al. 1985) or 
nuclear-reactive autoantibodies (Rizzatti and Underwood, 1990).
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Holmberg and colleages (1984a, 1984b) found specific binding between the 
variable regions of 2 monoclonal IgM antibodies from the same mouse (untreated 6 
day old BALB/c mice) as well as a number of positive low affinity binding reactions 
against constant regions when nine monoclonal autoantibodies were tested against a 
panel of 70 neonatal autoantibodies. This "connectivity" could not, however be 
demonstrated amongst adult mitogen-reactive antibody repertoires (Holmberg et al. 
1986).
Natural antibodies have been demonstrated to bind to a number of cytoskeletal 
proteins in a number of studies. Dighiero and collegues (1982,1983,1985,1988) have 
demonstrated specific binding against actin, tubulin, myosin, TNP-BSA, 
double-stranded DNA and single-stranded DNA in a collection of hybridomas 
produced in 6 day old (CBA/N x BALB/c)Fl mice. In another study (Underwood et 
al. 1985), hybridomas were produced from normal BALB/c, nude BALB/c, 
germ-free BALB/c and 8-day old BALB/c with between 4-17% of the hybridomas 
(depending on the type of mouse) recognising intracellular components of mouse 
fibroblast and mouse 3T3 cells that had been acetone-fixed, with none of these 
antibodies recognising cell surface antigens of 3T3 cells, fibroblasts, RBC or 
thymocytes. One monoclonal (out of 1020) from an 8 day old BALB/c reacted with a 
cell surface antigen on syngeneic thymocytes. The majority of the autoreactive clones 
were IgM secretors (43 out of 45 stable hybridoma lines). There is a wide range of 
antigens recognised by this collection of hybridomas such as thyroglobulin, 
p-galactosidase, cardiolipin, phosphatidylethanolamine, diptheria toxin, tetanus 
toxin, DNP-ovalbumin, fluorescein-ovalbumin, cytochrome-c, myoglobin and 
carbonic anhydrase (Rizzatti and Underwood 1990).
In other studies aimed at determining the extent of the antibody repertoire in 
germ-free BALB/c mice (Bos et al. 1987) young suckling mice were allowed 
mother's milk until about 15-18 days old and then fed a chemically defined 
ultrafiltered diet to limit dietary antigens. They concluded that the specificity of the 
splenic IgM repertoire is independent of exogenous antigenic or mitogenic 
stimulation, but that environmental stimulation found amongst conventionally reared 
BALB/c can enhance the level and rate of development of background IgG and 
IgA. In the germ-free mice, the levels of IgA were lower and they did not catch up to
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adult levels by 70 days after birth. Others have demonstrated a high level of natural 
lymphocyte activation in the spleen lymphoid population (10-20% of lymphoid 
population B and T cells) during the postnatal development of germ-free and 
conventional specific pathogen-free BALB/c mice (Fomi et al. 1988). They suggest 
that a second wave of activated B cells appear at 6 weeks in specific pathogen-free 
mice due to polyclonal activation via bacterial products.
Hybridomas produced from the peritoneal cells of unimmunised mice have been 
found to bind to BrMRBC. Anti-BrMRBC peritoneal cell hybridomas produced from 
NZB mice have been found to recognise RBC from a number of different species 
(Pages and Amaud 1980; Poncet et al. 1985) or trimethylammonium compounds 
(Serban et al. 1981; Pages et al 1982; Poncet et al. 1985) while hybridomas from 
normal mice bind to cholesterol particles coated with phosphatidylcholine 
(Kawaguchi 1987b). Peritoneal cell hybridomas derived from NZB and 
LPS-stimulated BALB/c mice have been shown to secrete antibodies to BrMRBC but 
not to either DNA or cytoskeletal proteins, in contrast to splenic hybridomas that 
secrete polyspecific antibodies that bind to DNA, cytoskeletal proteins (Kaushik et 
al. 1988).
1.3.6. Y-genes and V-regions of natural autoantibodies.
Natural monoclonal anti-BrMRBC autoantibodies prepared from NZB and CBA 
mice have similar V-region structures as determined by amino acid sequencing 
(Poncet et al. 1985) and there is evidence to suggest that natural autoantibodies from a 
number of strains of inbred mice may be structurally related (Kaushik, et al. 1986). 
Serban and Witz (1988) also found that anti-BrMRBC antibodies share a common 
idiotype. Other evidence for the high homology displayed by anti-BrMRBC 
antibodies derived from peritoneal B cell populations comes from studies directed 
towards defining the genes encoding the V region (Reininger et al. 
1987,1988,1990a,1990b; Pennell et al. 1988,1989; Poncet et al. 1989,1990). 
However, splenic populations of anti-BrMRBC appear to be able to use different Vpj 
genes in addition to Vpj 11 (Conger et al. 1989; Hardy et al. 1989, Poncet et al. 
1990; Kaushik et al. 1990).
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It has been shown that diversity in VH regions of peritoneal cell anti-BrMRBC 
antibodies is limited or restricted and they appear to comprise a new family , 
VH 11 (Reininger et al. 1987,1988). Similarly, VL appear to preferentially use VK9 
(Reininger et al. 1987). VH 11 expression did not occur in NZB, BALB/c or 
(CBA/N x BALB/c)Fl splenic hybridomas from new bom mice, and yet they were 
found in peritoneal cell hybridomas that expressed anti-BrMRBC antibodies (Poncet 
et al. 1989). In NZB mice three Vjj  gene families (J558, J606 and 3609) and five 
VK groups (8, 9, 19, 21 and 28) were found to encode anti-BrMRBC antibodies 
(Reininger et al. 1990). In studies with Ly-1+ B cells derived from CH lymphomas 
(Pennell et a l . 1988,1989), it has been found that only two heavy chain and k  chain 
V-region gene combinations were used suggesting that they are germline encoded. 
The CH27 lymphoma studied here appeaifto belong to another other unique Vjj 
group, whereas others belong to Vjj  11 . The Vj^ region also appears to be highly 
conserved with and VK9 used by anti-BrMRBC antibodies. They suggest clonal 
selection by antigen as a mechanism for the large number of highly homologous V 
regions encoded by these antibodies and suggest that the selecting antigen " is either 
endogenous or ubiquitous in the environment".
It has been confirmed that natural antibodies from peritoneal B cells use the 
common Vjj  region sequence (V 11) and a single common L chain VK 9 (VK BrM) 
but diversity has been demonstrated in LPS-stimulated splenic B-cells with four Vjq 
families utilised (Conger et al. 1989) . In the LPS-stimulated splenic population it 
was found that one anti-BrM antibody did not bind to trimethylammonium, while 4 
anti - (BrMRBC+SRBC) antibodies also reacted with trimethylammonium, and 8 
clones reacted with trimethylammonium and BRMRBC, but not SRBC. These 
results were supported by a study in which anti-BrMRBC antibodies originating in 
the spleen were examined (Hardy et al. 1989). Most antibodies examined were from 
the Vj_j 11 family, while one hybridoma derived from an Ly “ B cell used S107Vjj 
and another two anti-BrMRBC antibodies using the Vjq gene described by Pennell 
that are used by the CH27 lymphoma (Pennell et al. 1988). Diversity was also noted 
in the V K groups used by anti-BrMRBC antibodies derived from Xid mice, with 
predominant pairing of Vjj  11 and VK 9, and the occasional involvement of VK 1,10 
and 19 (Kaushik et a l . 1990).
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Evidence to suggest an endogenous origin of antigen stimulation is suggested in 
studies with adult germ-free mice raised on a chemically defined diet in antigen-free 
conditions that established an adult pattern of J558 usage (Bos and Meeuwsen,1989). 
These germ free adults retained the preferential u fo f  PC7183 however, and when the 
antigen binding specificities of hybridomas from LPS-stimulated splenic B cells from 
adult germ-free BALB/c mice were compared to hybridomas derived from 5-day old 
conventional BALB/c mice, neonatal mice had a large proportion of multireactive B 
cells that recognized "autoantigens" (rat stomach,liver and kidney, acetylcholine 
receptor from Torpedo California and mouse antiidiotypic antibodies) and bacterial 
antigens. Similar patterns of reactivity were seen with adult antigen-deprived mice 
(Bos etal. 1989).
Recent studies with murine rheumatoid factors (Shlomchik et al. 1986) and 
natural autoantibodies to DNA (Naparstek et al. 1986) suggest that the V-regions 
encoding these natural autoantibodies also belong to structurally-related families and 
that there are a limited number of germline V region sequences encoding the 
specificities.
1 .4 .  BR O M ELA IN -TR EA TED  M OUSE RED BLOOD CELLS-
CHARACTERISATION OF A " HIDDEN” AUTO ANTIGEN.
The exact nature of the in vivo epitopes involved with BrMRBC are not known 
with certainty. There is strong evidence that phosphatidylcholine forms part of this 
epitope, but phosphatidylcholine alone as the BrM antigen cannot account for all of 
the characteristics described for this epitope, such as the occurence, regulation, organ 
distribution and possible functional significance. In this section, the regulation of 
anti-BrMRBC responses will be examined briefly, followed by a comprehensive 
examination of studies directed towards elucidating the BrMRBC antigen.
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1.4.1. Regulation of the anti-BrM RBC response.
Regulation of the anti-BrMRBC response has been suggested to involve a 
number of different mechanisms, viz., involving suppressor T cells, regulation by the 
BrMRBC antigen itself and anti-idiotypic interactions. "Self’-tolerance or regulation 
in the BrMRBC system could be most readily explained by an active suppression 
mechanism (Cunningham 1975,1976) rather than the alternative explanation of the 
appearance of forbidden auto-reactive clones (Burnet 1959). There is growing 
support for some type of immunoregulatory processes regulating the response to 
autologous antigens rather than clonal deletion, especially as specific non-immune T 
cells have been demonstrated to recognise autologous erythrocytes (Hooper 1987; 
Hooper and Taylor 1987). There is also a progressive loss of functioning suppressor 
T cells in aged NZB mice, which suggests that a breakdown in active suppression 
due to factors associated with aging is partly responsible for the appearance of 
autoantibodies to mouse erythrocytes (Moore and Calkins 1985; Miller and Calkins 
1988). T-cell involvement in the control of autoantibody production in the BrMRBC 
model was shown by Ramshaw and Eidinger (1977) when they demonstrated 
delayed hypersensitivity to BrMRBC . In contrast to this, Cox, Baddams and Evans 
(1977) established that there was no delayed hypersensitivity to BrMRBC, although 
there was to BrSheepRBC and Sheep RBC, and no increase in the level of natural 
autoantibodies when mice received injections of BrMRBC, although the protocols of 
these experiments were different.
There appears to be a dichotomy of T cell dependence by peritoneal and spleen 
cell-derived anti-BrMRBC producing cells (Huetz et al. 1988,1989). The peritoneal B 
cell population was found to be T-cell independent, but there is evidence for 
regulation of the splenic population by T cells. It was shown that 1 in 360 anti-BrM 
precursors could be found in the spleen of BALB/c mice, but virtually none (1 in 
9086) in the nude counterpart. However, in nude mice reconstitued with T cells the 
level of detectable precursors approaches that found in BALB/c (1 in 812), 
suggesting a T-cell dependence on the generation and activation of anti-BrM B cells in 
the spleen.
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Lord and Dutton (1975b) also demonstrated that the antibody production by 
mouse peritoneal cells in culture could be inhibited by co-culture with 
bromelain-treated mouse erythrocytes, so that in addition to T-cell control of 
autoantibody production, other mechanisms involving direct blocking of self-reactive 
lymphocytes by antigen may be operative.As little as 2 to 5x 10^ BrMRBC per 
culture caused 98% suppression of anti-BrMRBC response when compared to 
control cultures. The same level of NMRBC had no suppressive effect, but the 
BrMRBC had to be present at the beginnning of the culture for the suppressive effect 
to occur. Recently,a monoclonal autoantibody specific for mouse RBC was derived 
from an aged NZB mouse and found to be capable of inducing autoimmune 
haemolytic disease in BALB/c mice (Caufield et al. 1989). This antibody could be 
inhibited by mouse red blood cell sonicates used by these authors, however, although 
this demonstrates suppression of an "anti-self’ response by antigen, this does not 
really distinguish whether the antigenic substance occurred at the cell surface or if it is 
a cytoplasmic antigen.
The regulation or inhibition of natural autoantibody responses to mouse 
erythrocytes involves both T-cells and BrMRBC antigens. In one study (Cox et al. 
1979), the number of BrM-specific plaque forming cells was found to increase if 
RBC were lysed with ammmonium chloride before culture, and significantly decrease 
if co-cultutred with NMRBC or BrMRBC. An increase was also noted if cultures of 
peritoneal cells were pre-treated with complement and anti-0, suggesting that T-cells 
are crucial to regulation of the response. In addition, Wieties and Moticka (1986) 
have shown that autoantibody secretion may be partially controlled by anti-idiotypic 
regulation, and there is suggestive evidence that a non-complement fixing IgM may 
be involved with the regulation of the autoantibody response (Jablonska 1977).
Regulation of the anti-BrMRBC response may be complicated because there is 
evidence from studies with germ free-mice that the anti-BrMRBC response may arise 
from endogenous stimulation rather than some kind of external stimulation . 
Germ-free BALB/c spleens contained 1400 PFC per 108 nucleated cells against 
bromelain-treated mouse RBC, whereas even nude mice (nu/nu) had an average of 
560 PFC per 108 nucleated cells (Cunningham 1974a). Forty eight hours after a 50
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p.g i.p. injection of LPS, CBA mice had 206,000 anti-BrMRBC PFC per 10^ 
nucleated cells, when compared to 5,320 PFC found in unstimulated CBA mice. PFC 
capacity against BrMRBC occurs in strains of germ free, specific pathogen free and 
nude mice, indicating perhaps the thymus independence of this response 
(Cunningham (1976) although regulation may be achieved by different mechanisms 
given the capacity for antigen to inhibit peritoneal cells directly (Lord and Dutton 
1975b).
1 .4 .2 .C haracterisation of the hidden autoantigen on autologous
erythrocytes.
In the search for the identity of the BrMRBC epitope, cross-reactions have been 
demonstrated against erythrocytes from different species (Pages and Bussard 1975; 
Pages and Arnaud 1980 ), isologous mouse IgG (Fc) (Cunliffe and Cox 1980), 
trimethylammonium compounds (especially phosphatidylcholine) and lipids (Serban 
et al. 1981; Poncet et al. 1985; Cox and Hardy 1985; Mercolino et al. 1986, 
1988,1989 ; Kawaguchi et a l  1987b,1988b; Serban and Witz 1988), and 
autoantigens expressed principally in the gastrointestinal tract (Cunningham and Steele 
1981). These different types of antigens will be reviewed with a view to establishing 
the true in vivo nature of the BrMRBC antigen.
In earlier studies, autoantibodies to erythrocytes were reported to occur in 
normal strains of mice and at elevated levels in NZB mice (Wilson, Warner and 
Holmes 1971; Lord and Dutton 1975a). In normal mice, intact erythrocytes are not 
normally antigenic unless they are treated with proteolytic enzymes, such as 
bromelain or papain, and to a lesser effect, trypsin (Cunningham 1974a, 1976). 
Linder and Edgington (1972) had demonstrated the presence of two antigens, X and 
HB, on the erythrocytes of the autoimmune NZB strain of mice. The X antigen was 
present on the surface of the red cell membrane, while the HB antigen was exposed 
only after proteolytic treatment of erythrocytes with bromelain. Bromelain-treated 
RBC, however, could remove both X and HB activity from sera. Large numbers of 
autoantibody-secreting cells in NZB mice were found to be specific for both the X 
and HB antigens (Linder and Edgington 1972, DeHeer and Edgington 1974; DeHeer
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et al. 1978). Both the HB and X antigens could be purified from mouse plasma 
(Linder and Edgington 1973a, 1973b) and used to specifically inhibit anti-X or 
anti-HB antibodies purified from NZB erythrocytes. In addition, it was found that 
bromelain-treated stroma could inhibit 85% of anti-HB plaque forming cells, whereas 
intact stroma could inhibit 90% of anti-X plaque forming cells (DeHeer and 
Edgington 1974).
Peritoneal cells in culture were found to be able to secrete antibodies that 
specifically bound to Sheep RBC and BrMRBC, but not NMRBC, thus establishing 
a link between the peritoneal cell phenomenon and a hidden autologous erythrocyte 
antigen (Pages and Bussard 1975). In addition to sheep RBC, anti-BrMRBC 
antibodies derived from peritoneal cells of NZB mice were found to bind to intact 
pigeon and human RBC, whereas horse and sheep RBC were found to be negative : 
BrMRBC (highly stained) >Human A and 0>Pigeon RBC>Rat RBC>Human B> 
rabbit>chicken RBC>untreated mouse RBC>Goat, sheep, horse (unstained) (Pages 
and Amaud 1980). It is interesting that no activity could be demonstrated against 
Sheep RBC suggesting that, in this case , the anti-BrMRBC antibodies were not 
cross-reactive as had been demonstrated previously for peritoneal cell cultures (Pages 
and Bussard 1978). Similarly, monoclonal anti-BrMRBC antibodies may bind to 
BrMRBC, BrRat RBC, Sheep and Br-Sheep RBC, Br-Horse RBC , chicken RBC 
and Br-Chicken RBC and Br- Frog RBC, but not to MRBC, rat RBC, horse RBC or 
frog RBC to different degrees in haemolytic assays (Kawaguchi 1986). The fact that 
there is some kind of hierarchy of binding may suggest a fundamental difference in 
the presentation of surface antigens in the topology of different RBC from different 
species.
What is the nature of the cross reactive epitope on sheep RBC ? In an unusual 
study, a water soluble fraction of sheep RBC devoid of all membrane that contained a 
highly immunogenic protein fraction called FI was produced (Seman et al. 1971). FI 
and FII was prepared from sheep RBC lysate, FI was the main protein fraction in the 
void volume of a Sephadex G 100 column. FII consisted of haemoglobin. Mice 
injected with FI had a strong response, but some membrane components were found 
to be required for the full expression of antigenicity of this protein.The protein, 
although abundant, was not further purified or characterised.
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The effect of the proteolytic enzyme bromelain on mouse red blood cells is to 
reveal a previously hidden epitope. Bromelain removes only Band 3 , an integral 
membrane protein involved in anion transport, from the membrane and even after 
extensive bromelain digestion only an additional two spectrin bands are removed 
(Cunliffe and Cox 1979).Thus membrane proteins would appear to be fairly resistant 
to proteolytic degradation, and it is not thought that bromelain directly acts upon the 
BrMRBC epitope, because anti-BrMRBC antibodies may be raised in rats by 
injection of intact mouse erythrocytes (Cunningham 1974a). This suggests that 
bromelain reveals an epitope that is normally hidden. That the two responses were 
made by different populations of rat antibodies was shown by absorption 
experiments. Absorption of rat anti-mouse RBC semm with NMRBC could remove 
only slight reactivity against BrMRBC, and the converse was also found to be true. 
If, in contrast, BrMRBC are injected into mice, the number of antibody-producing 
cells does not increase from a background level of 5,500-10,000 found in 
unimmunised mice (Cox et al. 1977). BrMRBC had similar levels of resistance to 
osmotic lysis as NMRBC suggesting that bromelain treatment did not grossly deform 
RBC and that therewereno recognisable neo-antigens created on BrMRBC that could 
stimulate a response above the background levels displayed.
Strong evidence has accumulated to support trimethylammonium compounds 
(specifically phosphatidylcholine) as being involved in the BrMRBC antigenic 
determinants. Bussard and colleagues using anti-BrMRBC IgM monoclonal 
antibodies derived from peritoneal B-cells from NZB mice found that they recognised 
trimethylammonium compounds (choline) (Serban et al. 1981; Pages et al. 1982; 
Poncet et al. 1985; Serban and Witz 1988). Compounds such as choline chloride, 
phosphorylcholine, betaine and betaine hydroxide at concentrations of between 
12.5mM and lOOmM were found to be capable of specifically inhibiting the 
complement-dependent lysis of BrMRBC by natural autoantibodies (Serban et al. 
1981) and direct binding to trimethylammonium by anti-BrMRBC antibodies has 
been demonstrated in radioimmunoassasys (Serban and Witz 1988).The ability for 
these compounds to inhibit the plaque-forming capacity of peritoneal cells has also 
been demonstrated (Pages et al. 1982). Phosphoserine and phenyltrimethyl- 
ammonium as well as ghosts prepared from NMRBC also have the ability to inhibit
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anti-BrMRBC antibodies (Poncet et al. 1985) suggesting that a membrane 
phospholipid or an integral membrane protein may be recognised. Serban and Witz 
(1988) have shown the presence of natural autoantibodies in murine sera at a level of 
13.8|ig/ml, with an increase in the presence of a trimethylammonium-binding 
idiotype with age or with certain autoimmune strains [69.3pg/ml for (NZB x NZW) 
FI bearing the 141 lymphoma]. Also, they found that the BrM-epitope was revealed 
after bromelain-treatment of mouse, rat, sheep , rabbit, human and chicken RBC (and 
Normal CRBC), and that this could be inhibited with trimethylammonium.
Cox and Hardy (1985) showed that anti-BrMRBC antibodies displayed strong 
crossreactivity with the polar headgroup of the ubiquitous membrane phospholipid, 
phosphatidylcholine. Inhibition of anti-BrMRBC antibodies could be achieved at 
lower levels (2qg/ml) than those required to demonstrate inhibition with 
trimethylammonium compounds. Phosphatidyl dimethyl ethanolamine dipalmitoyl, a 
closely related phospholipid was found to have no inhibitory effect on anti-BrMRBC, 
thus showing that the polar head group is important, however, the entire 
phosphatidylcholine molecule is required for maximum inhibition of haemolysis. It 
must be noted that the effects of inhbition are diminished by several orders of 
m agnitude (10-1000 times) when m ixed liposomes, containing either 
phosphotidylinositol or phosphatidic acid were used in conjunction with 
phosphatidylcholine.This can be attributed to a charge effect of negative 
phospholipids on the polar headgroup of phosphatidylcholine. Mercolino and 
collegues have found that phosphatidylcholine in liposomes is recognised specifically 
by Ly-1+ lymphomas ( Mercolino et al. 1986) and also that peritoneal Ly-1+ B cells 
isolated from normal mice also bind specifically to phosphatidylcholine (Mercolino et 
a l  1988).
In a recent study, Hardy and Cox (1990) provided evidence for a 
phopholipase-sensitive structure on mouse red blood cells recognised by mouse 
peritoneal cells. This is good evidence to show the importance of phosphatidylcholine 
in the BrMRBC epitope, however, at best only a 40% reduction in binding of 
peritoneal cells to these cells can be achieved, suggesting that some other structure 
may still be recognised. In addition, second enzyme treatments are employed to 
further digest any protein epitopes, with no further effect on the binding of
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anti-BrMRBC antibodies. In the "second enzyme" digestion, cells that have been 
bromelain-treated are subjected to further proteolytic degradation with bromelain or 
other proteolytic enzymes. This may not be the correct approach to take if N- or 
O-linked carbohydrates are involved in the epitope, especially if they were attached to 
some cytoplasmic protein as a second enzyme digestion may not be able to effectively 
digest intracellular proteins. Further, the second enzymes used may not further cleave 
peripheral erythrocyte proteins after the bromelain-sensitive proteins have been 
removed. Cunningham (1974a) has shown by raising anti-BrMRBC antibodies in 
rats by the injection of NMRBC, that the epitopes revealed by bromelain are not 
modified by bromelain but are hidden structures on NMRBC. The study with second 
enzymes and their effect would have been clearer to assess if SDS-PAGE had been 
conducted to determine what, if anything, was removed from the whole cell, so these 
studies do not rule out a complex epitope involving perhaps protein, glycoprotein or 
carbohydrate.
Kawaguchi (1987b) has demonstrated that anti-BrMRBC antibodies , in 
addition to recognising phosphatidylcholine, bind to human and chicken low density 
lipoproteins (LDL), but not mouse or rat LDL. Four of the IgM monoclonal 
antibodies were found to bind differently to different "natural" or animal derived 
liposomes and to synthetic liposomes. One did not bind to liposomes, another could 
bind to liposom es containing dipalm itoyl, distearoyl and diarrachidoyl 
phosphatidylcholine, and the remaining two could bind to the same but could not to 
phosphatidylcholine liposomes with unsaturated fatty acids or short chain fatty acids 
(less than 10 C chains). It was suggested that phosphatidylcholine may be spaced 
apart at the wrong distance for the antibodies to bind. Further, it was shown that there 
were differences in the fine specificity of antigen binding for phosphatidylcholine 
among different idiotypic groups of anti-BrMRBC monoclonals. In a related study, 
Kawaguchi (1988) found that anti-BrM antibodies that were similar to those induced 
by LPS stimulation could be obtained by injection of chicken egg LDL emulsified in 
Incomplete Freund's adjuvant.
It is not known if the cross-reactive determinant on sheep RBC contains 
phosphatidylcholine, but there is some evidence to the contrary. Studies on the lipid 
composition of sheep and mouse erythrocytes have found that sheep RBC do not
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contain phosphatidylcholine (Saito et al. 1983, Nelson 1967). Mouse erythrocyte 
lipids contain phosphatidylcholine and show a similar type and percentage of lipids to 
rat erythrocytes (as measured by Nelson), with two strains, C57BL/6 and C3H/He 
showing minor variation in percentage of lipids. There is also evidence that lipids by 
themselves are poor immunogens, however, they may enhance the immunogenicity 
of protein antigens (Marcus and Schwarting 1976; Marcus 1984). Thus, although 
phosphatidylcholine may be bound by natural antibodies and form a portion of the 
BrMRBC epitope, there is a question as to whether they may by themselves stimulate 
the anti-BrMRBC lymphocytes to secrete anti-BrMRBC antibodies.
Huetz and Poncet (1989) have provided arguments to suggest that 
anti-phosphorylcholine antibodies are not identical to anti-BrMRBC 
(phosphatidylcholine) antibodies. Thus, conventional anti-phosphorylcholine 
antibodies do not lyse BrMRBC in conventional lysis assays; the affinity of 
anti-BRMRBC for phosphorylcholine is low; mice use different V-genes for 
phosphorylcholine and BrMRBC and lastly, no antiphosphorylcholine idiotype 
recognises anti-BrM idiotypes.
The exact identity in vivo of the responsible stimulating determinants is 
unknown. There is evidence that blood group substances isolated from the murine 
gut are recognised by anti-BrMRBC antibodies and that gut-derived antigens may be 
responsible for the initial high level of anti-BrM lymphocytes early in ontogeny 
(Cunningham and Steele 1981). Whether blood group substances are involved in the 
BrMRBC autoantigen(s) requires further investigation, bearing in mind that blood 
group carbohydrates may be bound to either proteins or lipids on red blood cells or 
expressed predominantly on proteins in the gastrointestinal tract (Kabat 1956,Watkins 
1974, Feizi and Childs 1985, Feizi 1990). In humans, Moore and collègues (1982) 
have demonstrated that phospholipid is an important component of the human Rh 
antigen, but that a protein (as yet unidentified apart from molecular weight 28.5 kD) 
is also involved in the epitope recognised as the Rh antigen.
In studies using antigen inhibition and/or antigen absorption of the complement 
mediated lytic assay, BrMRBC-like antigens (BrM-antigens) were found in the 
gastrointestinal tracts of normal inbred CBA/J mice (Cunningham and Steele 1981)
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and germ-free outbred Swiss mice (Steele and Cunningham, 1979). In addition, 
complement-dependent lysis of antibody-sensitized BrMRBC could be specifically 
inhibited with a partially purified "blood-group-like" substance extracted from mouse 
stomachs (Cunningham and Steele 1981) following the methods of Kabat (1956). 
The gastrointestinal distribution and emergence of the BrMRBC antigen early in 
ontogeny and the subsequent appearance of specific natural autoantibodies in one 
week old mice, suggest that the BrMRBC antigen may act as an important stimulator 
of large numbers of potential autoantibody-secreting B-cells (Steele and Cunningham 
1978,1979; Cunningham and Steele 1981). It was established that both the capacity 
to synthesise BrMRBC specific IgM antibody and the natural form of the BrMRBC 
antigen appeared by the end of the first week of life and reached adult levels by the 
third week.
The BrMRBC antigen is not normally detectable in a wide range of tissues 
including foetal gut, but appears at high levels in gut tissue shortly after birth 
(Cunningham and Steele 1981). Tissues from the stomach and upper small intestine 
were a rich source of antigenic material, capable of specifically absorbing the IgM 
anti-BrMRBC antibody, whereas the salivary glands, liver and kidney were found to 
be variably positive (lung, brain, spleen, bone marrow, thymus, peritoneal cells, 
foetal intestine, food pellets, testes and ovaries were negative). If foetal stomach and 
intestine had been pretreated with pepsin at pH 4, it behaved like adult stomach in its 
ability to remove anti-BrM RBC antibodies from serum. Further, it was shown that 
complement-dependent lysis of antibody-sensitized BrMRBC could be specifically 
inhibited with a blood group like substance extracted from mouse stomachs.
The restricted distribution of the BrMRBC antigen has been demonstrated 
independently in studies by Garzelli and collegues (1987). They examined the 
reactivity^anti-BrMRB C antibodies and the tissue distribution of the antigen by direct 
immunofluorescence on frozen tissue sections. Anti-BrMRBC antibodies were said to 
be "polyspecifc" since they react with multiple organs, however, this does not 
exclude that the same antigenic epitopes may occur in different tissues. Anti-BrM 
reacted with cellsclose to the lumen of the seminiferous tubules of the testis, the
A s .
lamina propria of gastric mucosae, the cytoplasm of cel^ in the salivary glands, 
scattered cells in the thymus and lymph node, and the cytoplasm of about 20% of
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nucleated cells in the bone marrow. BrM-antigen has also been found on erythocytes, 
platelets, thymus,bone marrow and spleen cells after proteolytic treatment 
(Kawaguchi 1988a). Platelets were also found to react with anti-BrMRBC antibodies 
at 0°C but not at 37°C. Stronger reactivity can be demonstrated with thrombin-treated 
platelets (Kawaguchi 1989).
1.5. RED BLOOD CELL ANTIGENS
Erythrocytes play a central role in mammals in the transport of oxygen to 
tissues and removal of carbon dioxide (Schmidt-Nielsen 1983). The cell membrane of 
erythrocytes is a complex structure with many different proteins, glycoproteins, 
phospholipids and carbohydrate moieties present in a lipid bilayer (for reviews see 
Bretscher 1973; Steck 1974; Surgenor 1974; Marchesi and Furthmayr 1976). The 
outer part of the human erythrocyte lipid bilayer mainly contains phospholipids with 
choline moieties (Zwaal, et al. 1973) and the principal components of the membrane 
skeleton of human red blood cells are actin, spectrin, ankyrin, Band 3, Band 4.1, 
tropomyosin and myosin (Table 1.7.; Bennett 1985).
The ABO blood group antigens and the naturally-occuring isohaemagglutinins 
in humans are of primary importance in the practice of blood transfusion, and hence, 
much is known of the structure and composition of the blood group antigens (Kabat 
1956; Watkins 1966,1974). Many environmental antigens, such as food substances, 
dust, blood group substances from other species, simple sugars and microorganisms 
are cross-reactive with human ABO blood group substances and natural antibodies to 
blood group antigens have traditionally thought to be due to antigenic stimulation with 
these environmental antigens (Kabat 1956).
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Table 1.7. Erythrocyte membrane proteins (Modified from Bennett, 1985)
Peripheral proteins Subunit M w t Integral proteins Subunit M wt
Spectrin a = 260,000 Band 3 89,000
b = 225,000 Glycophorin A 31,000
Ankyrin 215,000 Glycophorin B 23,000
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Natural antibodies also recognise minor blood group antigens. In many 
species, there is a developmental change in the expression of carbohydrate antigens 
on the surface of the erythrocyte (Feizi and Childs 1985) i.e. with the human Ii 
blood group there is a switch from the expression of foetal i antigens to mature I 
antigens. Natural antibodies to the Ii blood groups are usually abundant in certain 
types of autoimmune haemolytic anaemia but are also present in normal individuals 
(Hakomori 1981). These natural antibodies can also recognise tumour-associated 
antigens of gastric carcinomas (Feizi and Childs 1985) and antigens expressed by 
foetal intestinal glycoproteins (Feizi 1985).Carbohydrate antigens comprise the 
major allogeneic antigens (Blood group antigens in man), Forssman antigen and 
differentiation markers such as SSEA-1 (Solter and Knowles 1978). Forssman 
antigens are carbohydrate structures that are attached to lipids and occur on the 
erythrocytes of certain animals (Hakomori and Kannagi 1983, 1986).Forssman 
antigen positive animals are guinea pig, horse , cat, dog, sheep, goat, mice, pigeon, 
chicken and turtle.Forssman negative animals are rabbit, rat, cow, pig, human, 
monkey and frog.
There are other glycoprotein and protein structures present in red blood cell 
membranes, such as MHC antigens (Spackjr. and Edidin 1986; Nakashima et al. 
1986), LPS receptors (Springer et al. 1973, 1974) and other receptors or 
transporters, which are potentially capable of acting as autoantigens. However, as 
well as the wide range of cell surface antigens, it is also known that some "buried" 
antigens or intracellular components from red blood cells may also react with 
natural antibodies (as outlined above). In human erythrocytes, a buried region of 
Band 3 has also been identified as an autoantigenic target for IgG in autoimmune 
haemolytic anaemia (Lutz 1983).
Erythrocytes only have a limited lifespan in circulation, in the human it is said 
to be 120 days (Dacie and Lewis 1976) whereas in the mouse it has been measured 
at about 40-45 days (Cox and Cunliffe 1979). It is pertinent to ask why these cells 
are removed from circulation, how and what happens in the breakdown of RBC ? 
With human erythrocytes, it has been suggested that haemoglobin may become 
denatured to form Heinz bodies which complex with the anion channel to form
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autoantigenic epitopes signalling that the cell can no longer function as a transporter 
of oxygen (Schluter and Drenckhahn 1986), but haemoglobin is presumably 
enclosed within a membrane - how does it signal to the immune system that it is 
aging and requires removal ?
Thus in addition to membrane lipids, there are a number of potential targets 
that have been briefly mentioned here that could be recognised as antigenic on 
erythrocytes. Most of these structures are "surface" antigens, and it must be borne 
in mind that erythrocytes normally have a coating of erythroglycan which normally 
protect the intact cell from interactions with IgM or IgG (Jamefelts et al. 
1978,1982). Bromelain treatment removes Band 3, a major component of the anion 
channel, (Cunliffe and Cox 1979), thus certain cytoplasmic proteins and/or lipids 
may become exposed to reveal BrMRBC autoantigens.
1.6. AIMS OF THE STUDY
Several facts emerge when these studies are viewed together. There is high 
potential for anti-BrMRBC available in the potential murine Ig repertoire (Steele and 
Cunningham 1978), and there is a demarcation of anti-BrMRBC activity to the 
peritoneal cavity and the pleural cavity, and the distribution of the BrM-antigen is 
restricted to specific sites and specific organs (Cunningham and Steele 1981). Does 
this indicate a high local level of stimulating autoantigen at these sites? Is there a 
possibility that another autoantigen apart from phosp hatidyl choline may be 
involved in the BrMRBC autoantigen (s) ? What is the nature of autoantigenic 
epitopes in the gut and are they related to the BrM-antigens expressed on 
erythrocytes?
The principal aim of this thesis is to examine mouse red blood cells and the 




2 .1 .1 . M ice
Retired female breeder CBA/H £ an mice (10-19 weeks old) were obtained
from the Animal Breeding Establishment of the John Curtin School of Medical 
Research, Canberra, Australia, and housed at the Animal House, University of 
Wollongong until required. Occasionally, Balb/c and CBA/H cross C57B/6 from 
the same source were used for antibody absorption.
2.1.2. Rabbits
Rabbits were immunised to make specific high titre IgG anti-BrMRBC 
antibodies (Chapter 3, Table 3.2) or left unimmunised as sources of complement. 
One outbred male rabbit died during immunisation with BrMRBC. One NZW male 
rabbit that was used to produce anti-BrMRBC antibodies became ill during 
immunisation with BrMRBC with stomach lesions evident upon autopsy. Vetlar 
(Ketamine Hydrochloride, Parke Davis; anesthetic) was administered i.m. at 
25mg/kg to produce anesthesia in conjunction with 3mg/kg Rompun (Xylazine, 
Bayer, muscle relaxant & sedative) and the rabbit was bled from the heart. NZW 
rabbits obtained from New South Wales University from the Psychology 
Department, and housed at the Animal House, University of Wollongong, were 
used as sources of complement for haemolysis assays.
2.2. ANTIBODIES AND COMPLEMENT
2.2.1. LPS stimulated serum and normal mouse serum
CBA/H mice, received lipopolysaccharide (LPS) from Escherichia coli strain 
0127:B8 (Phenol extract, Sigma no L-3129, Sigma Chemical Co. St.
CHAPTER TWO 49
Louis,MO,US A) 50 |ig intraperitoneally (i.p.) in 0.1 ml of sterile physiological 
saline . LPS-stimulated serum (LPS-serum) from a group of mice was collected 
and pooled 7 days after injectionAstored in small lots at -20°C until use. Several 
batches of LPS serum were produced over a number of years (Chapter 4 Table 
4.1.).
Normal mouse serum was collected freshly from individual CBA/H retired 
female breeder mice as required. The levels of IgM present in LPS stimulated 
serum and normal mouse serum were quantified by radial immunodiffussion in 
agar (Section 2.2.3.).
2.2.2 Monoclonal antibody culture
FUB 1 is an IgM monoclonal antibody produced by fusion of an LPS 
stimulated C3H mouse spleen with P3.653 . The monoclonal was selected for its 
ability to specifically lyse BrMRBC and not NMRBC in standard haemolysis 
assays and specifically binds to phosphatidylcholine micelles (K.O.Cox, S.Hardy, 
P.Kenny, unpublished manuscript). FUB 1 was originally produced in Professor 
Cox's laboratory by Peter Kenny and the B-cell hybridomas (FUB 1, FUB 3 and 
FUB 4) arrived by post from Dr. Paul Lalor of the Walter and Eliza Hall Institute 
(WEHI) , University of Melbourne who had them in culture in June 1988. FUB 3 
is crossreactive with BrMRBC and Rat RBC, while FUB 4 is specific for Rat 
RBConly (Table 2.1.).
The three hybridoma lines, FUB 1, FUB 3 and FUB 4 (see Table 2.1) each 
containing approximately 5x10^ cells from log phase cultures arrived and the 
volume was adjusted to 6ml with C-DMEM. Five millilitres was cultured initally 
in a 25cm^ flask and 1ml as a backup cultured in a 25 well cluster plate (Sterilin, 
Middlesex, England).
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Table 2.1. Background information on monoclonal hybridomas.
FUB 1 LPS injected into C3H; spleen fused with P3.653;
IgM anti-BrMRBC, anti-phosphatidylcholine
FUB 3 Rat RBC injected into C3H; spleen fused with P3.653; IgM anti-BrMRBC, 
anti-RtRBC
FUB 4 Rat RBC injected into C3H; spleen fused with P3.653; IgG anti-RtRBC
Cell viability was determined by mixing one volume of hybridoma 
suspension with one volume of 0.1% trypan blue (Sigma,T-0887) in sterile 
phosphate buffered saline (PBS) and counting healthy yellow cells and dead blue 
cells under a phase contrast microscope (Olympus C011) with a haemocytometer. 
Viability of hybridomas expressed as a percentage was determined as the number 
of viable cells divided by the total number of cells x 100, and this was used as an 
indication of the health of the culture or if feeding or subculturing was required.
All cell lines sent from WEHI were screened for mycoplasma contamination 
with a Mycotrim kit (Hana Media Inc., California T500-000) by aseptically 
removing 1.0 ml of hybridoma culture medium containing 10^ to 10^ cells and 
incubating this in a flask containing agar to support mycoplasma growth. This 
flask is incubated for 4-7 days and examined for the growth of colonies and if 
negative, the agar reinoculated by tilting the broth over the agar surface again and 
incubated with the agar side up. All cell lines were negative for mycoplasma.
The hybridomas were maintained in 25 cm^ sterile flasks with canted neck 
(Lux scientific corporation, 5350) or 75 cm^ sterile tissue culture flasks (Coming, 
25110) with complete Dulbecco's Modification of Eagle's Medium (DMEM) in a 
water-jacketed 5% CO2 incubator (Forma Scientific). Each flask was flushed with
5% CO2 in air through a 0.2 |im Acrodisc filter (Gelman Sciences, 4-192).
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One litre of DMEM powder (FlowLaboratories 10-331-20 powder) was 
reconstituted by the addition of 3.7 g/L sodium bicarbonate and 5 x 10"^ M 
2-mercaptoethanol in 1 Litre of autoclaved glass distilled water and the pH adjusted 
to 7.2 with sterile HC1 and NaOH. The medium was divided into 90ml aliqouts 
and stored at 4°C until required. To make complete DMEM (C-DMEM), 10% 
foetal calf serum (FCS) and antibiotics ( 5.0 IU/ml Penicillin and 5mg/ml 
streptomycin, Flow Laboratories, 16-700-49) were added to 90ml DMEM prior to 
use. Foetal calf serum (Flow Laboratories, 29-101-49) was complement 
inactivated by incubating in a water bath for 30 minutes at 56°C.
After storage at 4°C for 15 days C-DMEM was further supplemented with 
584 mg/L filter sterilised L-glutamine (Flow Laboratories, 15-801-13). Medium 
was sterilised by filtration through 0.22jim membranes (Millipore, type GS) 
connected to a suction filtration unit (Millipore, X X I104700). All glass and plastic 
disposable items were sterilised by autoclaving for 15-20 minutes at 115-120°C if 
they had not previously been sterilised by gamma irradiation , and all hybridoma 
work was conducted in a laminar flow cabinet (Gelman Science,CF 435).
Monoclonal antibodies were tested for anti-BrMRBC activity by suspension 
c-ELISA with BrMRBC and NMRBC, harvested from culture supernatants and 
stored at -80° C (long term storage) or -20°C (short term storage). The moifclonals 
were used in various ELISA and immunoblotting experiments. IgM concentrations 
of FUB 1 and FUB 3 monoclonal antibodies were quantified by immunodiffusion 
in agar (see Section 2.2.3)
For freezing down cell lines, hybridomas were placed in liquid nitrogen 
when actively dividing cells covered approximately 80% of the surface area of the 
flasks. The cell suspensions were counted and centrifuged in sterile 25 ml 
centrifuge tubes for 2500 rpm for 10 minutes. The supernatant was removed, and 
the pellet resuspended in ice cold sterile FCS 40% + C-DMEM 60% and an equal 
volume of dimethyl sulphoxide (DMSO) 20%+C-DMEM 80% was added 
dropwise with stirring for a final cell concentration of 1-5 x 10^ cells /ml. The final 
ratio of DMSO: FCS: C-DMEM in the freezing medium is 1:2: 8. One to
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two millilitres of cell suspensions were then placed in freezing vials (Sterilin,506) 
held on ice, transferred to a -80°C freezer overnight and then placed in liquid 
nitrogen the following morning.
Hybridomas were thawed by removing vials from liquid nitrogen and 
swirling the vials in a 37°C water bath. The cell suspension was transferred to a 
25ml centrifuge tube containing 15 ml of ice cold growth medium in C-DMEM 
centrifuged at 2500 rpm for 10 minutes. The growth medium consisted of 20% 
foetal calf serum in hypoxanthine thymidine medium (2% of 50 x HT stock 
solution , Flow Laboratories 16-809-49). Cells were washed twice by this 
procedure, resuspended in 7ml of growth medium and transferred to a 50 ml flask. 
Depending upon the viability of the cells, supplements of 2-3ml of growth 
medium were added to cultures from 2 to 5 days.
2.2.3. Quantitation of IgM from LPS-serum, normal mouse serum 
and mouse monoclonal antibodies.
i '
Several antibodies were quantised for the level of IgM present using a radial 
immunodiffusion kit from The Binding Site (R.N. 278.2). Plates were removed 
from storage at 4° C and allowed to equilibrate to room temperature. LPS-semm 
was diluted 10-fold so that it would fall into the recommended assay range and 
applied to the wells with a Hamilton syringe. Normal mouse serum was diluted 1:2 
and the concentration of the monoclonal antibodies was doubled by two fills of the 
wells over 30 minutes. The endpoint method for reading the results was adopted 
because the calibrators could not be located, thus the minimum time required for 
diffusion of IgM is 100 hours. The diameter of the rings was measured at 76,100 
and 120 hours to determine the maximum ring diameter and the concentration of 
IgM determined by reference to a table supplied with the kit.
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2.2.4. Mouse IgM Myeloma
Serban et al. (1981) have previously used MOPC 104E as a negative control 
antibody for BrMRBC. It is an IgM myeloma protein with a specificity for
a - 1,3,linked dextran (Potter 1972). MOPC 104E was obtained as clarified 
ascities from Sigma (M 2521).
2.2.5. Preparation and purification of immune rabbit serum IgG.
Rabbits were bled from the marginal ear vein into sterile containers. The 
blood was allowed to clot overnight at 4°C and the serum removed the following 
morning. In a 40ml polypropylene centrifuge tube, 1 volume of ice cold saturated 
ammonium sulphate (BDH 45206) was added to one volume of immune rabbit 
serum dropwise with stirring and left for 2 hours on ice before centrifuging in a 
refrigerated centrifuge at 0°C for 20 minutes at 10,000 rpm. The pellet was washed 
once in 50% ice-cold ammonium sulphate , dissolved in one volume of sterile 
saline and dialysed overnight against several changes of physiological saline and 
then distilled water. Small aliqots were stored at -20°C before use.
2.2.6. Preparation and purification of rabbit complement
For the preparation of complement, rabbits were bled from the marginal ear 
vein into sterile 50ml containers and immediately placed on ice. Blood was allowed 
to clot on ice for 30 minutes and then centrifuged at 2000 rpm for 10 minutes in a 
prechilled centrifuge (0°C, Sorvall RC 5B fitted with a HB-4 swing out rotor). 
Serum was removed and absorbed on ice 3 times with 0.5 volumes of packed cold 
MRBC, and 3 times with 0.5 volumes of BrMRBC. Absorbed rabbit serum for 
use in complement dependent lysis assays was then stored at -80°C until required.
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2.2.7. Sources of other antibodies
Other commercial sources of second antibody conjugates obtained from 
Sigma were used in ELISA and blotting procedures, including goat a-mouse IgM 
(p-chain specific)-alkaline phosphatase conjugate (A 7784), goat a-mouse IgM 
(p-chain specific)-biotin conjugate (B 9265), streptavidin-alkaline phosphatase 
(Dakopatt D 396) and goat a-Rabbit IgG-alkaline phosphatase conjugate (A 7539).
2.2.8. Preabsorption of primary and secondary antibodies with 
erythrocytes.
Commercial second antibody preparations used for immunoblotting and 
ELISA were routinely absorbed to remove a-BrMRBC and a-NMRBC antibodies 
and later a-carbonic anhydrase antibodies. Second antibody (20 |il of stock diluted 
10-fold in 1% Bovine serum albumin in PBS) was absorbed on ice three times 
with 500 pi of packed NMRBC and then an additional three times with 500 pi of 
packed BrMRBC.
For the pre-absorption of FUB 1 and LPS-serum, a 20% (v/v) packed pellet 
of either BrMRBC or NMRBC was added for 60 minutes on ice then centrifuged 
and the absorbed serum added to another packed erythrocyte pellet. This step was 
repeated for a total of three rounds of absorptions .
2.2.9. Reduction of IgM to monomers with 2-M ercaptoethanol, 
2-mercaptoethylamine and Dithiothreitol.
For certain ELISA experiments, IgM monomers were produced to determine 
if inhibition of binding to BrMRBC by carbonic anhydrase could be achieved more 
effectively with monomers than experiments where IgM remains intact. Three 
different methods of reduction were attempted using 2-mercaptoethanol, 
2-mercatoethylamine and dithiothreitol.
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One millilitre of FUB 1 or 1:10 LPS was treated with either 0.01 M 
2-mercaptoethylamine (Sigma M 9768) at 37°C for 75 minutes (Nisonoff et a l  
1960), or treated with lOmM 2-mercaptoethanol at 37°C for 90 minutes or 0.02M 
dithiothreitol at room temperature for 30 minutes (Stanworth and Turner, 1986). 
The preparations were alkylated at room temperature with 50% molar excess of 
iodoacetamide (Sigma I 6125) with the pH held between 7 and 8 with Tris-HCl 
buffer. Reducing agents and iodoacetamide were removed by either dialysis or by 
passage over a Sephadex G-25 column and the preparations returned to their initial 
volumes by treatment with Aquacide.
2.3.ERYTHROCYTES
2.3.1. M ouse erythrocytes
Red blood cells were collected under ether anaesthesia from adult female 
CBA/H mice , placed into Alsever's solution and used on the day of collection. 
Erythrocytes were washed three times in phosphate-buffered saline (PBS, pH 7.4) 
before use, carefully removing the buffy coat after each centrifugation step. 
Bromelain-treated mouse red blood cells (BrMRBC) were prepared as described 
by Cunningham (1974). One volume (0.5-1.0 ml) of packed RBC was treated 
with one volume of 10 mg/ml bromelain (EC 3.4.22.4 , Sigma no. B 2252) in 
PBS for 30 minutes at 37 °C. BrMRBC were washed an additional three to five 
times in 10 ml volumes of PBS before use.
2.3.2. Mouse erythrocytes ghosts
Mouse erythrocyte ghosts were prepared basically as outlined by Dodge et al. 
(1963). Mouse red blood cells were collected, pooled and washed in PBS. Some 
cells were treated with bromelain and washed in PBS as outlined above (Section 
2.2.2) and referred to in subsequent steps as BrM-ghosts as opposed to ghosts 
created from normal mouse erythrocytes. A 50% (v/v) suspension of RBC was 
made in isotonic PBS and to every 2ml of this suspension, 28ml of ice-cold 20
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milliosmole hypotonic phosphate buffer , pH 7.4, was added. Ghosts were 
pelletted by centrifuging in 40 ml polypropylene centrifuge tubes at 12,000 rpm 
for 1 hour (20,000g) in a Sorvall RC-5B refrigerated centrifuge set at 4°C and 
fitted with a HB-4 swing out rotor The supernatant is carefully decanted and the 
pellet resuspended in hypo tonic lysis buffer and washed a further three times. 
The washed ghost pellet was finally resuspended overnight in 0.1 N KOH at 
room temperature to prepare protein-free ghosts as outlined by Dodge et al. 
(1963). Small aliqouts were washed in isotonic PBS to remove KOH before use. 
Protein-free ghosts were used in initial experiments, but in later experiments 
ghosts were finally resuspended in isotonic PBS instead of KOH and stored at 4°C 
for immediate use or -20°C for longer term storage.
Ghosts prepared from NMRBC form a pearly white p e lle t. It was noted 
however, after hypotonic lysis (under identical conditions in a number of different 
experiments) that BrM-ghosts were still slightly pinkish, possibly indicating that 
not all of the haemoglobin could be removed from BrM-ghosts. Protein was 
determined by a micro-Lowry assay using Bovine serum albumin (BSA; 
Boehringer Mannheim 775860 Fraction V) as a standard (Section 2.7.1.), the 
number of ghosts/ml were counted using a haemocytometer, and dry weight/ml 
determined by drying and weighing aliquots of ghost suspensions.
2.3.3. Erythrocytes from other species.
Blood from a range of species including CBA/H mice, NZW rabbits, and 
young Wistar Rats- was obtained by standard methods of either ear bleeding or 
heart puncture into Alsever's solution from animals housed at the University of 
Wollongong. Defibrinated sheep and horse red blood cells were obtained from 
Filtron Pty Ltd, Brooklyn Victoria. Human group O blood was supplied by the 
author into Alsever's solution. All red blood cells were tested for A and B blood 
group substances by direct agglutination with typing sera obtained from 
Commonwealth Serum Laboratories, Victoria (Anti-A 01011001 & anti-B 
01021001).
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2.4. ASSAYS FOR BROMELAIN-TREATED MOUSE RED BLOOD 
CELLS
2.4.1 Haem olytic assay
The technique of Cunningham and Steele (1981) was used. Serial dilutions 
of LPS-serumwere made in 50 jil vol of Hank's balanced salt solution containing 
5% BSA, 25 pi of Rabbit complement (as in Section 2.2.6 above), followed by 
25 |il of either 1% NMRBC or 1% BrMRBC. The endpoint of titration was read as 
approximately 50% lysis after lhr.
2.4 .2 . Suspension C ellu lar Enzym e-linked Im m unoassays For 
Erythrocytes
A suspension c-ELISA was used to detect BrMRBC-specific antibodies 
because fixatives such as Poly-L-Lysine and glutaraldehyde, as well as the process 
of adsorption of normal erythrocytes to plastic microtitre plates, exposes 
neo-antigens on normal red blood cells (Jonusys and Steele, 1988). Microtitre 
plates were blocked overnight at room temperature with I O O jllI  of 1% BSA in PBS. 
Plates were aspirated and serial two- or three-fold dilution of antibody were made 
in 1% BSA. Fifty microlitres of a 2% suspension of RBC in PBS were added and 
allowed to incubate for 90 minutes at room temperature.
Erythrocytes were pelleted in microtitre plates by centrifugation at 2,000 rpm 
for 5 minutes and washed three times with 100pl of 1% BSA in PBS. 
Subsequently, centrifugation at 1,000 rpm for 5 minutes was found to be sufficient 
to pellet RBC without excessive lysis occurring and was used in later experiments. 
RBC were transferred to another microtitre plate that had been blocked overnight 
with 1% BSA in PBS and 50pl of second antibody applied. The transfer steps 
were found to be essential to remove background due to antibodies and complexes 
of antibody and lysed red blood cells binding to plastic microtitre wells that are a 
source of background in conventional ELISA with erythrocytes (Jonusys and 
Steele, 1988).
CHAPTER TWO 58
When alkaline phosphatase conjugated goat a -m o u se  IgM second 
antibodies were used, the incubation was allowed to proceed for 1 hour before a 
further round of washing and substrate application. In some later ELISA 
experiments, a biotinylated second antibody was used in conjunction with 
streptavidin alkaline phosphatase. Fifty microlitres of 1:5000 biotinylated goat 
a-mouse IgM second antibody added to each well and left for 3 hours. Plates were 
centrifuged and aspirated, then 50|il of 1:2000 streptavidin-alkaline phosphatase 
added and left for 1 hour. The replicate error between duplicate titrations in ELISA 
assays expressed as a percentage varies between 2-10%.
A method published by Klinman and Steinberg (1988) using fixed RBC to 
evaluate anti-BrM spleen cells was found to be unsuitable for serum antibodies and 
monoclonals. In this method, 0.1% RBC are allowed to form a monolayer and 
adhered to microtitre wells by the addition of 0.15% gluteraldehyde in PBS for 5 
minutes. The plates are washed with PBS and air-idriedL for 3 hours before 
blocking in 1% BSA and the assay continued as for a conventional ELISA assay 
by titrating antibodies instead of spleen cells. When this method of attaching 
erythrocytes to microtitre wells was adapted to ELISA assay conditions rather than 
an ELISA-Spot assay, high binding titres were noted against both BrMRBC and 
NMRBC. Thus, this method of attaching NMRBC to ELISA plates was found to 
be unsuitable and therefore not routinely used.
2.4.3. Direct agglutination of mouse erythrocytes (Direct Coomb's 
test)
Rabbit anti-BrM serum that has been extensively absorbed with NMRBC to 
remove cross reactive antibodies was titrated against BrMRBC and NMRBC in 
two or three fold steps from neat in 50 |il of 1% BSA for measurement of total 
specific immunoglobulin. For the measurement of IgG, serum was titrated in the
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presence of 1:70 2-mercaptoethanol (BDH 44143) and incubated at room 
temperature in a fume hood for 1 hour. Fifty microlitres of a 2% RBC suspension 
was added to each well and incubated at 30°C.
2.4.4. Direct Binding ELISA for erythrocyte ghosts.
Ghosts were allowed to bind to microtitre plates for two hours, centrifuged 
for 15 minutes at 1,000 rpm and washed twice in 1% BSA in PBS. Plates were 
blocked in 1% BS A in PBS for 90 minutes. First antibodies were applied, then the 
plates were treated in the same manner as descibed for the suspension assay from 
this step onward.
2.5.BLOOD GROUP SUBSTANCES AND SEROLOGICAL TESTS 
FOR RBC.
2.5.1. Preparation of blood group substances.
Blood group substances were prepared from a pool of 90 CBA/H retired 
breeder female mice and a separate pool of 71 mice according to the Kabat method 
(Kabat 1956). Mice were given water but food pellets were removed the night 
before the collection of stomachs. Stomachs were removed and flushed with 
approximately 1ml of sterile PBS (gut washings), then the stomach open ed and 
the mucosal surface was gently scrap ed with the handle of a scalpel blade into 
approximately 2ml of sterile PBS (gut scrapings).
Gut washings and scrapings were digested separately with pepsin (Sigma, 
Porcine stomach mucosae P6887) in 0.5 M citrate-HCl buffer , pH 2.3, and 
incubated at 37 °C with the addition of 1ml of toluene to maintain sterility. The pH 
was checked daily and adjusted with HC1 if required. On day 12, the digest was 
filtered , brought to pH above 5 with solid sodium acetate and blood group 
substances were precipitated overnight with 3 volumes of ice-cold absolute 
alcohol. The precipitates were washed twice with absolute ethanol, dried and used
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at concentrations of lm g solid/ml diluent without further purification or evaluation 
in dot blot experiments.
Occasionally, an extract of fresh gut was prepared from 1-2 mice by scraping 
the mucosae into sterile saline , centrifuging the solids and evaluating the proteins 
in the supernatant by SDS-PAGE or immunoblotting.
2.5.2. Treatment of erythrocytes with AET and periodate.
One way to determine if blood group antigens are involved in unknown 
erythrocyte epitopes is to use substances that are known to destroy these antigens 
specifically on human red blood cells. A 6% aqueous solution of 
2-aminoethylisothiouronium bromide (AET, Sigma A 5879) destroys antigens that 
are part of the Kell blood group system. Incubation of NMRBC or BrMRBC in 
aqueous solutions of AET results in lysis, so AET was also dissolved in PBS, pH
7.2. Four millilitres of 6% AET is added to 1ml of washed and packed RBC and 
incubated for 20 minutes. The treated RBC are then washed three times in PBS 
before use (American Association of Blood Banks Technical manual 1985).
Aqueous solutions of sodium meta-periodate have been used to destroy 
human A, B, O, H, P, M, N, D and Lea human blood group antigens 
(Kabat,1956). Periodate solutions were prepared at 0.005M pH 4 and 0.001 M pH 
5 and were used in a 1:1 ratio with packed NMRBC and BrMRBC for 15 minutes 
at room temperature in a foil-covered test tube. Cel^were washed three times m 
PBS before use.
2.6. PREPARATION OF AFFINITY COLUMNS
A ffin ity  chrom atography gels were prepared with cyanogen 
bromide-activated Sepharose 4B according to manufacturer’s recommendations 
(Pharmacia Fine Chemicals, North Ryde, Australia; Affinity Chromatography 
principles and methods, 1979). An appropraite amount of cyanogen-bromide
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activated Sepharose was weighed and regenerated in ImM HC1 for 15 minutes. 
The gel was then washed three times with 200ml/g Sepharose of 1 mM HC1 on a 
sintered glass filter attached to a Buchner flask and vacuum pump. The gel is then 
washed with coupling buffer, 0.1 M NaHCC>3 containing 0.5 M NaCl, pH 8.3,
and transfered to a sterile centrifuge tube containing the ligand to be coupled to the 
gel at 5-10 mg protein per ml. Three types of ligand were coupled to Sepharose,
namely BrM-ghosts, Rabbit a-BrMRBC serum and bovine carbonic anhydrase.
Coupling was allowed to take place on an end-over-end rotator overnight at 
4°C. Coupling efficiency was determined by measuring the amount of protein in 
the original sample and the amount of protein remaining in the supernatant after 
conjugation by measuring the optical density in quartz cuvettes at 280nm. The 
coupling efficiency is determined b y :
Coupling efficiency -  Protein before conjugation - protein after conjugation x jqo
Protein before conjugation
Reactive groups were blocked for 2 hours at room temperature with 1M 
ethanolamine, pH 8.0, and the gel was washed in alternating cycles of coupling 
buffer and acetate buffer (0.1M acetate containing 0.5M NaCl, pH 4). The gel was 
stored at 4°C in PBS-0.1% sodium azide.
2.7.PURIFIED ANTIGENS AND CHEMICALS
2.7.1. Purified proteins and protein assay
A number of purified proteins were purchased from Sigma and assessed by 
western blotting including glycophorin A ( G 5017), human asiaologlycophorin (A 
9791), carbonic anhydrase from bovine(C 7500), human (C 6892), rabbit (C 
1266) and dog (C 3513) erythrocytes. Fetuin (F 2379) and asialofetuin (A 1908) 
were purchased from Sigma and used as controls to assess the removal of sialic 
acid by neuraminidase and O-linked carbohydrates by O-glycanase.
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Lowry protein asays (Lowry et a l  1951) were scaled down so that they 
could be conducted in eppendorf tubes and processed in microtitre plates. 
Standards were prepared from a stock solution of 500jig/ml BSA in 200|il 
volumes. Protein samples were diluted so that the amounts of protein were within 
the same range as the standards. Lowry reagents were made up on the day of use 
and consisted of : Reagent A - Na2CC>3 w/y) in 0.1M NaOH; Reagent B -
lml of CuS04. 5H20  (1% w/v) and 1 ml potassium tartrate (2% w/v); Reagent C
- 2ml of Reagent B and 48ml of Reagent A; Reagent D - 1:1 ratio of Folin & 
Ciocalteu’s phenol reagent and distilled water.
To each 200|il sample or standard, 1 ml of reagent C was added and allowed 
to incubate at room temperature for 15 minutes. Reagent D is then added at 0.1ml 
per tube, mixed by inversion and allowed to incubate for 30 minutes. A 200 jxl 
aliquot from each tube was transferred to the wells of a microtitre plate and the 
optical density measured at 630 nm. The amount of protein in the sample was 
determined by reference to a standard curve and the line of best f i t .
2.7.2. Buffers
Alsever's solution was obtained as a filter sterilised solution from the John 
Curtin School of Medical Research. Sterile saline was prepared by autoclaving a 
0.85% (w/v) NaCl solution. Phosphate buffered saline consisted of 0.85%(w/v) 
NaCl, 0.107% (w/v) Na2H P04, 0.39% (w/v) Na H2P 0 4 and 0.2% (w/v) NaN3, 
pH 7.2.
Bovine serum albumin was prepared as a 1% or 3% (w/v) solution in PBS 
with 0.1% (w/v) NaN3 from a 10% (w/v) stock solution of BSA in water. Gelatin
was prepared as a 0.5%(w/v) solution, with 0.5%(v/v) NaCl and 0.5%(v/v) 
polyoxyethylene monolaurate (Tween 20).
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2.8. POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE) 
2.8.1.SD S -PAGE
The discontinuous SDS-PAGE method of Laemmli (1970) with 4-6%T 
stacking gel and 15-20%T separating gel was used in a minigel system (Biorad 
Mini Protean II) at 200V constant for approximately 55 mins for 0.75x 10 x 7 cm 
gels . M inigels were poured from a 30% total acrylamide (%T), 2.67% 
crosslinked (%C) stock, diluted to 10%T, 12.5%T, 15%T or 20%T as indicated. 
Acrylamide solutions were made 0.1% with respect to SDS and polymerisation 
initiated with N,N,N,N,-tetramethylethylenediamine (TEMED, Biorad 161-0800) 
and catalysed with ammonium persulphate (Biorad 161-0700). The separating gel 
was cast and overlayed with water saturated butan-l-ol to exclude oxygen and 
allow polymerisation to proceed uninhibited. Before the stacking gel was poured, 
butanol and any unpolymerised acrylamide are washed off with distilled water and 
a litde unpolymerised stacking gel solution. Stacking gels were poured with the 
appropriate combs.The composition of the upper and lower gel buffers is given in 
Table 2.2:
Table 2.2. Gel com position
Composition of gels(ml) 
Total (10ml)
Stacking gels 
4% T 6% T
Separating gels 
10% 12% 15% 20%
Distilled water (autoclaved Milli-Q) 6.1 5.4 4.02 3.19 2.35 0.68
Lower gel buffer (1.5M Tris-HCl,pH8.8) - - 2.5 2.5 2.5 2.5
Upper Gel Buffer (1.5M Tris-HCl, pH6.8) 2.5 2.5 - - - -
10% SDS 0.1 0.1 0.1 0.1 0.1 0.1
Acrylamde/bis acrylamide (30% stock) 1.3 2.0 3.33 4.16 5.0 6.67
10% Ammonium persulphate 0.05 0.05 0.05 0.05 0.05 0.05
TEMED 0.01 0.01 0.005 0.005 0.005 0.005
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Samples were diluted in either 2x or 5x sample buffer either with or without 
2-mercaptoethanol as a reducing agent, and either boiled at 100°C for 5-10mins or 
allowed to remain at room temperature before loading onto gels. Sample buffer (5x) 
consisted of 4 ml of distilled water, 1 ml of 0.1M tris-HCl, pH 6.8, 0.8ml of 
glycerol, 1.6ml of 10% stock SDS, 0.4ml of 2-mercaptoethanol and 0.2ml of 0.05% 
bromophenol blue. Sample loads were adjusted depending upon the staining 
method to be used, since Coomassie Blue will stain approximately lpg  of protein 
and silver stain lng. Minigels were electrophoresed at 200V constant for 30-50 
minutes or 100V constant for 60 minutes depending upon the migration of the 
bromophenol blue tracking dye.
After electrophoresis, gel^were stained or electroblotted or photgraphed as 
appropriate, and stored in sealed plastic bags with either 7% acetic acid or distilled 
water-0.1% sodium azide. Molecular weight markers were purchased from Biorad 
(Low range 161 0304 and High range 161 0303 ) and prestained molecular weight 
markers from Sigma Chemical Co. (SDS-7B) were used to ensure transmission of 
protein to nitrocellulose in pilot western blotting experiments (Table 2.3). Standard 
proteins of known pi were purchased from Biorad (161 0310) for use in IEF 
experiments.
2.8.2 Staining methods for proteins and glycoproteins
Gels were stained for proteins using either Coommassie Blue, collodial 
Coomassie Blue for detecting nanogram amounts of proteins in gels (Neuhoff et al. 
1988) or silver staining and for glycoproteins by Alcian Blue or periodic acid-Schiff 
Base stain. The composition of the stains is presented in the following Tables. Silver 
staining was conducted according to the method of Merril et al. 1981 using a kit 
from Biorad (Table 2.5) and occasionally gels were double stained with Coomassie 
Blue and silverstained following the methods of Dzandu (Dzandu et al. 1984,1985a 
&b; Deh etal. 1985).
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The Alcian Blue (Wardi and Michos 1972) and Periodic acid-Schiff methods 
(Sams and Palade 1979) were used to stain gels for glycoproteins. Alcian Blue is 
used in histology to stain acid mucopolysaccharides, sulphated mucopolysaccarides 
and sialic-acid containing compounds (Kieman 1981). Gels are soaked overnight in 
40% methanol/10% Glacial acetic acid, stained in Alcian Blue (0.5%w/v Alcian Bue, 
3%v/v glacial acetic acid to 100ml with distilled H^O; filter and add a crystal of
thymol) for 10-30 min and rinsed in running distilled water until the background is 
clear.
For Schiff s staining for carbohydrates, gels were fixed in 40% methanol/10% 
glacial acetic acid overnight and reswollen in 7% acetic acid. Gels were oxidised 
with 1% periodic acid in 7% acetic acid for 1 hour in the dark at 4°C and washed 
several times with 7% acetic acid over 24 hours. Schiff s Acid Fuschin (Sigma S 
5133) was used to stain the gels for 1 hour at 4°C and then destained in either 10% 
acetic acid or 1% sodium metabisulphite in 1% HC1.
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Table 2.3. SDS-PAGE and IEF molecular weight markers
Proteins Mwt (Daltons) High* Low Prestained IEF(pI)
Phycocyanin 232,000 (4.65)
Myosin (rabbit muscle) 200,000 •
Alpha 2 macroglobulin 180,000 •
(human plasma)
Beta-galactosidase E.coli, 116,000 • ♦
Phosphorylase B 97,400 • ♦
(rabbit muscle)
Fructose-6-Phosphate Kinase 84,000 •
(rabbit muscle)
Bovine serum albumin 66,200 • •
Haemoglobin A (human) 64,500 (7.10)
Haemoglobin C(human) 64,500 (7.50)
Pyruvate Kinase (chicken muscle) 58,000 •
Lentil lectin (Three bands) 49,000 (7.8,8.0, 8.2)
Fumerase (Porcine heart) 48,500 •
Ovalbumin 45,000 • •
Lactate dehydrogenase 36,500 ♦
(Rabbit muscle)
Carbonic anhydrase 31,000 • (6.00)
(Bovine erythrocyte)
Human Carbonic anhydrase 28,000 (6.50)
Trióse Phosphate isomerase 26,600 •
(Rabbit muscle)
Soybean Trypsin inhibitor 21,500 ♦
Beta-Lactoglobulin B 18,400 (5.10)
Myoglobin (Equine) 17,500 (7.00)
Lysozyme 14,400 ♦
Cytochrome c 12,200 (9.60)
* High molecular weight markers; Low molecular weight markers; Prestained markers 
with Coomassie Blue attached to allow direct visualisation of separation of proteins 
during an electrophoresis run and visualisation of blotting efficiency; IEF -isoelectric 
focussing markers and corresponding pi.
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Table 2.4. Coomassie Blue stains for proteins.
Coomassie Blue R-250 stains for proteins
Conventional Neuhoff et al. 1988
Fixative 40% Methanol,10% Acetic acid 1 hr 12% Trichloroacetic acid, 1 hr
Stain composition 0.1% CBB R-250 in fixative. 6% w/v ammonium sulphate 
0.1% w/v CBB R-250 




40% Methanol, 10% Acetic acid 
(1-3 hours,overnight)
Hg
No destaining required, 
ng
Table 2.5. Silver stain ing protocol.
Fixative 140%Methanol/10%HoAc(v/v) 
Fixative II 10%Ethanol/5% HoAc (v/v) 
Oxidizer (potassium dicromate/nitric acid) 
Deionized water 
Silver reagent (silver nitrate)
Deionized water
Developer (sodium carbonate/paraformaldehyde) 
Stop 5% acetic acid
30 min 
2 x 15 min 
5 min 
2 x 5  min 
20 min 
1 min
30 sec, then 2 x 5min 
5 min
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2.9. IM MUNOBLOTTING TECHNIQUES
2.9.1. W estern Blotting
W estern blotting is a powerful technique to separate and visualise 
immunoreactive protein components of cells or mixtures of proteins (Towbin et a l  
1979; Burnette 1981; Gershoni and Palade 1983; Beisiegel 1986). Western blotting 
onto nitrocellulose was conducted according to the principles of Towbin et a l  (1979) 
using a mini-transfer system (Biorad Mini Trans-blot) and a 25 mM Tris-192 mM 
glycine, 20% (v/v) methanol buffer, pH 8.3 for 1 hour at 100V constant 
(250-260mA). Blots were dried at room temperature, blocked with 3% BSA in PBS 
overnight at room temperature on a rocker, and washed extensively with 20 ml PBS 
containing 0.1% Tween 20 during all washing steps. Various times of incubation 
and concentrations of primary antibody were used and have been indicated in the 
appropriate sections.
The biotinylated goat a-mouse IgM antibodies (Sigma B 9265) used at 1:2500 or 
1:5000 to develop the blots, were routinely preabsorbed with NMRBC and 
BrMRBC to remove antibodies that were capable of directly binding to carbonic 
anhydrase-associated determinants on mouse erythrocytes. An alkaline phosphatase 
detection system (Leary et al. 1983) involving 1:2000 or 1:2500 streptavidin-alkaline 
phosphatase (Dakopatts D396), nitroblue tetrazolium (Sigma N6876) and 
5-brom o-4-chloro-3-indolyl phosphate, p-toluidine salt (B 8503 Sigma) 
(NBT/BCIP) in diethanolamine/HCl buffer pH 9.2 was used. For 100ml of 
diethanolamine buffer, 0.033g NBT in 440 p.1 of 70% dimethylformamide and 
0.0165g BCIP into 330jil of 100% dimethylformamide are used. NBT and BCIP 
are added to diethanolamine immediatlely before use and the reaction on 
nitrocellulose blots was allowed to proceed for 15-30 minutes. The reaction may be 
terminated by washing each blot extensively with running deionized water then 
drying with a hair dryer.
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In earlier western blotting experiments, including most of the dot blots, Fast Red 
was used as a substrate for alkaline phosphatase. Napthol ASBI phosphate (Sigma 
No N2250) was dissolved in 0.1M  Tris-HCl buffer containing lOOmg/L
M gCl2 7 H2O. Fast Red (Sigma No F I500) was added to the Napthol solution at 
lmg/ml, mixed vigourously, filtered and adjusted to pH 9.2 before use.
Some blots were stained for total protein using Amido Black 10B (Syu and 
Kahan 1987). Blots were placed in 0.1% (w/v) Amido Black in 45% (v/v) 
methanol, 10% (v/v) acetic acid for lOmins and destained with 90% (v/v) methanol, 
2% (v/v) acetic acid.
2.9.2. Lipid im m unoblotting
Two methods of lipid immunoblotting have been published (Buehler and Macher 
1986; Towbin et al. 1984). Following the basic procedure of Buehler and Machler 
(1986), 20jal of fresh gut and NMRBC were spotted on Silica gel 60 thin layer 
chromatography microslides (Analtech) and allowed to dry at room temperature. The 
slides w ere p laced  into chrom otography tanks preequilibrated with 
chloroform:methanol:water (60:35:8), and allowed to run until the solvent front was 
0.5cm from the top of the slide. Microslides were removed from the tank and 
allowed to dry for 1 hour in a fume hood. The TLC plate was sprayed with 
isopropanol:water (2:1) from an atomiser until damp, and nitrocellulose layed over 
the plate with pressure applied with a 1-2 kg weight for 2 hours. Nitrocellulose was 
removed and allowed to dry, then blocked with 1% gelatin and treated with LPS 
serum (1:40), goat anti-mouse IgM-alkaline phosphatase conjugate (1:1000) and 
Fast Red substrate.
CHAPTER TWO 70
2 .10 . ISO E L E C T R IC  FO C U SSIN G  AND TW O -DIM ENSIO NAL  
MAPS OF MOUSE ERYTHROCYTES
2.10.1 Isoelectic  focussing
The aim of conducting isoelectric focussing experiments was two-fold, to 
establish if the immunoreactive bands on SDS-PAGE were due to one type of 
protein only and to determine the isoelectric points of these bands. Isoelectric 
focussing has been used by several groups to determine 2-D maps of human 
erythrocyte membranes (O'Farrell, 1975) or whole red cell lysates (Edwards et al. 
1979).
Isoelectric focussing was conducted in capillary tubes using a Miniprotean II 
tube cell ( B iorad) according to the method of O'Farrell (1975). The composition 
of the gel monomer and sample buffers is summarised in Tables 2.6, 2.7 and 2.8. 
Capillary tubes were filled with monomer solution and allowed to polymerise.
Table 2.6. Tube gel m onomer solution (10ml)
9.2M urea 
4% acrylamide 
2% Triton X-100 
1.6% Biolyte 5/7 ampholyte 
0.4% Biolyte 3/10 ampholyte 
Distilled water
0.01% ammonium persulphate 
0.1% TEMED
5.5g
1.3ml stock acrylamide/bis (30%T/5.4%C) 
2.0ml of 10% deionized Triton X-100 
0.400ml 5-7 ampholyte 
0.100ml 3-10 ampholyte 
1.97ml
lOpl 10% ammonium persulphate 
10pl
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Table 2.7 F irs t dim ension sam ple buffer (10ml):
9.5M urea 5.7g
2% Triton X-100 2.0ml of 10% deionized Triton X-100
5% p-Mercaptoethanol 0.5ml
1.6% Biolyte 5/7 ampholyte 0.400ml 5-7 ampholyte
0.4% Biolyte 3/10 ampholyte 0.100ml 3-10 ampholyte
Distilled water to 10ml
Store at -80°C in 0.5ml aliquots
Table 2.8. F irs t dim ension sam ple overlay buffer (10ml):
9.0M urea 5.41g
0.8% Biolyte 5/7 ampholyte 0.200ml 5-7 ampholyte
0.2% Biolyte 3/10 ampholyte 0.050ml 3-10 ampholyte
bromophenol blue 0.050ml of 0.05% stock solution
Distilled water to 10ml
Store at -80°C in 0.5ml aliquots
The tube gels were pre-electrophoresed using either a Pharmacia 2000/2.0 or an 
LKB 2197 power supply at 200V for lOmins, 300V for 15 mins and 400V for 15 
mins with degassed 20mM NaOH present in the upper chamber and lOmM H3PO4
in the lower chamber. Protein samples dissolved in first dimension sample buffer 
were then loaded , overlayed with overlay buffer and electrophoresed at 500V for 
lOmins, then 750V for 3.5 hours. IEF gels were removed from the capillary tubes 
and either stained directly for protein or soaked for 10 minutes in SDS equilibration 
buffer (Table 2.9) prior to layering the gel onto a second dimension SDS-PAGE.
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For staining proteins in IEF gels, the gel was fixed in 5% sulphosalicylic acid 
(Merck 1194746) and 10% trichloroacetic acid (TCA, Ajax chemicals,558) for 1 
hour. Ampholytes were removed by methanol:acetic acid:water (3:1:6) and then 
stained with 0.2% Coomassie Blue R-250 in the ampholyte removal buffer or 
silverstained (Table 2.5.). Gels were fixed with 30% methanol,10% TCA, 3.5% 
sulfosalicyclic acid for 1 hour and rinsed several times over 2 hours with 30% 
methanol/10% TCA to remove the carrier ampholytes before silver staining.
2.10.2. Two dimensional electrophoresis of red blood cell lysates.
Isoelectric focussing in the first dimension was performed as outlined in the 
previous section. Tube gels were extruded from the capillary tubes and equilibrated 
in SDS sample buffer (Table 2.9.), then placed onto the top of a conventional 
SDS-PAGE gel and electrophoresed in a standard way (Section 2.8.1.). Two 
dimensional protein maps are useful for determining if a single band in SDS-PAGE 
gels is composed of one or more proteins, or determining if some protein component 
of cells is altered in disease states (O’Farrell 1975; Edwards et aL 1979; Dunbar 
1987.). Low molecular weight markers were electrophoresed in the second 
dimension in a separate well to assist in locating the murine carbonic anhydrase 
bands on two dimensional maps.
Table 2.9. SDS sam ple equilibration buffer
0.0625 M Tris-HCl,pH6.8 
2.3% (w/v) SDS








2.5ml of 0.05% (w/v) stock 
to 100ml
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2.11 . EN ZY M E-LIN K ED  IM M U NO ASSAY S FOR CARBONIC  
A N H Y D R A SE .
2.11.1. Direct binding assays for carbonic anhydrase
For the measurement of antibody titres against carbonic anhydrase, the inner 60 
wells of a glastic microtitre plate were coated overnight at room temperature with 
50jil of a QrS- mg/ml solution of bovine carbonic anhydrase that had been either left 
untreated (dissolved in phosphate-buffered saline) or denatured in various ways. 
Carbonic anhydrase was denatured by the following treatments: Acid treatment- 
lm M  HC1, pH 2.4 ; Heat- 60°C for 15 mins in phosphate-buffered saline; SDS + 
Heat- Heat in 10% SDS (Laurylsulfate, sodium salt L 4509) for 15 mins at 60°C; 
Urea - 10M urea (Sigma U 5378); Gu-HCl - 8M guanidine-HCl (Sigma G 4505). 
Concentrations of urea and guanidine-HCl used here are above the concentrations 
known to produce random coils of purified human carbonic anhydrase (Carlsson et 
al 1973).
Wells were aspirated and then blocked with lOOjil of 1% bovine serum albumin 
for 90 mins at room temperature. FUB 1 was titrated in three-fold steps and allowed 
to incubate for 90 mins. Plates were washed three times with lOOjil/well of 1% BSA 
and then coated with 50jil of 1:5000 Biotinylated Goat a-mouse IgM for 3 hours. 
Plates were aspirated and 50jil of 1:2000 Streptavidin-alkaline phosphatase allowed 
to bind for 1 hour. After three more washes,lOOjil of p-nitrophenylphosphate 
substrate in diethanolamine/HCl buffer, pH 9.2, was applied to each well and 
absorbance read at 410nm at 30 and 60 minutes. Endpoint titres were defined as the 
reciprocal of the dilution of FUB 1 at an OD cutoff point of 0 .2  at 30 minutes.
2.11.2 Competitive inhibition assays for carbonic anhydrase
In competitive inhibition assays with carbonic anhydrase, plates were coated 
overnight with 50|il of 500p.g/ml bovine carbonic anhydrase. Wells were blocked 
for 90 mins with lOOpl of 1% BSA in PBS. FUB 1 was titrated in the presence of
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200jj,g/ml carbonic anhydrase with the remainder of the procedure the same as a 
standard ELISA from the second antibody step onward.
2.12 MURINE CARBONIC ANHYDRASE
2.12.1. M ouse stomach carbonic anhydrase
The method of Carter and Parsons (1970) for the separation and purification of 
guinea pig gastric mucosae carbonic anhydrase was followed. 30 CBA/H retired 
breeder female mice were exsanginated under ether anaesthesia. Blood was collected 
as before, and the stomach was removed. The contents were washed out with 
ice-cold sterile PBS, and the mucosae removed with a glass slide that had been 
swabbed with 70% ethanol. The pooled mucosae was homogenized (6.2g wet 
weight) with 10ml of 0.3 mol/L sucrose in sodium phosphate buffer 30m mol/L, pH
7.2 at 0°C, using a glass homogenizer and teflon-coated plunger (10ml capacity, 50
(vJ/vz )
return strokes). Excess protein was precipitated with 55% ammonium sulphate 
(326g solid/L supernatant). Concentrate supernatant with Aquacide if required before 
fractionation on Sephadex G-75. Running and eluting buffer for run 0.1 mol/L 
solution of Na2SC>4 containing sodium phosphate buffer (0.05mol/L) pH 7.2.
Fractions tested for protein by the micro-Lowry method, and positive fractions mn 
on SDS-Page and western blots.
2.12.2. M ouse erythrocyte carbonic anhydrase
Erythrocytes were collected from the same 30 mice, pooled and washed in PBS. 
One volume of packed RBC were lysed with 2 volumes of ice-cold distilled water
(u / v  )  _
and fractionated with solid ammonium sulphate (45%ftof final volume). The pH was 
monitored and maintained at pH 7.2 by the addition of NH3 solution while the
solution was stirred on a magnetic stirrer for 1-2 hour at 2-4°C. The precipitate 
containing most of the haemoglobin was removed by centrifugation at 10,000 rpm 
for 1 hour at 0-4°C. The supernatant was retained and fractionated on DEAE
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-Sephacyl (Pharmacia) with 8mmol/L Triethanolamine-HCl (Sigma T1502), pH 7.8 
and 25 mmol/L Triethanolamine-HCl, pH 4.6. Protein-containing fractions were 
analysed by SDS-PAGE.
2.13. EPITOPE ANALYSIS OF CARBONIC ANHYDRASE
2.13.1. Carbohydrate epitopes
Examination of the mouse carbonic anhydrase II sequence obtained from 
examination of DNA suggests that possible sites of glycosylation (Ser , Thr and 
Asn) are located at the N-terminal end. On the basis of the molecular weights of the 
constituent amino acids of carbonic anhydrase, between 3-6% of the molecule may 
be accounted for by post-translational modifications such as carbohydrates. From the 
mouse CA II sequence, any carbohydrate linkages are likely to be of the O-linked 
type, with linkages on Ser and Thr only, because there is no sequence of tripeptides 
that follows the m otif for N-linked carbohydrates i.e. Asn-X-Ser(Thr) (Spiro 
1973). At this stage it was considered superfluous to use additional enzymes to 
remove N-linked carbohydrates when the possibility of them occurring seemed 
improbable. Two main methods of deglycosylation were attempted. In one method, 
carbonic anhydrase was deglycosylated with specific enzymes to remove O-linked 
carbohydrates and in the other method sodium meta-periodate was employed. The 
enzyme that specifically removes O-linked carbohydrates is endo-alpha- 
N-acetyl-D-galactosaminidase from Diplococcus pneumoniae (O-glycosidase 
Boehringer Mannheim Cat No 1012 142 or O-glycanase EC 3.2.1.97 pH 6-7 Mwt 
160,000).This enzyme has been shown to specifically remove O-linked 
oligosaccharides attached to either Ser and Thr (Umemoto et al 1977). It is known 
that sialic acid may interfere with this reaction, thus the glycoprotein must be treated 
with neuraminidase prior to endoglycosidase treatment.
In experiments where carbonic anhydrase was deglycosylated with enzymes, the 
reaction mixture (total final volume 40fil) containing 10jil of lmg/ml protein 
(lOOjig) was prepared in 20mmol/l sodium cacodylate buffer. Control proteins
CHAPTER TWO 76
included fetuin to check for the effectiveness of the neuraminidase digestion, and 
asialofetuin as a control protein for O-glycosidase digestion. Ten milliunits of 
neuraminidase i.e. 10|il (1U, Boehringer) was added to the protein and incubated at 
37°C for 19 hours. 2.5 mU of O-glycosidase i.e. 5 jli1, from Diplococcuspneumoniae 
was then added and incubated at 37 °C for 24 hours. The reaction was quenched by 
addition of IOjllI of 5X reducing sample buffer.
In some preliminary experiments, mouse carbonic anhydrase bands were excised 
from SDS-PAGE gels or whole mouse erythrocytes were digested with 
neuraminidase and O-glycanase and electrophoresed on a second SDS-PAGE gel. 
These conditions that digested an aqueous solution of protein were not optimum for 
digestion of carbohydrates from whole cells or proteins immobilised in 
polyacrylamide gels.
Periodate oxidation was conducted according to the method of Spiro (1966). 
BCA was dissolved at 5mg/ml in 0.05M sodium acetate buffer, pH 4.5. Sodium 
metaperiodate in sodium acetate buffer was added at final concentrations of 0.01M 
and 0.08M, due to the unknown amount of carbohydrate present and the unknown 
consumption of periodate. The reaction took place at 4°C in the dark overnight. The 
solutions are then place in dialysis bags and dialysed extensively against 3x 0.15M 
NaCl x 3L, then 3x d ^ O  x 3L. The volume is reduced back to the original volume
with Aquacide.
2.13.2. Protein analysis
One approach to defining the sites on carbonic anhydrase that are recognised by 
LPS serum and FUB 1 would involve proteolytic cleavage of the protein at certain 
restricted sites to give a limited number of cleavage products (Cleveland et al. 1977, 
Cleveland 1983). Upon electrophoresis and immunoblotting, the antigenic portions 
of the molecule may then be determined or defined. From examination of the mouse 
C A II sequences available derived from the nucleotide sequence, mouse CAII has a 
73%-81% homology to CA from other species (Curtis et a l . 1983). It contains 34 
amino acids unique to mouse CA II including an additional Arg in position 171, with
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a corresponding lack of Arg at position 57 in an area that is considered to be an 
invariant portion of the molecule for other species.
A number of proteolytic enzymes, including trypsin, chymotrypsin and chemical 
cleavage agents such as cyanogen bromide and hydroxylamine were considered, but 
they would have resulted in too many cleavage sites per carbonic anhydrase molecule 
and it would have been difficult to resolve the antigenicity of these smaller 
fragments. Thus endoproteinase Arg-C and papain were selected because a limited 
number of larger fragments would result. Once a larger fragment was recognised by 
immunoblotting techniques, the fragment could be further digested to determine the 
amino acids involved.
Endoproteinase Arg-C EC 3.4.21.40 is a serine protease isolated from mouse 
submaxillary gland that specifically cleaves proteins on the carboxylic side of 
arginine (Levy et al. 1970, Schenkein et al. 1981, Bousfield and Ward 1988.). The 
expected cleavage sites of endoproteinase Arg-C for mouse carbonic anhydrase II are 
indicated in Figure 5.1. in Chapter 5.
Peptide mapping in one dimension was conducted for carbonic anhydrase 
(Cleveland 1970). Initially this method was attempted with gel slices from a 
polyacrylamide gel preequilibrated in gel slice equilibration buffer/protease dilution 
solution, but these experiments resulted in protein smears. In a second method 
rec ommended for soluble protein , 5jig of carbonic anhydrase in 5jil of sample 
buffer was applied to each well and the lOjil of protease solution containing 5.6ng of 
endoproteinase Arg-C was carefully layered over the top (100:1 ratio of protein to 
enzyme). The protease dilution solution consisted of 2.5ml of stacking gel buffer, 
0.1 ml of 10% SDS, 1.0ml of glycerol, 20 *il of 0.5M EDTA, 30|il of 
2-mercaptoethanol, 6.3 ml of distilled water and a trace of bromophenol blue. The 
overlay solution consisted of 2.5 ml of stacking gel solution, 0.1ml of 10% SDS, 
2.0ml of glycerol, 20jil of 0.5 M EDTA, 3 0 jj,1 of 2-mercaptoethanol and 5.4 ml of 
distilled water. Electrophoresis through the stacking gel was conducted at a lowered 
voltage of 100V to allow digestion of the protein to occur and then the voltage was 
increased to 200V during migration of the fragments through the separating gel.
CHAPTER THREE
ANALYSIS OF RED BLOOD CELL MEMBRANES , GUT 
M ATERIAL AND SPECIFIC  ANTI-BrMRBC ANTIBODIES.
3.1. PR EA M B LE
In order to resolve the immunochemical nature of the BrMRBC-type of 
antigens which occur in vivo , the initial aim of these experiments was to obtain a 
purified form of the aqueous-type of BrM antigen from mouse stomach that had 
been demonstrated by Cunningham and Steele (1981) . Blood group substances 
have been prepared from a number of different tissues from a variety of different 
animals (Kabat 1956), but little work has been done with rodents species, except to 
type H-2 antigens on mouse erythrocytes (Gorer 1936, Spack and Edidin 1986) or 
to identify the Ii blood group system (Fezi and Childs 1985). Initially, the aim was 
to prepare blood group substances from the gut because this is a more concentrated 
site for blood group substances than on erythrocytes (Kabat 1956). After this 
material had been purified by the use of various affinity columns, the aim was then 
to return to purifying the BrM antigen from erythrocytes . To purify the material 
from the gastointestinal tract the steps envis ged were to : 1) prepare and purify 
hyperimmune Rabbit anti-BrM serum 2) prepare affinity columns of BrMRBC 
treated ghosts to obtain a highly specific Rb anti-BrM IgG from the hyperimmune 
rabbit serum, and 3) prepare another affinity column coupled with purified Rabbit 
anti-BrMRBC and use this to extract an aqueous antigen (blood group substances) 
prepared from a mouse gastric mucosae suspension. However, there were several 
negative results and problems with this approach that can be contemplated in 
hindsight, and the problem of the identity of the aqueous BrM antigen was 
approached from a completely different direction (Chapter 4).
Here the aims were to examine the erythrocyte membrane and material from 
the stomach mucosae for the presence of the BrMRBC-type of antigen, and to 
isolate and characterise the antigen(s). Another aim was to prepare specific 
anti-BrMRBC antibodies such as rabbit anti-BrMRBC hyperimmune serum in 
addition to LPS-stimulated serum from mice. Finally a number of serological tests 
were employed to characterise mouse blood group antigens.
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3.2. PREPARATION OF RED BLOOD CELL MEMBRANES
3.2.1. Preparation and characterization of protein-free and 
protein-containing ghosts
Protein-depleted cell membranes (or ghosts) were prepared from normal or 
bromelain-treated mouse erythrocytes by the method of Dodge et al. (1963) 
(Chapter 2 , Section 2.3.2.). In that paper, the optimum conditions of osmolarity 
and pH are described for preparing ghosts from human erythrocytes in which 
"essentially all the lipid is recovered but some non-haemoglobin nitrogen containing 
substance may be lost". The final stage in the method is to transfer the membrane 
pellet to a volumetric flask containg 0. IN  KOH and stand overnight at room 
temperature to form a homogeneous ghost preparation. In later experiments (Tables 
3.1.& 3.3, Figure 3.1) , this alkali solubilisation step was ommitted because 
protein-free ghosts were not effective in inhibition tests and gave low titres when 
tested against LPS serum.
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T able 3.1 Preparation and characterisation of different batches of 
g h o sts




8.92fig/m l ± 1 .3  
(n=6)
3 .15 |ig /m l ±  0.2  
(n=6)
1 3 .2 8 x l0 7
8 .6 6 x l0 7
nd1I
ND
BrM still retain stubborn Hb 
after same number o f washes as 
NMRBC
T hese ghosts were solubilised  
(from  a pool o f  19 m ice) in 
0.1NK O H
Batch 2
BrM RBC 1720pg/m l + 1 1 .8 6  4 . 2 2 x l 0 8 
(n=4)
8 .55m g/m l G h o sts  prep ared  from  30  
retired breeder m ice.G hosts not 
treated with 0.1N KOH
Batch 3
BrMRBC 2408jig/m l ± 4 .9 7  
(n=4)
8 .2 x l0 8 12 .55m g/m l G h o sts  p rep ared  from  50  
retired breeder m ice. Ghosts not 




See Table 4.3 ND ND Ghosts prepared from 
25 retired breeder m ice. Used in 
SDS-PAGE experiments in Chapter 
4. (Table 4.3).
*Protein determined by a microLowry method, using BSA as standard . The protein in the ghost 
samples was determined from substituting the OD into the equation of the line of best fit (e.g. 
Batch 1, y=0.0012x+0.0039; correlation coefficient r=0.99, where y= Optical Density,4 lOnm & 
x= \xg protein {BSA standard}), and expressed as jig/ml average of duplicate determinations. The 
lines of best fit for each experiment are: Batch 2 y= 0.0023 =0.0056x; Batch 3 y=0.0039 = 
0.0012x; Batch 4 y=0.0036 = 0.0014x.
# ghosts/ml determined as "intact" ghosts after staining with methylene blue in sterile saline, 
f  Not determined
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3.3. IM MUNISATION OF RABBITS WITH BrMRBC.
3.3.1. Preparation of immune rabbit serum
One aim was to raise high titre anti-BrMRBC in rabbits for use in the 
purification of the erythrocyte and gut BrM antigens (see Table 3.2), Titres of the 
collected serum were determined by direct Coomb's test (Table 3.2).
p-mercaptoethanol (2-ME) was used to dissociate IgM so that levels of IgG 
specific for BrMRBC could be determined.
Certain problems were experienced in obtaining enough suitable serum from 
this method including : 1) the fact that the rabbits were of undetermined age and 
background, 2) antibodies were probably raised against other mouse erythrocyte 
antigens and 3) the time taken to raise high titre antibodies was fairly lengthy and 
occasionally the anti-BrMRBC titre would decrease upon repeated immunisation. 
Given the problems experienced it no longer became economical to dwell on 
producing rabbit immune serum and the design of other experiments that would 
give clearcut results took priority.
3.3.2. Testing of the ability of Rabbit serum to be inhibited by 
B rM -ghosts
In an experiment to test whether the '’BrM-ghosts" had retained the 
BrMRBC epitopes, an attempt was made to inhibit the binding of Rabbit P day 51 
serum to BrMRBC in direct agglutination assays with either 2.72|ig protein/well, 
5.44|ig protein/well or 13.6p.g protein /well BrM ghosts . Rabbit serum was 
titrated in three-fold steps in duplicate from an initial dilution of 1 in 3 , and the 
endpoint occurred at 1 in 2187 for all wells (results not shown), regardless of the 
presence of BrM ghosts as inhibitory particles. This may be due, in part, to the 
ghosts participating in an agglutination lattice or being used at too low a 
concentration to achieve inhibition..
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T a b l e  3.2.  I m m u n i s a t i o n  s c h e d u l e s  fo r  R a b b i t s  BW and  P
1. Rabbit BW
Day 0 0.1m l 10% BrM in sterile saline (no azide used in washing steps) i.v marginal ear vein 
Day 28 0.6m l 10% BrM in sterile saline (no azide used in washing steps) intradermally (0.2ml/ each 
leg, 0.2m l in neck fat fold); Day 36 B leed from marginal ear vein, allow to clot overnight. Absorb 
1.5ml Rb serum 4x 20% packed NMRBC (30 mins rt, 30mins ice) Test by direct Coombs test using 1% 
B SA  as a diluent. Reciprocal o f the endpoint o f the titrations is presented in these table. 
----------------------------------- NM absorbed unabsorbed
Rb antiB 512 1024
Rb anti-B 2-ME 256 512
Rb anti NMRBC 64 128
Rb anti N  2ME 64 128
Day 48 B oost as for d28;d52 Rabbit taken to a ’veterinary surgeon and put down 
2. Rabbit P
D ay 0 0.1m l BrMRBC i.v. in left marginal ear vein; Day 21 Boost 0.1m l BrMRBC i.v. in left
marginal ear vein; Day 4 4  B oost 0.6ml, 0 .2  ml to each hind leg, 0.2ml to the scruff o f then neck; 
Day 51 collected 30m l o f blood from ear vein and thus 12 ml sera, absorb 4x with 20% NMRBC
________________ *NM absorbed_______unabsorbed
Rb antiB 6561 19683
Rb anti-B 2-ME 6561 19683
Rb anti NMRBC 243 729




D ay 91, D ay 101 collected  blood from marginal ear vein (only a weak anti BrM repsonse.) and
pooled serum . NMabsorbed unabsorbed
Rb antiBrM 27 2187
Rb anti NMRBC 0 81
D ay 105 B oost ala 0.6ml id; Day 133 B oost 0.6m l i.d.; Day 140 Test bleed (2ml blood)
Day 144 Rabbit in com a by lunchtime. Terminal bleed from the heart under anesthesia (Rompon and 
Ketamine)
*NM  absorbed refers to rabbit serum that has been preabsorbed with packed NMRBC to remove 
anti-NMRBC antibodies, and unabsorbed refers to serum that has not been preabsorbed before use.
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3.4 PR EPA R A TIO N  OF GHOST AFFINITY COLUMNS AS A 
F IR S T  ST E P  IN  TH E P U R IF IC A T IO N  OF SPEC IFC  
ANTI-BrM RBC ANTIBO DIES.
3.4.1. Testing the binding titres o f LPS serum against BrM-ghosts 
in ELISA
In preliminary experiments with LPS stimulated serum, the suitability of 
ghost material was tested in ELISA . In a direct binding c-ELISA, wells of an 
ELISA plate were coated with 2% NMRBC, 2% BrMRBC and BrM ghosts 
resuspended from a stock solution at concentrations of 1.36 jig/well {lx}, 2.72 
M-g/well {2x} and 6.8 p,g/well {5x} . LPS stimulated serum was titrated in 3-fold 
steps from 1:10 (Figure 3.1a) and the binding titres expressed in Table 3.3. LPS 
serum bound to BrMRBC and BrM ghosts used at 6.8|ig/ml {5x BrM ghosts} at a 
higher titre than BrMRBC ghosts used at lower concentrations per well or 
NMRBC.
In a repeat experiments (Figure 3.1b and 3.1c), the basic pattern was 
repeated but the titres obtained under similar conditions were elevated. LPS serum 
bound to BrMRBC and BrMRBC ghosts but not to NMRBC in these experiments. 
The only significant change made was that different batches of BrM ghosts 
containing more protein were used, with a resulting higher titre. It would appear 
that not all protein was removed from ghosts left in PBS as opposed to ghosts left 
overnight in 0.1N KOH. On the basis of these results, BrM ghost columns were 
made with protein-containing ghosts (Section 3.4.2.), although the negative results 
obtained with the columns prompted a reexamination of BrM-ghosts in ELISA and 
their ability to inhibit binding against BrMRBC in competitive-inhibition ELISA 
assays was then evaluated ( Section 3.4.3).
These results demonstrate that when BrMRBC ghosts are allowed to adhere 
overnight to plastic microtitre plates antigenic sites are presented that LPS serum is 
capable of binding to in ELISA experiments. The binding titre of LPS serum may 
be increased if the BrM ghosts are not pretreated with KOH to produce protein-free 




Table 3.3. Binding titres i o f LPS serum against BrM ghosts , NMRBC and 
BR M RBC
Expedient 1 Experiment 2 Experiment 3 
Alkali-treated Batch #2 Batch #3
x BrM ghosts (jig protein/well)* (1.36) (13.6) (120.4)
lx  BrM ghosts* 180 2040 11000
2x BrMghosts {2.72jig/well} 190 nd nd
5x BrMghosts {6.8jj.g/well} 660 nd nd
BrMRBC 265 475 1358
NMRBC 23 12 50
$ Reciprocal of binding titre
* Protein measured by microLowry, ghosts washed in PBS before use and resuspended in PBS to 
give a higher concentration of protein/ml than the original samples in Table 3.1. Note that the 
concentration of lx  ghosts is vastly different in each separate experiment.
* In experiment 1, ghosts from the same batch were washed with PBS and then resuspended at 
either 1.36 jug protein/ well or 2.72 pg protein/well or 6.8 jig protein/well, hence lx, 2x and 5x 
BrM ghosts respectively.
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Figure 3.1. Titration of LPS stimulated serum against BrM-ghosts in 
suspension c-ELISA.
a) Experiment 1: LPS-serum was titrated in 3-fold steps from 1:10, second 
antibody at 1:500, OD read at 30 mins. Ghosts from Batch 1 Table 3.1.
Target antigens: 2% BrMRBC ( •  ), 2% NMRBC ( O ), lx  BrM-ghosts(B ), 2x 
BrM-ghosts (□ ) ,  5x BrM-ghosts (A ).
b) Experiment 2: Suspension c-ELISA conditions as above, but different batch of 
ghosts (see Table 3.2 Batch 2) Target antigens: 2% BrMRBC ( • ) ,  2% NMRBC 
( O ), lx  BrM -ghosts(B).
c) Experiment 3: Suspension c-ELISA conditions as above, but different batch of 
ghosts(seee Table 3.2, Batch 3) Target antigens: 2% BrMRBC ( • ) ,  2% NMRBC 
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3.4.2. The preparation of BrM ghost affinity columns and attempts 
to purify anti-BrM  antibodies from LPS serum.
A ffin ity  colum ns were prepared by attaching BrM -ghosts to 
cyanogen-bromide activated Sepharose, and used to purify anti-BrM ghost 
an tibodies from  L PS-stim ulated  serum . Follow ing m anufacturer's 
recommendations on the optimum levels of protein that can be attached to 
CN-Bromide Sepharose, 10 ml of freshly prepared and resuspended BrM ghosts 
(not alkali treated) from the batch of 50 mice containing approximately 20 mg/ml of 
protein were coupled with a coupling efficiency of 95.8% . These ghosts had been 
tested for reactivity with LPS-serum in suspension ELISA (Experiment 3 in Table 
3.1 and Figure 3.1c.).
In a preliminary experiment three ml of LPS serum was loaded onto the 
column, the effluent was collected and the column washed with 20ml of PBS. 
Antibodies were eluted from the column with 3M sodium thiocyanate and 1ml 
fractions collected; the optical density at 280nm measured with protein-containing 
fractions pooled and dialysed overnight against phosphate-buffered saline and 
adjusted back to the original volume with Aquacide.
LPS serum, the collected fall through and the anti-BrM eluate were tested for 
anti-BrM activity and anti-NMRBC activity in a suspension ELISA (Table 3.4). 
The column did not bind all anti-BrM antibodies in LPS-serum as shown by the 
anti-BrM activity present in the fall through, however the theoretically remaining 
anti-BrM activity cannot be accounted for in the anti-BrM eluate. Perhaps activity 
in the anti-BrM eluate was lost during elution with sodium thiocyanate and 
dialysis, or alternatively was still retained on the column and not dislodged by 
thiocyanate elution. Other reasons for the failure of BrM-ghost affinity columns 
will be discussed below in section 3.6.
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Table 3.4. Anti-BrMRBC and anti-NMRBC titres of LPS serum, column fall 
through and eluted anti-BrMRBC antibodies.
NMRBC# BrMRBC Voi anti-BrM Units* % activity^
LPS serum 5.2 2000 3ml 6000 100%
Fall through 0 160 5ml 800 13%
anti-BrM eluate 0 3 3 ml 9 0.15%
* (volume x titre)
# average of duplicate titrations
Setting the initial LPS titre against BrMRBC as 100% activity, the fall through retains only 13 % of 
the original activity and the anti-BrM eluate retains 0.15% activity.
3.4.3. C om petitive ELISA assays using BrM ghosts to inhibit 
binding of LPS serum to BrMRBC
One concern about using solid phase supports and adhering agents with
p
erythrocytes (and presumably ghosts) is that binding to solid-phase sugorts 
appears to create neo-antigens on normal red blood cells that confuse the situation 
when one is trying to sort out the nature of the "hidden" BrM antigen (Jonusys and 
Steele 1988). In theory this problem should not occur with suspension-type 
ELISA assays, however, inhibition assays would appear to be ideal in bypassing 
this problem because antibodies would bind to native antigens in solution.
In ghost inhibition assays, LPS serum was preincubated with various 
concentrations of ghosts overnight at 4°C, the supernatant was retained after 
centrifugation to sediment ghost-antibody complexes and used against NMRBC 
and BrMRBC in a suspension-type ELISA. NMRBC ghosts were used as control 
ghosts. In this series of experiments, NM-Ghosts or BrM ghosts did not inhibit 
binding of LPS serum to BrMRBC (result not shown). This may be due to a 
number of factors, namely the ghosts did not contain the BrM-antigen, or if the 
BrM antigen was present it may have not been present in sufficient concentration to 
achieve inhibition.
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3.5. SEROLOGICAL TESTS TO DETERMINE THE NATURE OF 
MOUSE BLOOD GROUP ANTIGENS.
3.5.1. AET and periodate treatment of NMRBC and BrMRBC.
Cunningham and Steele (1981) presented preliminary data that a blood-group 
-like substance may possibly be involved in the BrM-determinant isolated from 
mouse stomach. Thus, in order to demonstrate if blood group substances on 
erythrocytes are involved in the BrM determinant, chemicals to destroy blood 
group substances were employed. The aim was to destroy blood group substances 
using sodium periodate and 2-aminoethylisothiouronium bromide (AET) and test 
by direct agglutination with LPS-serum. A 6% aqueous solution of AET destroys 
antigen of the Kell blood group system, except Kx (AABB Tecnical
manual, 1988). 0.001M periodate at pH 5 for 15 minutes destroys M,N and D 
antigens while A ,B ,0,H ,P and Lea receptors are not affected and 0.005M 
periodate at pH 4 for 15 minutes is capable of destroying A,B, O, and H receptors 
(Kabat 1956).
Both AET and periodate in aqueous solution lyse mouse erythrocytes so 
these results were inconclusive, and when these tests were repeated with AET and 
periodate in PBS lysis of mouse RBC still occurred. This would indicate that 
further experimental conditions would need to be investigated to provide an 
environment in which lysis did not occur in the presence of these reagents, or 
changes may have to be made to the standard protocol for human red blood cell 
with regard to the concentration of reagents, times and temperatures of incubation.
3.5.2. Use of anti-A and anti-B typing reagents with vertebrate red 
blood cells.
Mouse RBC and BrMRBC are not agglutinated with anti-A or anti-B typing 
reagents.The same result occurred with sheep and human RBC and 
bromelain-treated SRBC and human group O RBC. Rat, rabbit and horse RBC 
and the bromelain-treated equivalents were all agglutinated by anti-B typing 
reagent. Thus, mouse red blood cells and bromelain-treated mouse red blood cells
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do not appear to carry A- or B-blood group substances, making these type of 
blood group substance unlikely target antigens on BrMRBC.
3.5 .3 . P reparation  o f B lood G roup Substances from  mouse 
stom ach.
Blood group substances were prepared as outlined in Materials and methods, 
however, due to the problems experienced in preparing and purifying specific 
Rabbit anti-BrM antibodies, they could not be purified as originally planned and 
were used in the next chapter in optimising conditions for dot-blotting.
3.6. DISCUSSION
Although the initial aims and approaches taken to purify the BrM antigen 
were theoretically achievable, a number of setbacks and negative results prompted 
a close examination of the problem and a new approach is outlined in the following 
chapters. One question raised by the preparation and use of BrM ghosts is 
whether protein-free ghosts actually contain the BrM epitope. The fact that lower 
titres are demonstrated against protein-free ghosts ELISA (Table 3.3; Figure 3.1) 
when compared to later batches of ghosts that contained significantly more protein 
as determined by the Lowry method tends to support this idea. Others have 
prepared BrM ghosts using the Dodge method with success to purify specifc 
anti-BrM or to specifically inhibit anti-BrM plaque formation (Pages and Bussard 
1978; Poncet et al. 1985). However, it was not exactly specificed in these papers if 
the ghosts prepared were alkali-treated protein-free ghosts as specificed by Dodge 
et al. (1963) or protein-containing ghosts and if so, the types of proteins have not 
been shown by SDS-PAGE. In the demonstration of the effect of bromelain on 
RBC membranes, Cunliffe and Cox (1979) did not strip all protein from 
membranes with alkali treatment and membrane proteins apart from Band 3 are 
well represented in these ghosts.
The most significant observation here however is that the binding titre is 
roughly dependent upon the protein content of the ghost membrane (Tables 3.1. 
and 3.2 and Figure 3.1.) as protein deficient BrM-ghosts appear to bind less LPS
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serum than those that contain protein. This of course raises the question of what 
types of proteins are present in BrM-ghosts and NMRBC ghosts that have not 
been treated with strong alkali, and this will be examined by SDS-PAGE in the 
next chapter.
The purification of in vivo forms of the BrM antigen from RBC and mouse 
stomach is dependent upon the use of specific anti-BrMRBC reagents. Mouse 
LPS-serum is easily prepared, but suffers from the disadvantage in deploying 
methods that depend upon high affinity of antibodies for a ligand in that most of 
the anti-BrM activity is confined to IgM (Cunningham 1976), and the possiblity 
that many antibodies with many different specificities may be present. Several 
unsuccessful attempts were made to produce specific rabbit anti-BrM IgG and 
alternative sources of BrM-specific antibodies such as LPS-stimulated serum and 
monoclonal antibodies were investigated and used for the rest of the project.
One of the major difficulties in using LPS stimulated serum to attempt to 
purify BrM-type antigens is that the the exact binding specificities of antibodies 
cannot be known with certainty. If LPS acts as a B lymphocyte mitogen, then 
presumably all resting B cells (virgin and /or memory) must be stimulated to 
produce antibodies. This is likely to result in a collection of high and low affinity 
antibodies all with differing specificities, with the only certain factor being that a 
high proportion of the B-cells and the antibodies they produce appear to 
specifically bind to unknown epitopes on autologous RBC that have been treated 
with bromelain. Consequently, in order to determine the unknown in vivo 
epitope(s), one must use at least one defined reagent of limited specificity, and 
Professor Cox of Flinders University, Bedford Park, South Australia agreed to 
allow me to use a monoclonal antibody, FUB 1, that had been selected for on the 
basis of reactivity to BrMRBC in complement dependent lysis assays. The use of 
this BrMRBC-specific reagent clarified some of the problems encountered here and 
allowed a fresh attack on the problem from a completely different approach, as will 
be outlined in the next chapter.
On the basis of the binding observered in these c-ELISA experiments (Table
3.3 and Figure 3.1), a BrM-ghost affinity column was constructed. However, 
when LPS serum was applied to the column and anti-BrM antibodies could not be
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eluted or recovered in total from the fall-through antibody fraction (Table 3.4), 
this may be due to a number of reasons: 1) Antigen was altered in the coupling 
procedure such that it was no longer recognized by autoantibodies; 2) The LP^ 
may not have been in contact with the column for sufficient time for binding to take 
place, as seen in the relatively high titre of anti-BrM in the fall through fraction, 
and yet sufficient LPS serum must have been bound for the decrease of anti-BrM 
titre in the fall through when compared to LPS serum. Alternatively, 3) the loss in 
anti-BrM activity in the eluate may have been due to inactiviation during 
thiocyanate treatment and dialysis, or incomplete elution from the column.
The experiments conducted to destroy blood group substances by either AET 
treat ment or periodate treatment were not conclusive because mouse red blood 
cells were particularly sensitive to lysis by these agents whether they were used as 
aqueous solutions or dissolved in phosphate-buffered saline. The results were 
inconclusive because the endpoint of the direct agglutination assay is difficult to 
determine when lysis occurs. Using human blood grouping reagents with RBC 
from various species, mouse RBC do not agglutinate with either anti-A or anti-B 
reagents. This suggests that mouse RBC or bromelain-treated mouse RBC do not 
contain the terminal immunodominant sugars N-acetyl glucosamine or N-acetyl 
galatosamine. Other blood group systems such as Ii have been shown to occur on 
mouse RBC (Feizi 1988), but reagents to test for these blood groups are not 
readil. y available . Crude blood group substances were prepared but could not be 
purified by passage over a specific anti-BrMRBC affinity column.
CHAPTER FOUR
IMMUNOBLOTTING OF MOUSE RED BLOOD CELLS
4.1. PREAM BLE
The initial aim of the project was to characterise the in vivo forms of the BrM 
RBC antigen(s), and the initial negative results obtained (Chapter 3) indicated that a 
completely different approach was in order. Protocols to determine the nature of the 
BrM-antigen(s) could not be designed without at least knowing whether a protein, lipid 
or carbohydrate or combination of these was involved in the epitope. Results obtained in 
the last chapter with erythrocyte ghosts indicate that proteins may be involved in the BrM 
antigen, and although the evidence supporting phosphatidylcholine is solid, it does not 
rule out entirely another component contributing to the BrM epitope. SDS-PAGE 
combined with Western blotting techniques of whole BrMRBC and NMRBC could 
either show or rule out if  proteins were recognised by anti-BrM antibodies. 
Alternatively, if this approach was not successful thin-layer chromatography combined 
with lipid immunoblotting could possibly give insight to the types of molecules involved 
in the BrM-epitope. After these avenues have been investigated, then the possible 
involvment of attached carbohydrates could be assessed if the BrM-epitope was found to 
be a glycoprotein or glycolipid.
Another problem of concern was that LPS serum that has been used previously 
was probably polyclonal. Thus, a specific anti-BrMRBC hybridoma, FUB 1, that had 
been produced by Prof. K. O. Cox's Laboratory at Flinder's University was obtained, 
subcultured and used in dot blot and ELISA experiments. FUB 3 and FUB 4 , with 
specific binding to BrMRBC/Rat RBC and Rat RBC respectively, were also cultured but 
not used extensively in this study.
In preliminary dot blots, BrMRBC, NMRBC, BrM-ghosts, NM-ghosts, gut 
washings and gut scrapings were evaluated with LPS serum and FUB 1 and FUB 3. 
Different patterns of binding were established for LPS serum and the monoclonal 
antibodies. However, background staining was a major problem and as a result all steps 
in the immunoblotting procedure were evaluated and modified. Whole BrMRBC and 
NMRBC were used in Western Blotting experiments with LPS serum and FUB 1 
mainly because whole cell preparations are normally used for haemolysis and
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cellular-ELISA assays, and it is possible that some antigenic epitopes may be lost in the 
preparation of erythrocyte ghosts. Immunoreactive bands were detected at approximately 
30kD and the identitiy of these bands and relationship to the BrMRBC antigen(s) will be 
established in this chapter.
4.2. OPTIMISING CONDITIONS FOR DOT BLOTTING .
4.2.1. Production and characterisation of the monoclonal 
antibodies FUB 1 and FUB 3.
Anti-BrMRBC (FUB1 and FUB 3) and anti-Rat RBC (FUB 3 and FUB 4) 
hybridomas were obtained and subcultured. The levels of IgM were determined for FUB 
1 and FUB 3, in conjunction with LPS serum and normal mouse serum by radial 
immunodiffusion in agar with a commercial kit (Table 4.1). Levels of IgG in FUB 4 
culture supernatants were not assessed for two reasons , namely, FUB 4 was not 
routinely used in this study and the cost of a separate kit for the determination of IgG 
was prohibitive.
Endpoint titres of LPS serum, FUB1 and FUB 3 were determined in a 
suspension c-ELISA against BrMRBC and NMRBC (Table 4.1.). For LPS serum the 
total level of IgM was determined by RID, whereas for FUB the level of IgM determined 
is indicative of the amount of anti-BrMRBC activity.
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Table 4.1 Levels of IgM in different batches of LPS stimulated serum (LPS), normal 
mouse serum (NMS) and Flinders University Biological Sciences Monoclonals (FUB) 
as determined by radial immunodiffusion in agar at 100 hours and reciprocal binding 
titres of LPS serum and FUB monoclonal antibodies against BrMRBC and NMRBC in a 
suspension c-ELISA
Antibody Level of IgM BrMRBC NMRBC
LPS (2/3/90) 7.6 mg/ml
NMS (1990) 722fig/ml
LPS (1988) 6.6mg/ml 850# 1.2
FUB 1A 65|ig/ml 65 0
FUB IB 65jig/ml 180 0
FUB 1C 60.5pg/ml 100 0
FUB3B 56pg/ml 0 0
LPS (1987)* 27.8jig/ml
* This batch of serum has probably deteriorated over time, serum was evaluated in 1990 from stocks 
kept at -20°C.
# Reciprocal endpoint titres of LPS serum and FUB monoclonals in asuspension c-ELISA experiment 
against BrMRBC and NMRBC. Average of duplicate titrations.
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4.2 .2 . O ptim ising conditions of blocking, washing and levels of 
second antibodies in Dot Blots o f mouse red blood cells, ghosts and 
blood group substances.
In preliminary dot-blot experiments, LPS serum, FUB 1 and FUB 3 were 
tested against BrMRBC, NMRBC, BrM ghosts, NM Ghosts, gut washings and gut 
scrapings (Figure 4.1.). The pattern of reactivity was found to be : IgM antibodies in 
LPS serum recognised all six target antigens; FUB 1 could detect BrMRBC and 
BrM-ghosts; whereas FUB 3 recognised BrMRBC alone. In the PBS control to detect 
if second antibody is binding directly to antigens, some binding is noted against 
BrMRBC and NMRBC, and the background on all blots was quite high. In other dot 
blot experiments, the minimum number of RBC detected was 1x10^ RBC/spot (not 
shown). When LPS-serum was titrated against 1x10^  RBC/spot similar levels of 
binding (for LPS serum at dilutions of 1:10 to 1:10,000) were seen against both 
NMRBC and BrMRBC, suggesting perhaps autoantigens similar to those revealed by 
bromelain occur on normal RBC when they are attached to a solid phase support like 
nitrocellulose. A similar situation to this was previously encountered in ELISA 
experiments where NMRBC were fixed to plastic microtitre plates (Jonusys 1986; 
Jonusys and Steele 1988)
In most of the early Western blot experiments, utilising 1% BSA as a blocking 
and diluting reagent the conditions were: LPS serum at 1:10 or 1:30, PBS as a 
washing buffer, 1:500 goat anti-mouse IgM-alkaline phosphatase conjugate and Fast 
Red substrate. Immunoreactive bands were present and recognised by LPS serum and 
FUB 1, however, the background staining was too high to clearly discern these bands. 
High background levels were a problem with optimising conditions in this system for 
several reasons. Firstly, some of the background interference on control blots is due to 
the second antibody binding directly to the same immunoreactive bands that LPS 
serum and FUB 1 bound to, suggesting that these bands may be a common target for 
for naturally occuring antibodies in many different animals. This problem was dealt 
with by absorbing all second antibody developing reagents with normal mouse 
erythrocytes and BrMRBC. The washing and blocking conditions also need to be 
fairly stringent when using IgM antibodies to remove antibodies binding 
non-specifically to nitrocellulose that contribute to high background. Efforts were 
concentrated on reducing the background staining and thus each aspect of the Western
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blot assay was tested, changed and improved. These improvements included using 
different washing and blocking buffers, decreasing the levels of primary antibodies 
used, changing the second antibody to a biotin-streptavidin system, preabsorbing the 
second antibody with RBC before use and changing the substrate to BCIP/NBT which 
gave a distinct purple band on a white background.
4.2.3. Comparison of different blocking and washing buffers
The relative effectiveness of BSA and gelatin as blocking agents was tested in 
dot blot experiments. Gelatin was found to give a reduced background. When gelatin 
and BSA were both used at 1%, and Tween-20 was added at 0.1% to washing 
buffers there was little difference to background binding observed (Figure 4.2.). Fresh 
gut was prepared and pooled from a group of 4 CBA/H retired breeder female mice. 
However, it shows as strongly positive on the control blot, suggesting direct staining 
of endogenous alkaline phosphatase or a second antibody-antigen interaction. In some 
dot blot experiments with 1% gelatin, it was noted that NMRBC were detected with 
natural antibodies (LPS serum and FUB 1). If a suspension c-ELISA is conducted 
with either 1% gelatin or 1% BSA, no difference can be detected in the patterns of 
binding although LPS serum appears to bind to BrMRBC with a higher titre in the 
presence of 1% BSA (Table 4.2.).
The dot blot experiment was repeated on a larger scale (Figure 4.3) to examine 
different levels of primary antibodies in LPS serum, BrMRBC absorbed LPS serum, 
NMRBC absorbed LPS serum and FUB 1 and FUB 3 in gelatin and BSA, with PBS 
as a washing buffer against a panel of six antigens (BrMRBC NMRBC, BrM ghosts, 
NM ghosts, Gut Washings, gut scrapings). Since there is no change in the pattern of 
reactivity of LPS serum that had been preabsorbed with BrMRBC, the titres of the 
antibodies used in the dot blot experiment were tested in a suspension c-ELISA 
against BrMRBC and NMRBC (Figure 4.4). For LPS serum absorbtions, 1ml of LPS 
serum was absorbed twice with 0.5ml packed RBC for 30 mins at room temp, and 30 
mins on ice. One volume of second antibody, Goat anti-mouse IgM alkaline 
phosphatase conjugate was absorbed twice with 1 volume of NMRBC, then twice 
with 1 volume of BrMRBC fo 30 minutes at room temperature and 30 minutes on ice, 
but this treatment did not remove all anti-BrMRBC activity from LPS serum. LPS 
serum therefore required far more extensive absorption to remove anti-BrM antibodies 
(section 4.3.4.).
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Figure 4.1. Initial dot blot experim ent to determine the binding patterns 
o f LPS serum , FUB 1 and  FUB 3 against RBC, ghosts and gut 
m a t e r i a l .  LPS-serum [A ], FUB1 (anti-BrM RBC)[B-D] and FUB 3 
(anti-BrMRBC/anti-RatRBC)[E-G] and the PBS control [H] were titrated at 1 in 10 
dilution against BrMRBC [top row left] and NMRBC[top row right], BrM 
ghosts [middle row left], NM Ghosts [middle row right], gut washing[bottom row left] 
and gut scrapings[bottom row right].
A B C D
E F G H
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4.2.4. Improvement in the staining protocols for alkaline phosphatase.
In an effort to reduce the background staining problem, different second 
antibody (biotinylated goat anti-mouse IgM) and staining protocols were evaluated. 
BCIP/NBT coupled with biotinylated second antibodies and streptavidin-alkaline 
phosphatase offered the clearest reduction in background when compared to 
streptavidin-peroxidase coupled with 4-chloro-l-napthol. Streptavidin, a neutral 
non-glycosylated protein, was used in preference to egg-white avidin because of the 
reported problems with avidin binding directly to sugar-binding proteins on cell 
surface (Wilchek and Bayer 1988).
In later immunoblotting experiments, Fast red substrate was replaced by 
BCIP/NBT due to the increased sensitivity and contrast obtained. Fast Red gave a 
bright pink band on a light pink background, whereas BCIP/NBT gave a purple band 
on a white background.
4.2 .5 .0ptim um  conditions for blotting.
The best results for blotting experiments were obtained with the following 
conditions. The membrane was allowed to dry at room temperature after electroblotting 
and prior to the blocking steps; 3-5% BSA in PBS was used as a blocking agent for 90 
minutes to overnight, while 1% BSA in PBS was used as a diluent for the first and 
second antibodies. PBS was used in initial washing steps, with PBS+ 0.1% Tween 20 
used as a washing buffer after the second antibody step. The second antibody was 
changed to a streptavidin-biotin system and BCIP/NBT was used as a substrate in the 
place of Fast Red.
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F ig u re  4.2. C o m p ariso n  of l% (w /v )  B ovine se ru m  a lb u m in  and  
l% (w /v ) gelatin  as blocking agents and  PBS versus PBS-Tween 20 in
dot blotting. Sheets 1-4 tested different antibodies. LPS serum was used at 1:50 
dilution (Sheet 1), FUB 1 at 1:10 ( Sheet 2) and FUB 3 at 1:10 ( Sheet 3), PBS 
control ( Sheet 4) . Plates were blocked in 1% gelatin and washed in PBS; second 
antibody was 1:500 Goat anti-mouse IgM-alkaline phosphatase conjugate, and Fast 
red substrate.
LPS at 1:50 was used on plates 5-8, with PBS-Tween/Gelatin (Sheet 5), 
PBS-Tween/BSA ( Sheet 6) PBS/Gelatin ( Sheet 7) and PBS/BSA( Sheet 8). Antigens 
applied to the plates were a) 12|il of l%BrMRBC, b) 12|il of 1%NMRBC , c) 12jil 
BrM ghosts , d) 12jil NM ghosts , e) Gut Washings - 12p,l of lmg/ml suspension , f) 
Gut scrapings - 12jil of lmg/ml suspension, g) Fresh gut and h) PBS.
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T able  4.2. Suspension c-ELISA  conducted  w ith e ither 1%  BSA o r 1% 
gela tin  as b locking  an d  w ashing  agen ts . Reciprocal endpoint titres of 
LPS-stimulated serum or FUB 1 against BrMRBC or NMRBC determined at the 
y=0.2, OD410nm at 30 minutes after the addition of substrate.
1% BSA 1% Gelatin
BrMRBC NMRBC BrMRBC NMRBC
LPS-stimulated serum 700 14 300 12
FUB 1 50 0 87 0
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F igure  4.3 Dot blotting experim ent to test the pa tterns of binding of 
LPS serum  and FUB 1 that have been preabsorbed with either BrM RBC 
or NM RBC.
Sheets 1-10 LPS serum; Sheets 11-20 BrMRBC absorbed LPS serum; Sheets 21-30 
NMRBC absorbed LPS serum; Sheets31-40 FUB 1; Sheets 41-50 FUB 3; Sheets 51 
&52 are PBS controls for 1% BSA and 1% Gelatin respectively. For LPS serum, 
second antibody was used at 1:500 and for the monoclonal antibodies at 1:200. Fast 
Red substrate used. The antigens used were in the same configuration as Figure 4.2.
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F ig u re  4.4. Suspension  c-E L ISA  to test the  an tibod ies used in the 
p rev ious experim en t fo r titre s  against B rM RB C and  NM RBC using 
e ither 1%  gelatin o r 1% BSA as blocking and diluting agents. A sample 
of the antibodies used in the previous dot blot experiment was concurrently test^ in a 
suspension ELISA against either BrMRBC (Figures 4 .4a) or NMRBC (Figures 4.4 b
a), in the presence of 1% BSA. Similar experiments were conducted in the presence of 
1% gelatin with BrMRBC (Figure 4.4c) or NMRBC (Figure 4.4d.) The following 
antibodies were examined :Unabsorbed LPS serum ( # ) ,  BrMRBC-absorbed LPS 
serum (O), NMRBC absorbed LPS serum (■), FUB 1 (□) and FUB 3 ( A ) .
O p tic a l D en sity , 410nm
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4 .3 . S D S -P A G E  AND IM M U N O B L O T T IN G  OF M OUSE  
ERYTHROCYTES.
4.3.1. SDS-PAGE of mouse erythrocytes.
Electrophoresing whole red blood cells is not a common procedure for two 
main reasons. Firstly, the red blood cell has been used principally as a ’’model cell 
membrane" or to study haemoglobin because both may be easily prepared free of 
contaminantion by cytoplasmic organelles. The abundance of haemoglobin in the 
erythrocyte can result in a smear if the desire is to clearly visualise membrane proteins, 
so the components of the membrane or haemoglobin are usually studied in isolation 
from one another. In this case, however, after experiences with protein-free ghosts I 
was determined to electrophorese the whole erythrocytes to ensure that a portion of the 
antigenic determinant was not inadvertently discarded. The best resolution of whole 
MRBC obtained by increasing the percentage of acrylamide of the separating gel to at 
least 15% T (Figures 4.5. and 4.6).
NMRBC ghosts contain only high molecular weight protein whereas BrM 
ghosts have high molecular weight bands in stacking gel, but in addition, there are 
diffuse bands present at 29kD and 42kD (Figure 4.5). In the lanes loaded with gut 
material, there is a smear of protein with prominent bands occurring between 
40-60kD. When NMRBC are electrophoresed, there is a prominent haemoglobin 
smear below 14kD, with the second highest protein bands occurring in 30kD region 
with faint but distinct bands present at other molecular weights. BrMRBC have the 
same basic pattern as NMRBC but with several bands faint or missing between 60 and 
90kD.
In SDS-PAGE experiments with mouse erythrocyte ghosts (Figure 4.6), it can 
be seen that alkali-treatment removes most of the protein with only some of the protein 
remaining in the stacking gel. Different proteins appear to be retained in BrM ghosts as 
opposed to NM ghosts and the amount of protein found in these ghosts used in 
Figure 4.6 is summarised in Table 4.3.
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Table 4.3. Protein content o f ghosts used in SDS-PAGE experiments
Ghost type (prepared from 25 mice) 
BrM ghosts
BrM ghosts(KOH treated) 
NMghosts
NMghosts(KOH treated)






1.5 x 10"12 
0.55 x 10'12 
1.0 x 10-12 
0.14 x 10'12
* Assuming that there is 3 x 10^ RBC/ml of whole blood, the amount of protein remaining after 
treatment on a per initial RBC basis may be determined by: {RBC protein pg /m l} divided by {3 x 
10^ RBC /ml}. The measurement of the number of ghost particles/ml was not determined for these 
samples.
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F ig u re  4.5. S D S -P A G E  c o n d u c te d  u n d e r  re d u c in g  c o n d itio n s  a n d  
C oom assie  B lue s ta in in g  of ghosts, gut sc rap in g s an d  m ouse red  blood 
cells. Lane 1 NMRBC ghosts; Lane 2 BrMRBC ghosts; Lane 3 Fresh gut scrapings; 








1 2 3 4 5 6
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F ig u r e  4 .6 . R e d u c e d  a n d  n o n - r e d u c e d  s a m p le s  o f  g h o s ts  
e le c tro p h o re sed  on 15% se p a ra tin g  gels
Lane 1 Low molecular weight markers;Lane 2 BrM ghosts;Lane 3 BrMghosts (KOH 
treated); Lane 4 NMghost; Lane 5 NM ghosts (KOH treated).
Reduced samples
Mwt (kD)
66.2 _  
4 5  _
31 -
21 . 5  ~
14 . 4  “
1 2 3 4  5
Non-reduced samples
Mwt (kD)
1 2 3  4  5
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4.3 .2 . W estern blot experim ents w ith  m ouse erythrocytes
In a num ber o f earlier western blotting experiments with LPS serum , FUB 1 
and Fast red substrate, bovine erythrocyte carbonic anhydrase from the marker lane 
and bands from  the 30 kD region of NMRBC and BRMRBC appeared as a dark pink 
band on a ligh t p ink  background with the Fast Red substrate. In subsequent 
experim ents (Figure 4.7.), the resolution o f the 30kD bands was im proved by 
employing biotinylated second antibodies with streptavidin-alkaline phosphatase and 
BCIP/NBT substrate (Materials and M ethods section 2.9.1.). W hole normal mouse 
red blood cells, BrM RBC and bovine carbonic anhydrase were electrophoresed on 
d iscontinuous SD S-PA G E (4% stacking gel and 15% separating gel) and 
electroblotted onto nitrocellulose in methanolic transfer buffer. A doublet band from 
the 30kD region o f both NM RBC and BrM RBC was detected with the monoclonal 
FUB 1 (1:10) and polyclonal LPS-stim ulated serum (1:10). The immunoreactive 
bands from mouse erythrocytes occurred at 31 kD and 29kD, while the band occurring 
at 28kD was not reactive. Occasionally the two immunoreactive bands occurring at 31 
and 29 kD on red blood cells are referred to as the "immunoreactive bands in the 30 kD 
region" or "bands in the 30 kD region" as a shorthand way of referring to these 
specific bands.
At first, it was thought that these bands may represent glycophorin as shown by 
Laing e t al. (1987, 1988) to occur on immunoblots o f Rat RBC recognised by mouse 
anti-RatRBC m onoclonal antibodies. Thus LPS serum and FUB 1 were tested in 
w estern blotting experim ents against purified human glycophorins and carbonic 
anhydrase from  a range o f different species. LPS serum (1:50) and FUB 1(1:2) 
detected 10pg/lane o f purified rabbit, bovine, dog and human erythrocyte carbonic 
anhydrase but not lOpg/lane human glycophorin or human asialoglycophorin (Figure 
4.8). In further experiments, erythrocytes from mice, rats, rabbits, sheep and horses 
were immunoblotted and carbonic anhydrase bands were detected in the 30 kD region 
(Chapter 5 , Figure 5.11).
To determine if the immunoreactive bands detected at approximately 30kD were 
glycoproteins, SDS-PAGE gels were stained with Alcian Blue or Periodic acid-schiff. 
The 29kD and 31kD immunoreactive bands found on mouse erythrocytes stain with 
both  A lcian  B lue and Periodic acid-Schiff stain indicating the presence of 
glycoproteins (Figure 4.9).
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4 .3 .3 . I so e le c tr ic  F o cu ss in g  an d  tw o -d im en sio n a l m aps o f  w hole  
m ouse red blood cells to  further characterise the im m unoreactive bands.
IEF w as conducted to determ ine the isoelectric points o f the 29kD and 31kD 
bands from  w hole m ouse red blood cells. Both bands have an isoelectric point of 
approxim ately 6.7 (Figure 4.10). This estim ate is based upon where m ost o f the 
carbonic anhydrase occurs on the two dim ensional gel, as certain difficulties were 
experienced with solubilizing whole RBC, so that only the proteins that are present in 
large quantities evident on 2-D maps and focussing the IEF gels for sufficient time 
w ithout excessive heat being generated. D ifferent m ethods o f solubilisation were 
attem pted, eg different types o f detergents tried and other methods o f solubilisation 
could be further pursued to establish a clearer picture o f other mem brane proteins, 
however, the data shown in Figure 4.10with CA doublet bands is relatively clearcut.
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F ig u re  4.7. SD S-PA G E  a n d  W estern  blot of m ouse red  blood cells and 
bovine ca rb o n ic  a n h y d ra se
Lane 1: Biorad low m olecular weight markers (10|il of a 1:20 dilution containing 
rabbit muscle phosphorylase B, 97.4kD; Bovine derum albumin, 66.2kD; ovalbumin, 
45kD; Bovine carbonic anhydrase 31kD; soybean trypsin inhibitor, 21.5 kD: and 
lysozyme, 14.4kD.) The position of carbonic anhydrase is indicated by an arrow. 
Lane 2 .-Normal Mouse RBC (lOpl of 2%RBC in reducing sample buffer). Lane 3: 








1 2 3 4 5
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F ig u re  4.7 b. W este rn  b lo t e x p erim e n t w ith  FUB 1 and  LPS serum .
FUB 1 and LPS serum applied to blots at 1:10. The lanes were the same as for the 
SDS-PAGE viz. Lanes 1& 5 Low molecular weight markers, Lane 2 NMRBC, LAne 
3 BrMRBC, Lane 4 Bovine carbonic anhydrase.Contol blots treated with PBS instead 
o f first antibody were negative. Biotinylated goat anti-mouse IgM was applied at 
1:2500, Streptavidin-alkaline phosphatase at 1:2000.
FUB 1 LPS serum
1 2 3 4 5  1 2 3 4  5
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F ig u re  4 .8 . W e s te rn  b lo ts  o f p u r if ie d  c a rb o n ic  a n h y d ra s e  from  
d iffe re n t species, h u m an  g ly co p h o rin  a n d  asia log lycophorin
LPS serum and FUB 1 were used at 1:10 in western blotting experiments against 
carbonic anhydrase from dog RBC [Lane 5], rabbit RBC [Lane 6], human RBC 
[Lane 4] and bovine RBC [Lane 7], NMRBC [Lane 8], BrMRBC [Lane 9 ] ,  human 
glycophorin [Lane 3] and asialsoglycophorin [Lane 2]. Low molecular weight 
M arkers [Lane 1] and prestained molecular weight markers [Lane 10] were used. 
Carbonic anhydrase could be detected on western blots using the Fast red detection 
system, however, glycophorin and asialoglycophorin could not be detected.




F ig u r e  4 .9 . G ly c o p r o te in  s ta in in g  o f  S D S -P A G E  gels  w ith  A lc ian  B lu e  
a n d  P A S .
In Figure 4.9a) Alcian Blue staining was conducted with the following protein 
samples: Lane 1 Low molecular weight markers, Lane 2 Normal Mouse RBC ghosts, 
Lane 3 BrM RBC ghosts Lane 4 NMRBC and Lane 5 BrMRBC. In Figure 4.9.b) the 
same samples have been stained for glycoproteins with PAS staining.
A) Mwt (kD)
8 4  _
5 8  -
4 8 . 5  -
3 6 . 5  -
2 6 . 6  -





4 8 . 5
3 6 . 5
2 6 . 6
1 2 3  4 5
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F ig u r e  4 .1 0 .  T w o  d im e n s io n a l  m a p  o f  w h o le  m o u s e  e r y th r o c y te  
prote in s  a n d  IE F  s ta n d a r d  curve.
Lane A molecular weight markers run in the second dimension SDS-PAGE.
Capillary isoelectric focussing gels were layered over the SDS-PAGE in the second 
dimension. On the next page is the standard curve (figure 10b.)used for determining 
the pi from standard marker proteins focussed on different capillary gels under the 
same conditions.
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Figure 4.10.b.
Distance from anode (cm)
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Two different methods of solubilisation were tried with erythrocytes, Triton 
X-100 and Triton X -100/10% SDS. The RBC membrane proteins proved difficult to 
solubulise as noted previously (Rosenblum et a l  1982; Dockham et al. 1986; 
Rouyer-Fessard et al. 1987). Nevertheless, the two most abundant RBC proteins, 
haem oglobin and carbonic anhydrase can be visualised, and the p i of carbonic 
anhydrase determined by comparison to a standard curve (Figure 4.10).
These results suggest that there are two isoforms of carbonic anhydrase in 
m urine erythrocytes with similar isoelectric points o f 6.7 but slightly different 
m olecular weights . The molecular weight differences may be accounted for by 
"neutral" amino acid substitutions, glycosylations or phosporylations. The fact that 
both FUB 1 and LPS serum recognise a doublet suggests that only similar regions on 
the glycoproteins are recognised and not the regions that account for the difference in 
m olecular weight. The question o f which epitopes on carbonic anhydrase are 
recognised by autoantibodies is addressed in further experiments in Chapter five.
4.3.4. D eterm ination o f the involvem ent of carbonic anhydrase in the 
BrM  epitope.
An experiment to determine if the bands detected on Western Blots were related 
to the BrM  epitope on BrMRBC was conducted by preabsorbing antibodies (FUB 1 
and LPS-serum) with BrMRBC to try to remove anti-BrMRBC antibodies. Both the 
bovine carbonic anhydrase bands and the 30kD bands from mouse erythrocytes were 
reduced in staining intensity if FUB1 had been preabsorbed with BrMRBC (Figure
4.11, Blot 1), but not by absorbtion with NMRBC (Figure 4.11 Blot 2). Similar 
results were obtained with LPS-serum (Figure 4.12.), however, much more extensive 
absorbtion with BrMRBC was was required to remove the 30kD bands. When the 
absorbtions were carried out under identical condition to Figure 4.11, then not all 
anti-BrM activity could be removed from LPS serum. This problem was previously 
encountered in dot blot experiments ( Figure 4.3. and Figure 4.4.). LPS serum 
requires more extensive absorption with NMRBC and BrMRBC and this became 
evident when the levels o f IgM in LPS serum were determined (Table 4.1). This 
experim ent clearly demonstrates that carbonic anhydrase is associated with the 
serologically defined BrM epitope.
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4.4. L ipid  Im m unoblotting.
The technique of lipid immunoblotting (Chapter 2 Section 2.9.2) was employed 
with NMRBC, BrMRBC and an extract of fresh stomach in PBS. No immunoreactive 
spots were detected in preliminary experiments and the possible immunoreactive lipids 
were not further investigated (result not shown). It has already been established that 
phosphatidylcholine forms an important part o f the BrM-epitope (Mercolino et al. 
1986,1988; Cox and H ardy 1985, K aw aguchi 1987) but to dem onstrate 
phosphatidylcholine isolated from RBC or stomach may require some further 
extraction or concentration process. However, given the novelty of the results obtained 
with carbonic anhydrase and the fact that natural antibodies can recognise carbonic 
anhydrase on RBC without the need for extraction or concentration, it was decided to 
further investigate the epitopes on carbonic anhydrase recognised by natural 
autoantibodies in LPS serum and FUB 1.
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F ig u re  4 .11 .W este rn  b lo ts of ca rbon ic  an h y d ra se  and  N orm al m ouse 
red  blood cells trea te d  w ith unabsorbed  and  absorbed  FUB 1. Conditions 
for western blotting were standard, except that carbonic anhydrase (lane a) and 
NMRBC (lane b) were blotted side-by side and the nitrocellulose was stored dry 
before use. FUB 1 was preabsorbed extensively by either 20% packed BrMRBC 
(blotl), 20% NMRBC (blot 2) or unabsorbed (blot 3) before application to the blots. 
Preabsorption of FUB 1 with BrMRBC lowers the intensity of binding to carbonic 
anhydrase and the 30kD bands from NMRBC, whereas preabsorbing with NMRBC 
does not.
Blot 1 Blot 2 Blot 3
◄
a b a b a b
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F ig u re  4.12 W este rn  b lo t o f ca rb o n ic  a n h y d ra se  an d  no rm al m ouse 
e ry th ro c y te s  tre a te d  w ith  u n a b so rb e d  an d  ab so rb ed  LPS serum . In a
separate Western blot experiment with LPS serum used at 1:500 against NMRBC (lane 
a) and carbonic anhydrase (lane b) a similar result to Figure 4.11 was obtained. LPS 
was preabsorbed extensively with 40% packed BrMRBC (Blot 2), 40% NMRBC 
(Blot 3) or left unabsorbed (Blot 1) before application to the blots. Blot 4 is the PBS 
control. Similar results were obtained with LPS-serum at 1:100 and 1:5000 (not 
shown).
Blot 1 Blot 2 Blot 3 Blot 4
a b a b a b a b
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4.5 . D iscu ssion
In this chapter, it has been demonstrated that carbonic anhydrase forms part of 
the BrM RBC epitope and is recognised by monoclonal and polyclonal natural 
autoantibodies. The different approach attempted in this chapter has been successful; it 
may explain some of the negative results initially obtained in the previous chapter with 
erythrocyte ghosts.
FUB 1 was found to be specific for BrMRBC in the suspension c-ELIS A assay 
and does not react with NMRBC (Table 4.1.). One surprising result was that FUB 3 
had no recognisable anti-BrM RBC titre in suspension assays. FUB 3 had been 
originally selected for its ability to lyse BrMRBC in lytic assays, and it has been used 
in dot-blot experiments (Figures 4.1. ,4.2. &4.3.) but was found to have a low titre 
against BrMRBC in suspension c-ELIS A experiments (Figure 4.4.), and accordingly 
was not generally used in setting up dot-blot experiments. The levels of IgM were 
determined by radial immunodiffusion in agar (Table 4.1). LPS stimulation can 
increase the level o f IgM to levels that are ten-fold higher than those found for normal 
mouse serum. Similar levels of IgM were found in all batches of FUB 1.
In preliminary dot-blots NMRBC and BrMRBC were both recognised by LPS 
serum, suggesting that hidden antigens on NMRBC could be revealed by adhesion of 
cells to nitrocellulose. It was not clear, however, if these "neoantigens" are related to 
genuine BrMRBC antigens. The action o f the proteolytic enzyme bromelain is 
presumably to remove another molecule that shields a "hidden" antigen, as rats injected 
with NMRBC can make distinct antibody responses against BrMRBC (Cunningham 
1974). A similar reactivity against "normal" mouse erythrocytes was found in 
c-ELISA assays where fixatives were employed to adhere erythrocytes to plastic 
microtitre plates or when erythrocytes were allowed to settle and adhere overnight to 
microtitre plates (Jonusys BSc. Honours Thesis 1986; Jonusys and Steele,1988) or in 
certain haemolytic assays (Kennedy and Axelrad, 1971) where seemingly gentle cell 
fixation conditions are sufficient to reveal some antigenic determinants on normal 
erythrocytes.
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The fact that the same immunoreactive 30kD bands are recognised in NMRBC 
and BRM RBC would tend to support the idea that the hidden antigen revealed by 
attachment of cells to surfaces (plastic, nitrocellulose) is the same as antigens revealed 
by bromelain treatment. There is , therefore, an extremely subtle line between a 
non-antigenic NMRBC in solution and antigenic NMRBC attached to certain surfaces. 
A similar process could be envisioned to take place in vivo in the formation of blood 
c lo ts  and du ring  ag g reg a tio n  o r c lum ping  o f norm al ery throcytes.
The background staining on dot blots and western blots proved to be a major 
problem  in analysing the specificity o f IgM natural antibodies (section 4.2.3.). 
However, these problems were gradually resolved by improving upon the basic 
protocol, although some significant results were recorded during the initial stages of 
dot blotting. Different patterns of binding were noted with LPS serum, FUB 1 and 
FUB 3, with LPS serum binding to all target antigens and the monoclonal antibodies 
specifically recognising only BrMRBC and/or BrMRBC ghosts (Figure 4.1.). For the 
monoclonal antibodies, this indicates each antibody preparation is subtlely different in 
the capacity to bind to the antigenic site(s) displayed on BrMRBC or BrM ghosts. The 
difference is not due to different concentrations of IgM in the two preparations, but 
reflects a difference in fine specificities of the antigen combining sites. LPS serum, on 
the other hand, would perhaps have a number o f different antibodies with the 
capability of binding to antigenic sites on all target antigens tested.
The pattern of reactivity against different antigens is dependent upon the type as 
well as the level of blocking and washing solutions u se d . Gelatin appeared to result 
in a lowered background in some dot blotting experiments (Figure 4.2.) but FUB 1 
could recognise NMRBC when 1% gelatin was p resen t. This suggests that although 
gelatin is an effective blocking agent capable of reducing the levels of background 
staining , it also has an effect of allowing natural antibodies to bind to antigenic sites 
on normal erythrocytes that are not exposed when BSA is used. This pattern does not 
hold for suspension c-ELISA conducted in 1% gelatin or 1% BSA (Table 4.2.).
In the titration dot blot experiment (Figure 4 .3 .), preabsorption of LPS serum 
with BrM RBC and NMRBC did not appear to reduce or remove immunostaining 
against the target antigens when compared to unabsorbed LPS serum suggesting that
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either not all anti-BrM RBC activity had been removed from LPS serum or that 
"neoantigens" were formed when RBC attached to nitrocellulose. The amount of 
anti-BrMRBC activity removed was later tested in a suspension c-ELISA (Figure 4.4.) 
and this confirm ed that not all the activity (90-98.2% removal for antibodies 
preabsorbed with BrMRBC tested in 1% BSA, but only 32-36% removal if the same 
antibodies had been preabsorbed with BrMRBC in the presence of 1% gelatin) was 
removed by the absorption protocol followed, lending support to the first reason and 
not the second. It was decided to use BSA as a blocking agent due to the different 
binding patterns noted against NMRBC with FUB 1 when BSA or gelatin were used. 
FUB 1 is selective for BrMRBC and BrM ghosts, but only when 1% BSA is used for 
blocking, and this may reflect a better capacity for blocking than gelatin or represent a 
different charge effect.
In the suspension c-ELISA experiment (Figure 4.4.), FUB 3 was found to be 
of low titre, and was not further routinely used in western blotting. In suspension-type 
ELISA NM RBC are not recognised as antigenic, whereas they are on nitrocellulose 
(Figure 4.3.).
In experiments where components of mouse erythrocytes were electrophoresed 
in polyacrylamide gels, several important points emerged. Firstly, the most abundant 
proteins from erythrocytes are the haemoglobins, followed by carbonic anhydrase with 
the membrane proteins forming only a minor proportion of the total erythrocyte protein 
profile. In SDS-PAGE experiments with ghosts that have been pretreated with alkali or 
left untreated in PBS, there are distinctly different patterns of proteins depending upon 
the type of treatment. In general, treatment of BrMRBC and NMRBC ghosts with 
potassium hydroxide reduces the amount of protein to 14-37% of the corresponding 
untreated ghosts (Table 4.3.). W hen these ghosts are adjusted to the same protein 
concentration and electrophoresed under reducing or non-reducing conditions, there 
are bands present on BrMRBC ghosts that are not present on NMRBC ghosts and a 
further difference in pattern can be detected after KOH treatment. The ghosts were 
prepared initially from the same batch of RBC, then split into two groups one of which 
was left as NM RBC and the other batch treated with bromelain. NMRBC and 
BrMRBC were subject to hypotonic lysis under identical conditions and then further 
split into alkali treatment or untreated.
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Thus, the differences seen when untreated BrMRBC ghosts are compared with 
untreated NMRBC ghosts must be due to a rearrangement of the proteins in the RBC 
after bromelain treatment that are resistant to removal by further washes in hypotonic 
lysis buffer. Further, alkali-treated BRMRBC ghosts also tend to retain more protein 
than alkali-treated NMRBC.
In contrast to SDS-PAGE experiments with ghosts, when NMRBC and 
BrMRBC are electrophoresed under reducing conditions a full profile of cytoplasmic 
and membrane proteins may be seen (Figures 4.5. and 4.7.). When an extract of gut 
is electrophoresed under reducing conditions, many proteins are present (Figure 4.5). 
In w estern blotting experim ents with NM RBC and BrMRBC, a doublet at 
approximately 30kD was found to be specifically detected by FUB 1 and LPS serum 
(Figure 4.7.). Bovine erythrocyte carbonic anhydrase is also detected under the same 
conditions.
There are a number of bands present at 29-3 lkD  on human RBC membranes 
such as Band 7, glycophorin and tropomyosin (Bennet 1985). What is the nature of 
the doublet Band at 31kD and 29kD on mouse erythrocytes? Is it equivalent to 
glycophorin? W hy does the carbonic anhydrase band from the marker lane react in 
western blots?
Two factors fortuitously lead to the discovery of the cross reaction of 
anti-BrM RBC and carbonic anhydrase. Firstly, the marker lanes were not excised 
from blots for separate processing to determine the molecular weight because coloured 
molecular weight markers had been electrophoresed in earlier blots, and the second 
factor was that Biorad included carbonic anhydrase (CA) amongst proteins in its low 
molecular weight markers.
From glycoprotein staining with Alcian Blue and periodic acid-Schiffs base, 
these 30kD bands were found to be glycoproteins (Figure 4.9.). The carbohydrates 
present on carbonic anhydrase have not been characterised in depth, apart from a 
method where carbonic anhydrase had been purified on a lectin column and eluted with 
N-acetyl galactosamine suggesting that this sugar may be present (Femley et al. 
1988, 1989). It is not known if mouse carbonic anhydrase possess similar terminal 
sugars and if they contribute to the antigenicity o f the molecule. From IEF experiments
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the doublet bands were found to have the same isoelectric point o f 6.7 (Figure 4.10).
Mouse carbonic anhydrase has not been isolated and sequenced by traditional 
methods, and the sequence has been derived from cDNA sequences. Thus there is a 
paucity o f specific data relating to the isoelectric point or glycosylations that 
characterise mouse carbonic anhydrase. The isoelectric point has been published for 
various isoenzymes from a number of species (reviewed in Deutsch 1987)
In recent western blotting experiments it has been demonstrated that mouse 
anti-Rat RBC serum and monoclonal antibodies are capable of detecting glycophorins 
on rat erythrocytes (Laing et a l  1987,1988). In contrast, natural antibodies that are 
specific for BrMRBC bound to carbonic anhydrases exclusively in Western blots and 
do not generally recognise other m arker proteins, other erythrocyte proteins or 
glycophorins. This point is reexamined in the next chapter with studies on red blood 
cells from a range of species.
Preabsorption of FUB 1 and LPS serum with BRMRBC and the subsequent 
reduction in staining intensity of carbonic anhydrase bands from western blots (Figure 
4.11 and 4.12) suggests that part of the epitope on BrMRBC recognised by anti-BrM 
antibodies is carbonic anhydrase. The possibility that the disappearance of the 
immunoreactive bands may be caused by proteolytic cleavage of antibodies by trace 
contaminants of bromelain is unlikely for a number of reasons . Firstly, bromelain is 
not evident in BrMRBC lanes on SDS-PAGE gels. Secondly, given a removal 
efficiency (say) o f 95% of bromelain after each washing step the theoretical dilution of 
bromelain would be too low to account for the required levels of enzyme to cleave the 
antibody ( i.e. starting with 0.5ml RBC and 0 .5m l of a lOmg/ml bromelain solution, 
95% of 5mg of bromelain would be removed directly after the first centrifugation 
leaving 0.25 mg; aW  three rounds of washing each removing 95% the remaining 
brom elain would leave approximately 3.125 x 10 '°g  or 31.25pg of bromelain). 
Thirdly, the same BrMRBC are used in ELISA assays, thus if residual bromelain was 
responsible for cleavage of antibodies, there would be a reduced titres rather than 
elevated titres against BrMRBC. In absorption experiments conducted by Cunningham 
and Steele (1981) BrM RBC are capable o f specifically absorbing anti-BrMRBC 
antibodies and not anti-Horse red blood cell antibodies, and if cleavage of antibodies 
was non-specific in the presence of bromelain there would have been a reduction in the
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activity o f the anti-horse red blood cell serum which was not seen. These 
considerations imply that binding in absorption experiments is specific and that the 
reduction in binding seen due to preabsorption is due to specific binding to BrMRBC 
and not non-specific due to proteolytic cleavage of antibodies by bromelain. Thus, 
these experiments suggest that part of the carbonic anhydrase molecule may become 
exposed at the surface o f the erythrocyte after bromelain treatm ent o f mouse 
erythrocytes.
Some IgM antibodies in unabsorbed LPS serum also recognised haemoglobin 
subunits on blots suggesting that some other BrM-specific epitopes, recognised by 
other serum antibodies may be located on haemoglobin (the faint band in the 12-14 kD 
region Figure 4.12, Blot 1 lane a). This faint 12-14 kD band has been augmented in 
intensity following absorption of LPS-serum with NMRBC (Figure 4.12, Blot 3 »lane 
a), which may be due to IgM-haemoglobin complexes binding to the band.
Lipid immunoblotting was not successful in preliminary experiments. Therefore 
it was decided to further investigate the portion of carbonic anhydrase that was 
recognised by natural antibodies. This line of investigation may demonstrate whether 
endogenous lipids are recognised by anti-BrMRBC, but specific controls including 
anti-lipid antibodies and control lipids would need to be used to determine if this 
m ethod is suitable for cellular lipids. However, given that BrMRBC-specific 
antibodies have already been demonstrated to bind to phosphatidylcholine in a number 
of studies (Cox and Hardy 1985; Mercolino eta l. 1986,1988; Kawaguchi 1987b), the 
demonstration here that carbonic anhydrase may also be specifically recognised by 
anti-BrM RBC antibodies is novel and required a more detailed examination. In 
Chapter 5 the epitopes that natural antibodies bind to on carbonic anhydrase will be 
examined.
C H A PTER  FIV E
C H A R A C TER ISA TIO N  O F CARBONIC ANHYDRASE FROM  
M U RIN E STO M A CH , AND FR O M  ERYTHROCY TES OF 
D IFFE R EN T  SPECIES AND D ETERM IN A TIO N  O F 
CA RBO N IC ANHYDRASE EPITO PES RECOGN ISED 
BY LPS-SERU M  AND FUB 1.
5 .1 .  A B R IE F  IN T R O D U C T IO N  TO  C A RB O N IC ANHYDRASE
Carbonic anhydrase (E.C. 4.2.1.1) is an enzyme involved in catalysing the 
reversible hydration of carbon dioxide that is principally required for acid-base 
balance, fluid secretion and respiratory functions in mammals. The biochemistry, 
physiology and genetics of carbonic anhydrase have been extensively studied and 
reviewed since the discovery of the enzyme in red blood cell lysates by Meldrum 
and Roughton in 1933 (Meldrum and Roughton 1933; Maren 1967; Carter and 
Parsons 1971; Carter 1972; Bundy 1977; Baeur et al 1980; Tashian and 
Hewett-Emett 1984; Carter and Jeffery 1985; Deutsch 1987; Tashian 1989).
Carbonic anhydrase is a zinc metalloenzyme and glycoprotein consisting of a 
single polypeptide chain of 259 or 260 amino acids. It may exist as a number of 
different isoenzymes with different enzyme activities within the one tissue or organ. 
The m olecular weight is approximately 30 kilodaltons although this may vary 
between 27-35kD depending upon the species and the type of isoenzyme. The 
amino acid sequence is highly conserved amongst a range of different species 
(reviewed in Tashian and Hewett-Emett 1984; Deutsch 1987; Tashian 1989)
Carbonic anhydrase isoenzymes are located mainly in the gastrointestinal 
tract, erythrocytes, salivary glands, lungs and the kidneys (Maren 1967; Carter 
1972; Spicer et a l  1979,1990). Different isoenzymes are also present in platelets, 
osteoclasts, skeletal muscle and some brain tissue but are not found in osteoblasts, 
fibroblasts, m onocytes or granulocytes (Holmes 1976,1977; Tashian 1989). 
Carbonic anhyrdase has been found in follicle-associated epithelial cells in ileal
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Peyer’s patches o f lambs and goat kids (Landsverk et al. 1987) and in the gastric 
parietal cells, brush border of small intestine enterocytes, nephron, glial cells, 
erythrocytes and adipose tissue of rodents (Spicer et al. 1979). In a recent study, 
particles containing carbonic anhydrase that are associated with gut epithelial cells 
have been shown to be transported to lymphoid follicles in the gut of the foetal lamb 
where they fuse with the plasma membrane of lymphocytes in the early stages of 
the formation of Peyer's patches (Landsverk et al. 1990).
The sequences o f various isoenzymes of carbonic anhydrase have been 
ascertained for a variety o f species (reviewed by Hewett-Emmett et al.. 1984, 
Tashian 1989, Edwards et al. 1990), but relatively little work has been attempted 
with characterising the entire amino acid sequence of mouse carbonic anhydrase 
isoenzymes although some partial sequences have been published (Eicher et al. 
1976; Curtis 1983; Curtis et al. 1983; Venta et al. 1984, 1985,1987; Fraser and 
Curtis 1986; W hitney 1984; Tweedie and Edwards 1989; Amor-Gueret and 
Lévi-Strauss 1990). For the mouse, amino acid sequencing has been hampered 
because the N-terminus is "blocked" or acetylated, thus the available mouse 
carbonic anhydase amino acid sequences have all been derived from c-DNA cloning 
(Figure 5.1.). W hile this technique has given important information on the likely 
am ino acid  sequence, there is currently  no indication o f the possible 
post-translational glycosylations, phosphorylations or sulphonations that may be 
present on murine carbonic anhydrase or other carbonic anhydrases.
In studies on the genetics o f murine carbonic anhydrase, currently three 
closely linked genes on mouse chromosome 3 have been characterised (Beechy et 
al. 1990). Erythrocytes and stomach express Car-1 and Car-2, whereas Car-3 is 
restricted to skeletal muscle. Other isoenzymes are membrane-bound, such as the 
carbonic anhydrase present in the lung (Whitney and Briggle 1982) or are secretory 
types present in salivary glands (Femley 1988; Femley et al. 1989).
Different isoenzymes may be found in one organ, for example, high and low 
activity forms o f carbonic anhydrase have been demonstrated in erythrocytes 
although the function that these isoenzymes may play is not clear because the low 
activity form  is usually inhibited at physiological levels of anions (Maren et al.
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1976). Recently, the rate o f enzyme activity has been found to be enhanced when 
carbonic anhydrase is assayed in association with erythrocyte membranes, and this 
is thought to be due to an effect of distortion of the conformation to facilitate proton 
transfer at the active site of the membrane (Parkes and Coleman 1989). In red blood 
cells, carbonic anhydrase is the central enzyme of the Jacobs/Stewart cycle (1942) 
where hydrogen ions are produced to protonate haemoglobin to an activated form 
so that it can bind effectively to oxygen. Links have been established between 
carbonic anhydrase and haemoglobin (Silverman et al .1978,1979) and, although it 
has not been physically demonstrated, presumably carbonic anhydrase would also 
associate closely with the anion channel (Band 3 protein) in the membrane.
In this chapter, various aspects of the binding of natural antibodies to stomach 
and erythrocyte carbonic anhydrase will be examined. Firstly, experiments in which 
carbonic anhydrase has been denatured by various means were examined to 
determine if  the antigenic sites recognised by LPS serum and FUB 1 are due to 
certain structural conformations o f the glycoprotein or if a linear sequence is 
revealed and recognised when the protein is unfolded. Secondly, soluble carbonic 
anhydrase was used as an inhibitor in ELISA experiments to determine if natural 
autoantibodies recognise native or denatured sites on target carbonic anhydrase that 
has been allowed to bind to plastic. Thirdly, attempts were made to present carbonic 
anhydrase as inhibitory particles in suspension ELISA experiments with BrMRBC. 
Another aim was to determine if carbonic anhydrase isolated from the murine 
stomach and the erythrocytes of different species is recognised by LPS serum and 
FUB 1 in immunoblotting experiments. Finally, attempts were made to determine 
the regions o f the carbonic anhydrase molecule that were recognised by antibodies 
by cleavage of the glycoprotein with specific glycolytic and proteolytic enzymes.
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F ig u re  5 .1 . A m in o  a d d  se q u e n c e  d e riv e d  fro m  th e  n u c le o tid e  
sequence  o f Y B R  s tra in  m ice: Structure and Exon to protein  domain  
relationships o f  the m ouse carbonic anhydrase I I  gene. P.J. Venta. J.C. 
M ontgomery, D. Hewett-Emmett, K. W iebauer and R.E. Tashian J.Biol. Chem 
(1985) 260, 12130-12135. The theoretical sites of proteolytic cleavage by 
endoproteinase Arg-C and every 10 amino acids in the sequence are indicated. The 
theoretical m olecular weights o f the cleavage products can be determined by 
addition of the molecular weights o f the constituent amino acids and from the 
N-terminal end are o f relative molecular weight (rMW): 3.2 kD, 6.4 kD, 8.9 kD,
4.4 kD, 1.6kD, 2.2 kD, 864 D, 803 D.
M e t  S e r  H i s  H i s  T r p  G l y  T r y  S e r  L y s  H i s ^ °  A s n  G l y  P r o  G l u  A s n  T r p  H i s  L y s  A s p  P h e 20 
P r o  I l e A l  A s n G l y A s p  A r g  G i n  S e r  P r o 30  V a l  A s p  l i e  A s p T h r A l a T h r A l a  ( G l n / H i s )  H i s  40  
A s p  P r o  A l a  L e u  G i n  P r o  L e u  L e u  l i e  S e r 80  T y r  A s p  L y s  A l a  A l a  S e r  L y s  S e r  l i e  V a l  80 
A s n  A s n  G l y  H i s  S e r  P h e  A s n  V a l  G l u  P h e 70  A s p  A s p  S e r  G i n  A s p  A s n  A l a  V a l  L e u  L y s ®0 
G l y  G l y  P r o  L e u  S e r  A s p  S e r  T y r  A r g  L e u 00  l l e G I n  P h e  H i s  P h e  H i s  T r p  G l y  S e r  S e r ^ 00 
A s p  G l y  G i n  G l y  S e r  G l u  H i s  T h r  V a l  A s n ^ °  L y s  L y s  L y s T y  A l a  A l a  G l u  L e u  H i s  L e u  ^20 
V a l  H i s  T r p  A s n  T h r  L y s  T y r  G l y  A s p  P h e ^30  G l y L y s A l a  V a l  In  G i n  P r o  A s p  G l y  L e u ^40 
A l a  V a l  L e u  G l y  T y r  P h e  L e u  L y s  l i e  G l y ^80  P r o  A l a  S e r  G i n  G l y  L e u  G i n  L y s  V a l  L e u ^ 80 
G l u  A l a  L e u  H i s  S e r  l i e  L y s  T h r  L y s  G l y 170  L y s A r g A l a A l a  P h e A l a A s n  P h e A s p  P r o 180 
C y s  S e r  L e u  L e u  P r o  G l y  A s n  L e u  A s p  T y r 190  T r p T h r T y r P r o G l y S e r L e u  T h r  T h r  P r o 200 
P r o  L e u  L e u  G l u  C y s  V a l  T h r  T r p  l i e  V a l  2 ^ °  L e u  A r g  G l u  P r o  l i e  T h r V a l  S e r  S e r  G l u 220 
G i n  M e t  S e r  H i s  P h e  A r g  T h r  L e u  A s n  P h e 230  A s n  G l u G l u G l y A s p  A l a G l u  G l u  A l a  M e t 240 
V a l  A s p A s n  T r p  A r g  P r o A l a  G i n  P r o  L e u 250  L y s A s n A r g  L y s  l i e  L y s A l a  S e r P h e L y s  260
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5 . 2 . N A TU R A L A U T O A N T IB O D IE S R EC O G N ISE NATIVE AND  
DENATURED FORM S OF CARBONIC ANHYDRASE.
In the preceding chapter it was established in western blotting experiments 
that natural antibodies are capable of binding to carbonic anhydrase but it was not 
immediately obvious if FUB 1 and LPS serum could recognise carbonic anhydrase 
in its native or in a denatured form because of the possible denaturing steps that 
may occur during electrophoresis and blotting procedures. In order to investigate 
this question, an ELISA was conducted where FUB 1 and LPS serum was used to 
detect either untreated carbonic anhydrase or carbonic anhydrase that had been 
allowed to bind overnight to plastic microtitre plates in the presence of various 
denaturing agents (acid, urea, guanidine hydrochloride) or treatment with SDS or 
heat to form random coils or to irreversibly cross-link the protein respectively 
(Figure 5.2.). Urea and guanidine hydrochloride were used at concentrations 
slightly above the concentration known to cause human carbonic anhydrase to 
dissociate into random structures (Carlsson 1973).
These assays indicate a reduced ability o f FUB 1 to bind to heat and 
SDS-denatured BCA, whereas native BCA and other denatured forms of BCA are 
bound by FUB 1 and display similar titration curves. For LPS serum, high 
binding titres are observed for native and most denatured forms of carbonic 
anhydrase, the exception being SDS-treated carbonic anhydrase. This reduced 
ability o f FUB 1 to bind to SDS- or heat-treated carbonic anhydrase and of LPS 
serum to bind to SDS- treated carbonic anhydrase may be due to destruction of an 
antigenic portion of the molecule and/or a reduced ability of these forms of carbonic 
anhydrase to adhere firmly to plastic.
In dot blotting experiments conducted in parallel with the same samples used 
in Figure 5.2., LPS serum can detect 0.4p,g of untreated bovine carbonic 
anhydrase, or acid-treated BCA, heat-treated BCA or guanidine-HCl treated BCA, 
but only O.lmg spots of SDS-treated BCA or ljig  of urea treated BCA (Figure
5.3.). In contrast, FUB 1 can detect ljig  of untreated bovine carbonic anhydrase, 
or acid-treated BCA, heat-treated BCA or guanidine-HCl treated BCA and 0.1 mg
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of SDS and urea-treated BCA (Figure 5.3). From these results, FUB 1 and LPS 
serum are capable o f recognising native and certain types of unfolded carbonic 
anhydrase when they are bound to nitrocellulose membranes.
W hile these experiments show that both native and denatured forms of 
carbonic anhydrase are recognised by FUB 1 and LPS serum, there remains a 
problem in that "neoantigens" may be revealed when carbonic anhydrase binds to 
either microtitre plates or nitrocellulose. Thus, to determine if the same or different 
epitopes are exposed on plastic-bound carbonic anhydrase, soluble carbonic 
anhydrase was preincubated with FUB 1 in competitive ELISA experiments on CA 
coated plates (Figure 5.4a.), acid-denatured CA coated plates (Figure 5.4b. or 
guanidine -HC1 denatured CA coated plates (Figure 5.4c.). Acid denatured carbonic 
anhydrase could not inhibit FUB 1 at dilutions of 1 in 2 . It was inferred from 
observation o f from control plates coated with PBS only, that the high optical 
density seen was due to non-specific deposition of FUB 1-acid denatured carbonic 
anhydrase complexes onto the microtitre plate. However, in general, soluble forms 
of carbonic anhydrase could inhibit binding of FUB 1 to all CA-coated microtitre 
wells and this would indicate that the reduced binding titre of FUB 1 to microtitre 
wells coated with heated or SDS-heated carbonic anhydrase (Figure 5.2.) is 
probably not solely due to a loss of BrM-specific determinants but possibly due to a 
reduced ability of these heat-denatured forms of carbonic anhydrase to adhere to 
plastic.
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Figure 5.2. T itration curves for a) FUB 1 and b) LPS serum in an 
ELISA with native or denatured form s of carbonic anhydrase.
The wells of a plastic microtitre plate were coated overnight with 50 (il of a
2.5 mg/ml solution o f bovine carbonic anhydrase that had been left untreated (o) 
i.e. dissolved in phosphate buffered saline or denatured in various ways. The 
following denaturation treatments were used : acid treatment in ImM  HC1, pH 2.4 
(#); Heated in PBS at 60°C for 15 minutes (□ ); heated in 10% SDS at 60°C for 15 
minutes ( ■ ) ;  10M urea treatment (A); 8M guanadine-HCl (A). Antibodies were 
titrated in three-fold steps, biotinylated second antibody was applied for 3 hour at 
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F ig u re  5.3.
D ot blot o f native  o r d en a tu red  sam ples of carbon ic  anhydrase.
The samples of carbonic anhydrase from Figure 5.2. were also titrated onto 
nitrocellulose membrane in 1 pi volumes starting at a concentration of : (columns 
left to right) O.lmg, 0.03mg, 0.01 lmg, 3.7pg, 1.23pg, 0.41pg. FUB 1 and LPS 
serum were used at 1:10, biotinylated second antibody and streptavidin-alkaline 
phosphatase were used at 1:1000, with the Fast red developing substrate. The 
rows correspond to a) bovine carbonic anhydrase, b) acid-treated carbonic 
anhydrase, c) heated carbonic anhydrase, d) SDS-treated carbonic anhydrase, e) 
urea-treated carbonic anhydrase and f) guanidine-HCl treated carbonic anhydrase.
LPS serum FUB 1
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Polyclonal antibodies would presum ably recognise more than a single 
antigenic site on the protein, and it was thought that FUB 1 would be more suitable 
in clearly demonstrating competitive inhibition in these types of assays (Figure
5.4.). The binding of FUB 1 to carbonic anhydrase coated to microtitre plates is 
clearly inhibited by soluble forms of carbonic anhydrase in native or denatured 
form s, suggesting that the antigenic portions of carbonic anhydrase are not 
destroyed upon binding o f the enzyme to plastic. LPS serum was not included in 
these competitive ELISA experiments due to difficulties in clearly inhibiting binding 
using the same conditions under which inhibition could be demonstrated for FUB 
1. In direct ELISA experiments with LPS serum (Figure 5.2) high binding titres are 
noted against native and denatured forms of carbonic anhydrase, and clearly 
inhibition may have been difficult to demonstrate due to the binding of a number of 
different antibodies in polyclonal serum to more than a single specificity on the 
carbonic anhydrase molecule.
W hen the results in this section are viewed as a whole, it would appear that 
FUB 1 and LPS serum are capable of recognition of a linear portion of the carbonic 
anhydrase m olecule that does not strictly depend upon the three dimensional 
structure o f the protein.
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F igu re  5 .4 . C om p etitive  in h ib itio n  ELISA  w ith  un treated  or 
denatured carbonic anhydrase.
In control wells (O), FUB 1 was titrated in three-fold steps starting from a 1:3 
dilution in 1% BSA and allowed to incubate at room temperature for 90 minutes, 
while in test wells, FUB 1 was titrated in the presence of 200pg/ml carbonic 
anhydrase in 1% BSA (either untreated carbonic anhydrase (□), acid treated 
carbonic anhydrase ( • )  or SDS-treated carbonic anhydrase (■ ), urea-treated 
carbonic anhydrase (A) or guanadine-HCl-treated carbonic anhydrase (A). The 
antigen-coated plates were coated with either (a) bovine carbonic anhydrase, (b) 
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5.3. ATTEM PTS TO INHIBIT BINDING OF ANTIBODIES TO 
BRMRBC WITH VARIOUS FORMS OF CARBONIC ANHYDRASE.
While it has been demonstrated that FUB 1 and LPS serum are capable of 
binding to carbonic anhydrase in dot blot and ELISA experiments, and that FUB 1 
can be competitively inhibited from binding to carbonic anhydrase, it was thought 
that carbonic anhydrase may be capable of inhibiting the binding of FUB 1 and LPS 
serum to epitopes on BrMRBC. Several different attempts were made to inhibit 
antibodies against target BrMRBC with carbonic anhydrase but inhibition was 
difficult to achieve. Carbonic anhydrase was used at a number of different 
concentrations and in various forms such as soluble carbonic anhydrase, carbonic 
anhydrase conjugated to Sepharose beads and carbonic anhydrase crosslinked with 
glutaraldehyde.
Native bovine carbonic anhydrase was used to inhibit the binding of FUB 1 
and LPS serum against BrMRBC in a suspension c-ELISA by preincubation of 
antibodies with bovine carbonic anhydrase (Figure 5.5.). The inhibition observed 
was not significant, even when carbonic anhydrase was used at between 
200-500|J.g/ml. In some experiments, when titrations were conducted in the 
presence of bovine carbonic anhydrase, slight augmentation rather than slight 
inhibition was noted which may suggest an ability of IgM to bind simultaneously to 
both carbonic anhydrase and BrMRBC to form lattice complexes. This inability to 
inhibit binding of FUB 1 and LPS serum to BrMRBC may be due to several 
reasons, namely : the number of antigenic sites on BrMRBC may be greater than 
the number of inhibitory carbonic anhydrase molecules present; IgM autoantibodies 
may preferentially bind to BrMRBC due to a antigenic epitopes being presented in a 
recognisable array in conjunction with phosphatidylcholine or other membrane 
components, or conversely IgM autoantibodies may be capable of binding 
simultaneously to bovine carbonic anhydrase and BrMRBC via different antigen 
combining sites on IgM.
Conjugates of carbonic anhydrase immobilised on Sepharose beads were 
constructed to try to determine if carbonic anhydrase presented on particles would 
be capable of inhibiting the interaction of antibodies with BrMRBC. Carbonic
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anhydrase was coupled to Sepharose either in soluble form, or crosslinked with 
glutaraldehyde before conjugation. In a suspension c-ELISA conducted with these 
conjugates, FUB 1 failed to recognise carbonic anhydrase coupled to Sepharose in 
any form, but LPS serum demonstrated binding to all conjugates (Figure 5.6). A 
large proportion of the binding was however, directed towards control Sepharose 
beads that had no carbonic anhydrase attached, thus these conjugates were 
unsuitable to use in inhibiting the binding of antibodies to BrMRBC. This avenue 
was not further pursued because inhibition depends upon specific recognition of the 
inhibitor by the antibodies and this was not the case for both FUB 1 and LPS 
serum. This problem with inhibiting the binding between antibody and BrMRBC 
may be due in part to the way carbonic anhydrase is presented as an inhibitor, 
because on the BrMRBC carbonic anhydrase may be present at a certain distance or 
in the right conformational array to be recognised, or presented in association with 
other membrane constituents.
Since the problem of inhibiting binding of autoantibodies appeared to reside in 
the formation of lattices between IgM, carbonic anhydrase and BrMRBC, inhibition 
may be more clearly demonstrated by the reductive cleavage of IgM to monomers. 
Reduction o f IgM  was usually conducted with 2-m ercaptoethanol, 
2-mercaptoethylamine or dithiothreitol followed by alkylation with iodoacetamide. 
Similar patterns of low binding were demonstrated by all three reduction treatments. 
Two types of inhibition experiments were conducted with the IgM monomers viz. 
inhibition of the binding of the monomers to BrMRBC (Figure 5.7.) and inhibition 
of the binding to BCA plates (Figure 5.8.). By creating monomers, there is a loss 
in binding activity especially noted with FUB 1 in ELISA assays with CA-coated 
plates and suspension c-ELISA with BrMRBC. This indicates that the individual 
combining sites are of very low affinity and that the binding avidity of the intact 
antibody is due entirely to the increased valency of IgM.
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Figure 5.5. Attempt to inhibit binding of FUB 1 to BrMRBC with 
bovine carbonic anhydrase.
A standard suspension-transfer c-ELISA was used to detect specific inhibition 
of binding of antibodies against BrMRBC using 500pg/ml bovine carbonic 
anhydrase. Inhibition of FUB 1 binding to BrMRBC could not be demonstrated 
when FUB 1 was preincubated with 500|ig/ml carbonic anhydrase (□) for 2 hours 
at room temperature when compared to control titrations where bovine carbonic 
anhydrase was not present (■).
A different pattern was noted for LPS serum either preincubated with BCA 
(O ) or left uninhibited (#), with a marked prozone effect evident but inhibition 
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F igu re  5.6. B inding of LPS serum  to  CA -sepharose conjugates in a 
su spension  E L ISA .
LPS serum and FUB 1 were titrated in three-fold steps starting with undiluted 
antibodies. Conjugates of CA-sepharose were added at a rate of 50|il/well of a 1% 
suspension in PBS and allowed to incubate for 8 hours at room temperature. The rest 
of the ELISA was the same as for a suspension-transfer ELISA. FUB 1 bound at 
very low levels to the conjugates (not shown). Conjugates of carbonic anhydrase 
contained either 40 mg of carbonic anhydrase/g of Sepharose 4B that were untreated 
(O); or crosslinked with glutaraldehyde at 0.1% for 15 minutes (•) or 2 hours (□); or 
crosslinked with 1.0% glutaraldehyde for 15 minute (■) or 2 hours (A). Control 
beads were constructed that had no carbonic anhydrase but were allowed to bind to a 
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Figure 5.7. Reduction of LPS serum and FUB 1 to monomers and 
inhibition ELISA with BrMRBC.
In Figure 5.7a., LPS serum (#) was reduced by treatm ent with 
2-mercaptoethylamine (M) or dithiothreitol or left untreated and tested against 
BrMRBC in c-ELISA experiments to establish baseline binding in the absence of 
carbonic anhydrase. To demonstrate inhibition, untreated serum (O) or the 
monomers 2-mercaptoethylamine (□) or dithiothreitol (A) were inhibited with 50|il 
of 500 |ig/ml carbonic anhydrase for 2 hours before BrMRBC were added. In 
figure 5.7b., the same IgM monomers derived from LPS serum were tested against 
NMRBC.
In Figure 5.7c., FUB 1 (O) or the monomers created by treatment with 
dithiothreitol (□ )  were tested against BrMRBC in the absence of carbonic 
anhydrase. To demonstrate inhibition, FUB 1 (#) and the dithiothreitol monomers 
(■) were preincubated with carbonic anhydrase. Results for FUB treated with 
2-mercaptoethylamine could not be graphed due to lysis of BrMRBC and FUB 1 
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F ig u re  5 .8 . T i tr a t io n  o f m o n o m ers o f FUB 1 a g a in s t c a rb o n ic  
a n h y d ra se .
In F igure 5 .8a., LPS serum  was reduced by treatm ent with 
2-mercaptoethylamine (■) or dithiothreitol (A) or left untreated (#) and tested 
against carbonic anhydrase-coated microtitre plates to establish baseline binding in 
the absence of inhibitory carbonic anhydrase. Plates were coated with 50 |il of a 
500 |Xg/ml solution of bovine carbonic anhydrase overnight, washed and blocked 
with 100 (xl of 1% BSA in PBS for 60 minutes. To demonstrate inhibition of 
binding to carbonic anhydrase-coated plates with soluble carbonic anhydrase, 
untreated serum (O) or the monomers created with 2-mercaptoethylamine (□) or 
dithiothreitol (A) were titrated in two fold steps from 1:20 in fifty microlitres of 
500}ig/ml soluble carbonic anhydrase. In Figure 5.8b., comparable data is 
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Inhibition of binding between IgM autoantibodies and BrMRBC was difficult 
to achieve. This could be an effect of intrinsic low affinity of each antigen 
combining site in IgM as well as an effect of avidity due to the binding of the IgM 
to a multivalent array of different epitopes on the BRMRBC surface, i.e.FUB 1 
preferentially recognises murine carbonic anhydrase in the membrane in association 
with phosphatidylcholine and other membrane proteins. The likelihood of 
multipoint binding may indicate that it is difficult to achieve inhibition in this system 
using soluble bovine carbonic anhydrase.
The discrepancy in the antigen inhibition results for FUB 1 between the 
ELISA assays involving carbonic anhydrase-coated plates (Figure 5.4, Figure 
5.8b) and BrMRBC targets in suspension (Figure 5.7.) must be interpreted as 
evidence that the carbonic anhydrase associated BrMRBC epitope is only one of 
several ligands that can be accomodated within the antigen combining site of these 
naturally occurring murine IgM anti-BrMRBC antibodies. Thus, failure of soluble 
bovine carbonic anhydrase to inhibit binding to BrMRBC is interpreted as mainly 
due to an increase in binding avidity contributed by the multipoint array of several 
different epitopes on the surface of BrMRBC. This situation does not apply when 
soluble carbonic anhydrase competitively inhibits binding to carbonic anhydrase 
coated ELISA plates.
For LPS stimulated serum, the situation is slightly more complex due to the 
difficulties experienced with trying to inhibit polyclonal serum. A large loss of 
binding is noted however with monomers derived from LPS serum (Figure 5.8a) 
suggesting that the same sort of processes are at work with IgM antibodies in 
polyclonal serum i.e. binding to BrMRBC and CA is dependent upon the presence 
of intact IgM.
The production of monomers and the lowered binding observed raises 
questions of the binding affinity of each antigen combining site of IgM 
anti-BrM RBC antibodies. Perhaps a clearer picture will emerge once the 
measurement of "affinity" is conducted in a radioimmunoassay with radiolabelled 
bovine carbonic anhydrase. However, these experiments could not be conducted at 
the present due to time constraints and the need to examine other aspects of binding
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of natural antibodies to carbonic anhydrase such as the purification of carbonic 
anhydrase from stomach mucosae and the definition of antigenic epitopes on 
carbonic anhydrase.
The complement dependent haemolytic assay may be more appropriate to use 
in the demonstration of inhibition of the interaction of antibody with RBC. In 
preliminary experiments, specific lysis of BrMRBC (and not NMRBC) could be 
demonstrated for LPS diluted to 1 in 2187 and FUB 1 to 1 in 729. Thus, the 
antibody concentrations that gave approximately 50% lysis were 1 in 1100 for LPS 
serum and lin  360 for FUB 1. In assays using serial dilutions of carbonic 
anhydrase from 1 x 10"~* moles/well to 1.5 xlO '^ moles/well, inhibition of the 
haemolytic assay could be demonstrated with levels of carbonic anhydrase ranging 
from 1 x 10"^moles/well to 1 x 10'^moles per well for 1 in 1100 LPS serum . For 
a 1 in 360 dilution of FUB 1 inhibition of lysis could be achieved with carbonic 
anhydrase at 1 x 10"^ to 1 x 10"^ moles per well. It is difficult to compare the 
results between assays because the methods of determining endpoints are vastly 
different, and what may be considered as a significant result in the haemolytic assay 
is dealing with levels of antibody that would be considered background levels of 
antibody in c-ELIS A experiments. While c-ELIS A experiments offer the advantage 
of defining an endpoint more precisely than haemolytic assays, haemolytic assays 
would appear to be more appropriate for the further investigation of the ability of 
carbonic anhydrase to inhibit the interaction of binding between antibody binding to 
BrMRBC at different levels of antibody and inhibitors. The main differences 
between haemolytic assays and c-ELIS A would be the increased numbers of 
washing steps and incubation times in ELISA experiments that may remove 
antibodies o f low "affinity". These antibodies would however be present in 
haemolysis assays and may easily be competitively inhibited by carbonic anhydrase 
under the conditions used.
5.4. MOUSE STOMACH CARBONIC ANHYDRASE.
Since the murine stomach has been shown to be a rich source or BrMRBC 
antigen, one aim here has been to characterise autoantigens that arise from the 
stomach (Cunningham and Steele 1981; Chapter 3). A problem with attempting to
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demonstrate the presence of an autoantigen in murine gut using second antibody 
reagents that have an alkaline phosphatase detection system has been the 
interference of endogenous alkaline phosphatase activity in the stomach. Attempts 
were made to fractionate soluble gut material over Sephadex G-75 and assess the 
fractions for autoantigens by dot blotting, but this could not be achieved without 
interference from endogenous alkaline phosphatase. Other second antibody systems 
using peroxidase conjugated antibodies had been used but were not as sensitive as 
the alkaline phosphatase reagents used throughout this study. Western blotting with 
appropriate control blots are the best alternative to deal with this problem because 
although background staining due to endogenous alkaline phosphatase may be 
present, it may be controlled for by comparison between bands on test blots and 
bands on blots that have not been treated with first antibody.
Carbonic anhydrase was isolated from the stomach mucosae of retired breeder 
female CBA/H mice and semi-purified by ammonium sulphate precipitation, 
fractionation on Sephadex G-75 using a method that had been used to purify 
carbonic anhydrase from guinea pig stomach (Carter and Parsons 1970). Fractions 
from the column were tested for protein (Figure 5.9a.) and positive fractions were 
electrophoresed on SDS-PAGE and stained with Coomassie Blue (Figure 5.9b.). 
Of the protein containing fractions isolated from the column fractions (22 to 74 ), 
fractions 31 to 35 were found to contain most of the proteins in the 30kD region 
and bands from this region were immunoreactive in western blots when tested with 
FUB 1 and LPS serum (not shown; Fraction 32 is shown in Figure 5.10). In a 
side-by-side western blot, gut extract from the step immediately prior to passage 
over the Sephadex column and fraction 32 were western blotted with FUB 1 and 
LPS serum (Figure 5.10.). The bands present on the PBS blot indicate endogenous 
gut alkaline phosphatase and these bands may be clearly distinguished from the 
bands that FUB 1 and LPS serum react against.
The staining intensity of these bands is also significantly reduced if antibody 
sam ples are preabsorbed with BrMRBC, but not with NMRBC, which is 
indicative of carbonic anhydrase forming part of the BrM-epitope (Figure 5.10).
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F ig u re  5.9. C h arac te risa tio n  of m ouse stom ach carbon ic  anhydrase 
frac tions by m icro-Low ry and SD S-PAGE.
a) Micro-Lowry Assay of protein fractions, (next page)
A micro-Lowry protein assay was conducted to determine the protein containing 
fractions from the column. Carbonic anhydrase appears in the first major peak 
eluted from the column (principally Fractions 31-39).
Column details : Sephadex G-75 ; 30cm x 1.5 cm, V0 = 12ml, 100fJ.l of Blue
dextran 2000 applied to the column, eluted 10.5 to 11.5ml, 0.5 fractions 
collected
b) Fractions 31-39 were electrophoresed by SDS-PAGE and stained with 
Coomassie Blue. Bands in the 30kD region appear in all of these fractions.
M wt (kD)
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Mlcrolowry assay on fractions from separation of gut carbonic anhydraifl.
Column Fractions
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F ig u re  5.10. SD S-P age a n d  W este rn  b lo t o f w hole gu t e x tra c t and  
frac tio n  32 w ith  FUB 1 a n d  L PS serum .
SDS-PAGE (silver stained) of whole gut extract and fraction 32 with: Lane a. Low 
molecular weight markers; Lane b Column Fraction 32 ; Lane c Whole gut extract. 
In the western blots, Blot 1 PBS control versus a,b,c; Blot 2 FUB 1 unabsorbed
Fug»
versus a,b,c; B lot 3 NM RBC absorbed, versus b &c and ; Blot 4 BrMRBC
f » S i  A
absorbed, versus b&c.
A
In a separate experiment, LPS-serum was absorbed more extensively : Blot 
5 LPS stimulated serum versus c,b,a ; Blot 6 LPS stimulated serum NMRBC 
absorbed versus b,a,c and ; Blot 7 LPS stimulated serum BrMRBC absorbed 
versus b,a,c. Note the reduction in staining intensity of carbonic anhydrase bands 
upon absorption with BrMRBC, for Fraction 32 and whole gut extract. Enzymatic 
stain ing  o f gut alkaline phosphatase is evident on the PBS control.
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In Figure 5.10, there are high molecular weight bands that appear on the 
control blot in the whole gut extract lane (BLOT 1, lane c). These bands react 
directly with the substrate or are recognised directly by the second antibody because 
the second antibody has been preabsorbed with NMRBC and BrMRBC but not 
with gut extract. These nonspecific bands may be accounted for on test blots (lane
c). On blots where FUB 1 has been used as the first antibody (Blots 2-4) a 31kD 
band and a fainter 29kD band is recognised from fraction 32 (lane b), that 
disappears with FUB 1 that has been preabsorbed with BrMRBC (Blot 4) but not 
with NM RBC (Blot 3). In a separate experiment where LPS serum has been 
absorbed more extensively with NMRBC or BrMRBC, (Blots 5-7) a similar result 
is seen . LPS serum clearly recognises a 31 kD band and a fainter 29kD band from 
Fraction 32 that disappears after LPS serum has been absorbed with BrMRBC 
(Blot 7 lane b) but not NMRBC (Blot 6 lane b). As silver staining indicates (Figure 
5.10a) Fraction 32 contains a wide spectrum of proteins and cannot be considered 
to be purified  carbonic anhydrase, however both FUB 1 and LPS serum 
specifically recognise a 3 lkD  protein and a fainter 29kD protein that is present in 
the stomach mucosae.
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5 .5 .  M URINE IgM  A N TI-BrM RBC NATURAL AUTO ANTIBODIES  
R E C O G N IS E  C A R B O N IC  A N H Y D R A S E  F R O M  TH E  
ERYTHROCYTES OF DIFFERENT SPECIES.
Do murine IgM natural autoantibodies recognise carbonic anhydrase from the 
erythrocyte^of different species ? In a survey of red blood cells from a range 
of different species, a doublet band of carbonic anhydrase can be detected 
from mouse, rat and rabbit RBC, whereas a single carbonic anhydrase band 
is found upon immunoblotting sheep, horse and human RBC with LPS serum 
and FUB 1 (Figure 5.11). FUB 1 and LPS serum have been shown to be capable 
of specifically detecting purified carbonic anhydrase from human, dog and 
rabbit erythrocytes on Western blots (Chapter 4). These western blotting results 
suggest that common sites may be recognised on carbonic anhydrases of different 
species by natural antibodies. To provide evidence o f the universality o f this 
statement, it would be interesting to test natural antibodies from different species for 
their ability to bind to carbonic anhydrase from a range of species.
Suspension cell-ELISA experiment were also conducted with FUB 1 and LPS 
serum against a panel of erythrocytes from different species (Figure 5.12). FUB 1 
does not bind to untreated RBC at high levels ( Figure 5.12a), but shows some 
binding against BrMRBC and Bromelain-SheepRBC (Figure 5.12c). LPS serum, 
in contrast, binds to untreated rabbit and rat RBC (Figure 5.12b.) and all 
bromelain-treated RBC (Figure 5.12d.).
These suspension c-ELISA experiments and western blotting experiments 
with the same red blood cells allow a comparison of how CA may be presented on 
the erythrocytes of different species. In western blotting experiments, all carbonic 
anhydrases are recognised by FUB 1 and LPS serum because of the way that the 
proteins have been separated from their normal association with the membrane. In 
contrast, different results are obtained in suspension c-ELISA experiments. FUB 1 
can only recognise antigenic molecules on bromelain-treated mouse and sheep red 
blood cells, suggesting that portions of carbonic anhydrase may be presented in a 
recognisable form. On the bromelain-treated RBC from other species, FUB 1 
which is capable o f binding to carbonic anhydrase from these species is prevented
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from doing so by the incorrect presentation or orientation of carbonic anhydrase. 
LPS serum, on the other hand, is capable o f binding onto all bromelain-treated 
erythrocytes to varying degrees in western blots and suspension c-ELISA assays. 
This may reflect either the presence of antibodies o f higher avidity for carbonic 
anhydrase in LPS serum or of antibodies that recognise other species specific 
determinants in addition to carbonic anhydrase.
W hen mouse and rat RBC are probed with monoclonal antibodies that 
are specific for rat RBC (FUB 4 -IgG mouse anti-Rat RBC specific; and FUB 3 
-IgM  mouse anti-BrMRBC and Anti-Rat RBC), it was found (Figure 5.13) that 
LPS-serum, FUB 1 and FUB 3 recognise carbonic anhydrase on both mouse and 
rat RBC , whereas FUB 4 recognises two bands on rat RBC at 56 and 58 kD . 
Faint reactivity on both mouse and rat carbonic anhydrase was observed with FUB 
4. This result is an indication that IgM and IgG autoantibodies may recognise 
different targets on whole mouse and rat erythrocytes and warrants a more 
extensive investigation of the relationship between the targets recognised by natural 
IgM autoantibodies and those recognised by IgG autoantibodies.
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F IG U R E  5.11 SD S-PA G E  & W estern  b lot of RBC fro m  d ifferen t 
sp e c ie s
Erythrocytes were electrophoresed under standard conditions and stained with 
Coomassie Blue (N euhoffs method): Lane 1 markers, Lane 2 CBA/H mouse 
RBC, Lane 3 Wistar Rat RBC, Lane 4 NZW Rabbit RBC, Lane 5 human RBC, 
Lane 6 Sheep RBC, Lane 7 Horse RBC









Erythrocytes from rat, rabbit, human, sheep and horse were electroblotted under 
standard conditions, except that FUB 1 was used at 1:10 and LPS serum at 1:5000, 
Goat anti-mouse IgM -biotin was applied at 1:5000 and Streptavidin-alkaline 
phosphatase at 1:4000.
L ane  a. Rat RBC; L ane b. Rabbit RBC; Lane c. Human RBC; L ane d. Sheep 
RBC; L ane e. Horse RBC.
1 2 3 4 5 6 7
LPS-serum PUB 1 PBS control
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Figure 5.12 Suspension c-ELISA to test the capacity o f FUB 1 and 
LPS serum  to bind to normal and bromelain-treated erythrocytes from  
m ouse, rat, rabbit, sheep and human.
' FUB 1 (Figure 5.12a) and LPS serum (Figure 5.12b) were titrated against 
mouse ( O ), rat ( # ) ,  rabbit (□), human (■ ) and sheep (A) red blood cells. Horse 
RBC and bromelain-treated horse RBC lysed on all plates upon the addition of 
substrate buffer. In Figure 5.12c, FUB 1 was titrated against bromelain-treated 
erythrocytes and the results for LPS serum against bromelain-treated erythrocytes 
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F IG U R E  5.13. W este rn  b lo t o f RBC from  m ouse a n d  ra t  RBC 
d e te c te d  w ith  m o n o c lo n a l a n ti-B rM R B C  a n d  a n t i -R a t  RBC 
a n tib o d ie s .
Mouse and rat RBC were blotted side-by-side from 15% separating gels onto 
nitrocellulose. FUB 1 (BLOT 2), FUB 3 (BLOT 3), and FUB 4 (BLOT 4) were 
applied to the membrane at 1:10 and LPS serum (BLOT 1) was used at 1: 5000 
overnight at room temperature. BLOT 5 is the PBS control.The second antibody 
was 1: 5000 goat anti-mouse IgM biotin labelled for 3 hours at room temperature, 
followed by 1: 4000 streptavidin-alkaline phosphatase for 1 hour. The membranes 
were extensively washed (3 x 20ml x 30mins) between all steps. All antibodies 
tested could detect carbonic anhydrase bands from both rat and mouse RBC, 
however, in addition FUB 4 (an IgG anti-Rat RBC specific m onoclonal) detects 
two bands on Rat RBC at 56kD and 58kD. On rat RBC these bands have been 
shown by Laing et al. (1988) to be glycophorin dimers.
Blot 1 2 3 4 5
Lane M R  M R  M R  M R  M R
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5.6. Defining the epitopes o f carbonic anhydrase recognised by 
IgM  natural autoantibodies.
W hat portion of the carbonic anhydrase molecule is recognised by natural 
autoantibodies? Are carbohydrate epitopes or protein epitopes recognised ? From 
Alcian blue and PAS staining (Chapter 4) it is known that carbonic anhydrase is a 
glycoprotein, but there is currently no information on the nature of carbohydrates 
present. From previous ELISA results, it was established that FUB 1 could bind to 
denatured, as well as native forms of carbonic anhydrase indicating possibly that a 
linear protein epitope may be recognised. Hydrophilicity and mobility analysis are 
two theoretical indicators of the position of possible antigenic epitopes in proteins 
(Hopp 1986, Van Regemortel, 1986,1989).
From an examination of the mouse carbonic anhydrase II sequence (Venta et 
al 1985, Figure 5.1), there are a number of possible sites of glycosylation (Ser,Thr 
and Asn) present in the N-terminal end of the molecule. From this sequence, any 
carbohydrate attachm ents are likely to be through O-linkages rather than 
N-linkages, because the motif common for N-linkages viz. Asn-X Ser(Thr) (Spiro 
1974) is not present in the sequence. If the constituent amino acid molecular 
weights are totalled, other post-translational modifications of the protein account for 
about 3% of the molecule. Thus, due to these theoretical considerations, as well as 
the practical considerations o f lim ited time and funds only the O-linked 
carbohydates have been investigated at this stage. O-linked carbohydrates may be 
selectively removed with a specific enzyme, O-glycanase (Figure 5.14) or oxidised 
with sodium metaperiodate (Spiro 1966).
W hen bovine carbonic anhydrase is treated with neuraminidase and 
O-glycanase there is no obvious shift in molecular weight although control proteins 
such as fetuin and asialofetuin are digested. Thus, it appeared as if carbonic 
anhydrase was not heavily sialated or glycosylated, because it was difficult to detect 
a lowering of the molecular weight with these treatments. The situation was similar 
for whole mouse red blood cells treated with neuraminidase and O-glycanse, with 
no obvious shift in mouse CA bands noted (Figure 5.14 b). O-glycanase has a 
m olecular weight o f approximately 160,000, while the molecular weight of
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neuraminidase is approximately 97,000 (Boehringer literature).
In western blotting experiments (Figure 5.15), treatment of carbonic 
anhydrase with neuraminidase and O-glycanase does not alter the binding of 
LPS-serum to carbonic anhydrase. However, FUB 1 does not bind to carbonic 
anhydrase that has had O-linked sugars removed. Sodium metaperiodate oxidation 
treatment does not markedly alter the binding of LPS serum or FUB 1 to carbonic 
anhydrase and this may be due to the oxidised sugars remaining attached to the 
protein.
In another theoretical excercise concerned with protein epitopes, the likely 
sequence of amino acids that form a protein epitope may be determined by 
hydrophilicity/hydrophobicity analysis (Hopp 1986). In this scheme, each amino 
acid has been assigned a value on a scale of hydrophillicity or hydrophobicityand 
the likely antigenic sites would occur between amino acids 71-75, 26-30,101-105, 
111-115 and 251-254 (Figure 5.16.). There are a number of different methods 
available for attempting to define potential antigenic sites in proteins and there is still 
controversy as to the merit o f different methods (reviewed in Van Regenmortel 
1989). Hydrophilicity/hydrophobicity is thought to be appropriate in this case given 
that phosphatidylcholine is an established component of the BrMRBC epitope and 
that hydrophobic regions o f carbonic anhydrase may in teract with 
phosphatidylcholine to form a complex once membrane integrity has been breached.
Alternatively, protein epitopes may be investigated by limited proteolysis with 
proteolytic enzymes (Cleveland 1983), specific chemicals that cleave proteins such 
as cyanogen bromide or hydroxylamine (Lam and Kaspar 1980,Sam s et al .1983) 
or N-succinimide/urea (Lischwe and Ochs 1982) or heat (Rittenhouse and Marcus 
1984). Analysis of the sequence (Figure 5.1) suggested that cleavage of the mouse 
carbonic anhydrase at a limited number of sites may be the best approach to try to 
hone in on the specific site of recognition. Once antigenic epitopes could be isolated 
to large sections of protein , then other proteolytic enzymes could be used to further 
cleave antigenic portions into smaller sections. Initial experiments were conducted 
by a method of heat cleavage (Rittenhouse and Marcus 1984) which cuts proteins at 
the carboxylic side of arginine. For these experiments, mouse carbonic anhydrase
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bands were excised from an SDS-PAGE gel and incubated for 2 hours at 110°C in 
reducing sample buffer under mineral oil. This procedure was unsuccessful when 
the gel slices and sample buffer were electrophoresed for the second time due to the 
presence of smears of protein in place of bands, or to the lack of sufficient material 
in the second gel to resolve cleavage products.
By examination of a range of enzymatic and chemical cleavage procedures 
including, trypsin, chymotrypsin, pepsin, endoproteinase Lys-C, V8 protease, 
hydroxylamme, cyanogen bromide, papain, bromelain and endoproteinase Arg-C, 
it was decided that enzymes that cleaved at arginine such as endoproteinase Arg-C 
and papain would be the most suitable enzymes to cleave carbonic anhydrase. 
Protein cleavage of bovine carbonic anhydrase was conducted with Endoproteinase 
Arg-C & papain (Figure 5.17). In these experiments, proteolytic enzyme solution is 
layered over the carbonic anhydrase in the wells of the polyacrylamide gel and this 
procedure has been more successful to date.There are problems associated with 
spillage of the enzyme into other lanes that need to be resolved, because it was 
found that, especially with papain, there was a tendency for the enzyme to float 
across to digest other lanes even when increased levels of glycerol had been added 
to make the proteolytic enzyme less likely to do this. This series of experiments 
have raised a number of technical problems to resolve . Given sufficient time these 
could be resolved to yield information on the antigenic sites when coupled to 
western blotting procedures.
Further technical problems were encountered in preliminary Western blotting 
experiments, with LPS serum and FUB 1 binding to endoproteinase Arg-C (Figure 
5.18). Considering that the enzyme (0.45mg) has been purified from the 
submaxillary glands of 1000 mice (Boehringer literature) this may not under 
physiological concentrations act as an autoantigenic target in the mouse. Another 
problem encountered was due to the leakage of proteolytic enzymes across lanes 
prior to electrophoresis making determination of the exact molecular weight of the 
cleavage fragments difficult (Figure 5.18). Nevertheless, LPS serum appears to be 
capable of recognising a number of peptide fragments from the endoproteinase 
Arg-C cleavage (Lane 3), whereas FUB 1 only detects two faint bands (Lanes 3 
and 4). FUB 1 can detect endoproteinase Arg-C alone (Lane 1) but not after
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proteolysis (Lane 3). As FUB 1 recognises O-linked carbohydrates, the fact that 
two protein bands are recognised here would indicate that these segments of protein 
may carry O-linked carbohydrates. Clearly there is much information to be derived 
from futher experiments on carbonic anhydrase along these lines.
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Figure  5.14a) Digestion of ca rb o n ic  an hyd rase  with O-glycanase to 
rem ove O -linked carbohydrates.
SDS-PAGE was conducted on 15% separating gels under reducing 
conditions. In lane 1: Low molecular weight markers, Lane 2 5|ig bovine carbonic 
anhydrase, Lane 3 CA + neuraminidase, Lane 4 CA + neuraminidase + 
O-glycanase, Lane 5 Fetuin 2}ig, Lane 6 Fetuin + neuraminidase, Lane 7 Fetuin + 
Neuraminidase + O-glycanase, Lane 8 Asialo fetuin 2|ig, Lane 9 Asialofetuin + 
O-glycanase, Lane 10 Neuraminidase + O-glycanase.
Mwt (kD)
1 2 3 4 5  6 7  8 9  10
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F ig u re  5.14 b). D igestion of m ouse ery th rocy tes with neuram inidase 
an d  O-glycanase. SDS was conducted on 15% separating gels under reducing 
conditions and silver stained. The gel is overloaded for silver staining but allows all 
bands to be visualised, especially the purity of the commercial source of bovine 
carbonic anhydrase. Lane 1: lOpg bovine carbonic anhydrase, Lane 2: CA 
+neuraminidase Lane 3 NMRBC, Lane 4: NMRBC + neuraminidase, Lane 5: 
NMRBC +neuraminidase + O-glycanase Lane 6: Asialofetuin Lane 7: asialofetuin + 
O-glycanse Lane 8: O-glycanase and neuraminidase Lane 9: low molecular weight 
markers.
Mwt (kD)
_  9 7 .4
-  66.2
“  4 5
”  31
-  2 1 .5
1 4 .4
1 2 3 4 5 6 7 8 9
CHAPTER FIVE 1 7 3
F IG U R E  5.15 W este rn  b lo ttin g  ex p erim en t w ith  LPS serum  and  
FUB 1 an d  deglycosylated  ca rbon ic  anhydrase .
Carbonic anhydrase was treated with neuraminidase and O-glycosidase, or sodium 
meta periodate, blotted and probed with LPS-serum and FUB 1. Lane 1 Bovine 
carbonic anhydrase L ane 2 Neuraminidase treated CA Lane 3 O-glycanase 
treated CA L ane 4 0.0 IM  NaIÛ4 treated CA Lane 5 0.08M NaI04 treated CA .
Carbonic anhydrase was deglycosylated with sodium metaperiodate (0.01 and 
0.08M in sodium acetate buffer, pH 4.5, overnight at 4°C in the dark). These 
treatm ents did not alter the apparent molecular weight of bovine carbonic 
anhydrase. However, upon calculating the theoretical molecular weight based on 
the amino acids in the sequence, carbohydrate or other post-translational 
modifications to the protein would account for only 3% of the molecule. Upon 
blotting, carbonic anhydrase and the various de-glycosylation regimes did not alter 
the binding to carbonic anhydrase of IgM natural autoantibodies in LPS serum, 
which suggests that some portion of the protein is likely to be recognised. 
However,the monoclonal FUB 1 displayed reduced binding to carbonic anhydrase 
from which O-linked sugars had been removed with O-glycosidase, whereas 
polyclonal LPS-serum  could presum ably recognise de-glycosylated and 
glycosylated forms.
L P S  s e r u m  
L a n e  1 2  3  4  5
F U B 1
1 2  3  4  5
P B S  c o n t r o l  
1 2  3  4  5
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F igu re 5 .16 . H yd rop h ilic ity /H yd rop h ob ic ity  an alysis o f m ouse 
carbonic anhydrase:
Amino acids may be assigned a number on a scale of hydrophobicity, with 
high , positive numbers { +3} indicating a very hydrophobic amino acid and high 
negative numbers {-3} indicating hydrophilic amino acids (Hopp 1986). If these 
values are assigned to the mouse carbonic anhydrase II sequence a number of 
hydrophobic areas, which are thought to represent antigenic sites on the molecule 
appear (Bold type).
F r o m  H o p p  ( 1 9 8 6 )  r e v i e w  t h e r e  i s  a  s c a l e  o f  h y d r o p h o b i c i t y  s u c h  t h a t :
R A r g 3 . 0 A  A l a - 0 . 5
E  G l u t a m i c a 3 . 0 H  H i s - 0 . 5
D  A s p  a c i d 3 . 0 C  C y s t - 1 . 0
K  L y s i n e 3 . 0 M  M e t - 1 . 3
S  S e r 0 . 3 V  V a l - 1 . 5
Q G I u 0 . 2 I I s o l e u - 1 . 8
N  A s p a r 0 . 2 L  L e u - 1 . 8
G  G l y 0.0 Y  T y r - 2 . 3
P  P r o 0.0 F P h e - 2 . 5
T  T h r - 0 . 4 W  T r y p - 3 . 4
M  S H H W G Y S K H N G P Q N W H J L D F P I A  G  D  R  E  S P V f i T A T A  ( G / H )  H D P A  
L E P L L I S W f i K A A S K S I V N N G H  S F N V  ( E F D D S G P ) N A V L K G G P L  
S D S Y R L I E F H F W G S S f i G Q G S E H T V N L (  K  K  K  Y A A E _ ) L H L V H W N  
T K Y G D F G K A V Q Q P f i G L A V L G Y F L K I G P A S Q G L Q & V L E A L H  
S I ( K T K G K R ) A A F A N F D P C S L L P G N L D Y W T Y P G S L T T P P L L E  
C  V  T  W  I V  L  N  E  P  I T  V  S  S  E  Q  M  S  H  F  N  T  L  N  F  N  (  E E  G  D  A  £ E _ )  A  M  V  D  N  
w e p a q p l ( k n  R _ K I  K  )  A  S  F  K
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F ig u re  5.17 P ro te ly tic  cleavage of CA with endoproteinase Arg-C 
an d  papain .
SDS-PAGE conducted on 15% gels under reducing conditions,stained with 
Coomassie Blue. Lane 1; Endoproteinase Arg-C, Lane 2; papain, Lane 3; Bovine 
carbonic anhydrase + endoproteinase Arg-C, Lane 4; Bovine carbonic anhdyrase 
+papain, Lane 5 Low molecular weight markers. Since the molecular weight marker 
lane has been digested it is impossible to indicate molecular weight, however, 
endoproteinase Arg-C has a molecular weight of 25kD.
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F igure  5.18. W estern blot of carbonic  anhydrase that had been cleaved 
w ith  endoproteinase A rg-C  and  papain .
LPS serum was used at 1 in 1000 dilution and FUB 1 was used at 1:10. The second 
antibody was preabsorbed 1: 5000 biotinylated goat anti-mouse IgM, with 1:1000 
streptavidin-alkaline phosphatase. The samples from figure 5.17 are in the same 
configuration , hence, Lane 1; Endoproteinase Arg-C, Lane 2; papain, Lane 3; 
Bovine carbonic anhydrase + endoproteinase Arg-C, Lane 4; Bovine carbonic 
anhdyrase +papain, Lane 5 Low molecular weight markers.
1 2  3 4 5 1 2  3  4  5
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5.7. DISCUSSION
In this chapter a number of different aspects of the interaction between natural 
autoantibodies and carbonic anhydrase have been examined. These experiments 
attempted to further characterise a previously unknown erythrocyte and gut 
autoantigen. W ith a novel result such as has been demonstrated numerous 
experimental pathways would be possible. It was important however, to further 
dem onstrate links with previous studies by examining gut mucosae and 
erythrocytes from different species, as well as to forge ahead with attempting to 
define precisely the regions of the molecule that may be antigenic.
In the series of experiments with denatured forms of carbonic anhydrase, the 
aim was to determine if the native structure was important for recognition by IgM 
natural autoantibodies in LPS serum and FUB 1. FUB 1 and LPS serum could bind 
directly to the native and some of the unfolded forms of carbonic anhydrase. There 
was a decreased ability of FUB 1 to bind to heat and SDS-denatured forms of 
carbonic anhydrase, but as these molecules are subsequently found to be effective 
in competitive inhibition ELISA experiments or capable of being recognised on dot 
blots, the lowered binding titres observed in Figure 5.2 must be due to a reduced 
ability of these forms of denatured carbonic anhydrase to bind effectively to plastic 
microtitre plates rather than to the irreversible destruction of antigenic determinants.
A slightly different pattern of binding was noted between the direct ELISA 
with antigen coated plates and dot blotting experiments. SDS- and urea-treated 
forms are not readily recognised when attached to nitrocellulose. The action of the 
detergent SDS is to bind to amino acids in proteins to form rod-like structures with 
a strong net negative charge (Smith et al. 1987). Thus the reason for the lack of 
antigenicity may be due to the loss of tertiary structure or, more likely, the change 
in surface charges on carbonic anhydrase.
In the competitive inhibition ELISA assays with carbonic anhydrase coated 
plates, the epitopes displayed are not altered by the action of binding to the plastic 
microtitre plates because soluble native carbonic anhydrase can inhibit binding. The 
same pattern is seen when denatured forms of carbonic anhydrase are used for
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inhibition on untreated carbonic anhydrase plates (Figure 5.3a.). On plates coated 
with denatured forms of CA (Figure 5.3.b and c), binding may also be effectively 
inhibited with native and denatured forms of carbonic anhydrase. These 
experiments demonstrate that the site or sites bound by IgM natural autoantibodies 
are likely to consist of a linear sequence of ammo acids that can be recognised on 
the native carbonic anhydrase molecule. At high concentrations of FUB 1, FUB 1 
forms a complex with acid-denatured forms of carbonic anhydrase which are 
deposited onto plates,but this does not affect the demonstration of inhibition of 
FUB 1 at lowered antibody concentrations.
Attempts to inhibit binding of natural autoantibodies to BrMRBC with 
carbonic anhydrase in suspension c-ELISA experiments were generally 
unsuccessful (Figures 5.5 , 5.6 and 5.7). Soluble forms of bovine carbonic 
anhydrase could not inhibit the interaction of natural antibodies and BrMRBC 
(Figure 5.5) and carbonic anhydrase attached to Sepharose beads proved to be 
unsuitable for use in inhibition experiments using the suspension c-ELISA 
technique (Figure 5.6). Perhaps in these types of ELISA assays the optimum 
conditions to demonstrate inhibition may require some manipulation of the amounts 
of antibodies used or the amounts of target BrMRBC. No estimate has been made, 
as yet, of the number o f possible antigenic sites that occur per BrMRBC for 
carbonic anhydrase. However, considering that it is the second most abundant 
protein in erythrocytes after haemoglobin this may be quite high. The other 
possibility is that anti-BrMRBC autoantibodies will always preferentially bind to 
BrMRBC with at least one antigen combining site, leaving other antigen combining 
sites to bind freely to carbonic anhydrase or phosphatidylcholine. Another 
possibility is that carbonic anhydrase may need to be presented in conjunction with 
a membrane to effectively inhibit binding to BrMRBC.
Rather than a suspension c-ELISA assay where there are a number of 
stringent washing steps, inhibition may have been more conclusively demonstrated 
in an inhibition of haemolysis assay with the inhibitor continuously present. Some 
preliminary experiments indicated that CA may be inhibitory in haemolysis assays 
but the nature of the assay and defining an endpoint in this assay is vastly different 
to ELISA assays. Inhibition may then be difficult to demonstrate in cellular ELISA
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assays without drastically altering condtions of the level of target cells or the levels 
of antibodies and/or inhibitors used.
It was thought that a major part of the problem encountered with the inability 
to inhibit binding may have been due to the formation of lattices between IgM, 
carbonic anhydrase and BrMRBC. One way to demonstrate inhibition was to 
reduce IgM to monomers to prevent this type of lattice formation . Experiments 
with monomers of IgM were revealing (Figures 5.7 and 5.8). One would expect 
that the monomers should retain some binding activity against BrMRBC and 
carbonic anhydrase, but this was not the case. For FUB 1, and to a lesser extent the 
IgM autoantibodies in LPS serum, the binding of monomers was drastically 
reduced suggesting that the entire IgM molecule is required to bind to BrMRBC and 
carbonic anhydrase. This implies that the binding seen is due in a minor way to the 
"affinity" of each antigen combining site for BrMRBC but largely a consequence of 
having a number of low "affinity" binding sites per IgM molecule. Inhibition could 
still not be demonstrated whether monomers were produced or not.
In experiments with monomers of FUB 1, monomers of IgM antibodies from 
LPS serum and carbonic anhydrase-coated plates (Figure 5.8) the binding of all 
monomers is reduced regardless of the presence of inhibitors. Some difficulty was 
also experienced in attempting to inhibit the binding of LPS serum to CA-coated 
plates with carbonic anhydrase (Figure 5.8.) whereas some inhibition may be noted 
for FUB 1 in the presence of CA.
Characterising autoantigens from the stomach mucosa is important in order to 
try to identify the source of the BrM antigen that had been demonstrated by 
Cunningham and Steele (1981). Carbonic anhydrase from murine stomachs was 
sem i-purified from an aqueous extract of whole gut, electrophoresed on 
polyacrylamide gels and bound specifically by FUB 1 and LPS serum. The two 
immunoreactive bands from the gut extract were located at 31kD and 28kD, 
however the exact relationship between these bands and those expressed on 
erythrocytes has not yet been established by protein sequencing. The identity 
between carbonic anhydrase and the serological BrMRBC epitope has however, 
been demonstrated in western blotting experiments where FUB 1 or LPS serum
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have been preabsorbed with BrM RBC before use. In these experiments, 
preabsorbtion with BrMRBC but not NMRBC results in the disappearance of the 
immunoreactive bands from the whole gut extract and fraction 32.
Another important consideration was whether carbonic anhydrase could be 
detected from the red blood cells of different species in Western blotting and 
suspension c-ELISA experiments with murine IgM natural autoantibodies. A 
different pattern o f binding is observed depending upon the assay system. In 
western blotting, all red blood cell proteins are removed from the erythrocyte 
membrane and carbonic anhydrase bands are recognised from all erythrocytes. A 
doublet band is found for mouse, rat and rabbit RBC and a single band is noted for 
sheep, human and horse erythrocytes. In ELISA experiments, FUB 1 binds 
exclusively to BrMRBC and Br-SheepRBC, while LPS serum displays binding 
activity towards all bromelain-treated RBC and untreated rabbit and rat RBC. This 
binding is independent of whether the blood cells can be typed with anti-A or anti-B 
typing sera (Chapter 3) and suggests that bromelain may have different actions 
upon different RBC membranes as regards its ability to reveal carbonic anhydrase. 
Since FUB 1 is capable of recognising CA from all species on western blots, there 
must be a quirk of presentation to explain why it is only capable of recognising 
BrMRBC and to a lesser extent BrSheep RBC rather than all bromelain-treated 
RBC. For LPS serum, some binding titre is evident for untreated rabbit and rat 
RBC, and there is a spectrum of binding against bromelain-treated RBC:
BrMRBC > Br-Human RBC > Br Rabbit RBC > Br Rat RBC > BrSheep RBC.
W hen mouse and rat RBC are probed with anti-Rat RBC monoclonal 
antibodies, carbonic anhydrase bands are recognised by FUB 3 and FUB 4 . In 
addition FUB 4, an IgG anti-Rat RBC specific monoclonal, recognises bands at 56 
and 58 kD on rat RBC alone.
The series of experiments to define the epitopes of carbonic anhydrase 
recognised by LPS serum and FUB 1 were revealing, although the experiments 
conducted with the aim of examining protein epitopes had to be truncated due to 
time constraints. These experiments show that there is evidence for the involvement 
of carbohydrates with the BrMRBC epitope and this would be compatible with
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Cunningham and Steele's preparation of "blood-group-like" antigens from the 
stomach. A full examination of whether N-linked carbohydrates are present on 
carbonic anhydrase and the determination of the actual types of carbohydrates 
involved would be required to clarify the importance of carbohydrates to the 
BrMRBC-type o f autoantigen. Clearly the novel results presented here require 
further investigation and require a reexamination of some of the more puzzling 
aspects o f the BrMRBC phenomenon, such as the inability to elicit a response if 
BrMRBC are injected. Nevertheless, the results must lead us forward to examine 
the significance of the finding that carbonic anhydrase is specifically recognised by 
natural autoantibodies and also the relationship between carbonic anhydrase and 
phosphatidylcholine.
CHAPTER SIX
GENERAL DISCUSSION AND CONCLUSIONS
Carbonic anhydrase has been shown in this study to be related to the serological 
autoantigen(s) revealed on mouse erythrocytes that have been treated with bromelain. In 
this study, emphasis has been placed on characterising the endogenous autoantigens 
recognised by IgM natural autoantibodies on bromelain-treated red blood cells and in the 
stomach. The involvement of carbonic anhydrase with this autoantigenic epitope is a 
novel finding, as previously phosphatidyl choline and trimethylammonium compounds 
had been implicated in this autoantigenic determinant (Serban et al 1981; Pages et al. 
1982; Serban and Witz 1988; Cox and Hardy 1985; Mercolino et a l  1986,1988,1989; 
Kawaguchi 1987b). The involvm ent o f carbonic anhydrase in the BrMRBC 
autoantigenic epitope has far reaching implications on the role of this autoantigen in 
normal and autoimmune animals and this will be discussed below. The discovery of 
carbonic anhydrase has answered the basic aim of the study to characterise endogenous 
autoantigens expressed on bromelain-treated mouse erythrocytes and in murine gut. 
However, there are many questions raised by the fact that carbonic anhydrase may be 
recognised as part of this epitope and there are many experimental pathways to follow in 
the future from this finding. One major question to address in the future is the role of 
carbonic anhydrase and other types of autoantigens and natural autoantibodies in self 
tolerance and autoimmunity.
The early negative results can now be reviewed in perspective, since carbonic 
anhydrase has been found to be involved in this epitope (Chapter 4 and 5). In ELISA 
experiments (Chapter 3, Figure 3.1) LPS stimulated serum could be demonstrated to 
bind to ghosts. The degree of binding was found to be dependent upon the amount of 
protein present in the ghosts. When the ghosts were electro- phoresed, it was found that 
most of the protein remaining after formation of BrM ghosts occurred at high molecular 
weights and did not leave the stacking gel.A diffuse band of protein also occurred at 
29kD and there is some evidence of haemoglobin subunits at 12-14kD. If ghosts had 
been treated with potassium hydroxide using the Dodge method, all membrane proteins 
were stripped from the ghosts. Although binding of ghosts could be demonstrated in
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ELISA assays (Chapter 3, Figure 3.1.), difficulties were experienced when ghosts were 
used as inhibitory particles in ELISA assays (Chapter 3, Section 3.4.3.) or if they had 
been attached to affinity columns (Chapter 3, Section 3.4.2.). Several studies have used 
ghosts to show that part o f the BrM determinant may be accounted for by a portion of 
the RBC membrane ( Bussard et al. 1977; Pages et al 1982; Poncet et al. 1985) 
however, one criticism of these studies is that it is not clear if the ghosts used were 
protein-free or if they were resealed the right way around or inside out. In the 
production of erythrocyte ghosts, the membrane configuration may not be representative 
of the intact erythrocyte. Since it has subsequently been demonstrated here that IgM 
natural autoantibodies recognise carbonic anhydrase and that most of the carbonic 
anhydrase was removed when ghosts were produced, it is hardly surprising that the 
early experiments conducted were not successful.
One interesting observation on bromelain treatment is that BrMRBC do not lyse 
after proteolytic treatment but form echinocytes rather than the predominantly biconcave 
discs that are visible in intact NMRBC under the microscope. From this observation and 
the fact that NMRBC are not normally recognised by natural autoantibodies, it was 
thought that when erythrocytes have been treated with bromelain some the hydrophobic 
regions of some cytoplasmic proteins may assist to stabilise the membrane in association 
with membrane lipids and in doing so form a complex autoantigen.
The difficulties experienced with the earlier experiments coupled with the 
availability of a monoclonal antibody that showed specificity for phosphatidylcholine 
and BrMRBC, FUB 1, led to a different approach in characterising autoantigenic 
epitopes on mouse red blood cells. In order to define autoantigenic molecules on 
brom elain-treated and normal erythrocytes, whole erythrocytes were used in 
SDS-PAGE and Western blotting experiments. This is quite a novel approach because 
normally research has been focussed on membrane proteins exclusively (Fairbanks et 
al. 1971) or other cytoplasmic proteins such as haemoglobin, and a purification step 
would normally be included before electrophoresis. Experiments were conducted with 
whole cells in preference to membranes because most assay systems (haemolytic assay, 
ELISA) have demonstrated the BrMRBC to be present on "intact" cells.
Although care had to be taken to ensure the best possible signal- to- background 
noise conditions with immunoblotting experiments (Chapter 4, Section 4.2.), IgM
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natural autoantibodies in LPS serum and the monoclonal antibody FUB 1 detected a 
doublet band occurring at 29kD and 31kD from bromelain-treated and normal mouse 
erythrocytes (Chapter 4, Section 4.3). At the same time, bovine carbonic anhydrase 
from bovine erythrocytes was detected by the same IgM autoantibodies in the marker 
lane. Subsequent experiments showed that purified carbonic anhydrase from a range of 
species was recognised ( Chapter 4, Figure 4.8) and also carbonic anhydrase from the 
red blood cells of a number of different species could also be detected by western 
blotting ( Chapter 5, Figure 5.11.). Serological identity between the epitopes expressed 
by intact BrMRBC in suspension and the western blotted proteins was established in 
absorption experiments with BrMRBC and NMRBC ( Chapter 4, Figures 4.11. and
4.12.). Thus, absorbtion of FUB 1 and LPS serum with BrMRBC specifically removes 
the doublet band of carbonic anhydrase detected by western blotting.
In binding to both mouse carbonic anhydrase and bovine erythrocyte carbonic 
anhydrase, common sites on the proteins may be recognised by natural autoantibodies. 
Furthermore, carbonic anhydrases from a number of species, both purified and derived 
from erythrocytes, are also recognised by murine IgM autoantibodies. Carbonic 
anhydrase is a highly conserved protein with high sequence homology between different 
species for a particular isoenzyme (Hewett-Emmett et al. 1984 , Tashian 1989), so it is 
likely that a common site may be recognised on carbonic anhydrase from different 
species. Conversely, experiments will need to be conducted to determine if natural 
autoantibodies from different species may also recognise carbonic anhydrase as an 
autoantigen.
Both of the doublet bands of carbonic anhydrase from mouse erythrocytes were 
found to be glycoproteins ( Chapter 4, Figure 4.9) and both bands had a p i of 
approximately 6.7 ( Chapter 4, Figure 4.10). Alcian blue is used at low pH to stain acid 
mucopolysaccharides and sulphated mucopolysaccharides by salt linkage with acidic 
groups, whereas periodic acid- Schiff staining is a general carbohydrate stain for 
glycoproteins, heparin, chondroitin sulphate and polysaccharides (Kieman 1981) . 
Therefore, the difference between the two different forms of carbonic anhydrase is not 
due to one form being glycosylated and the other not. The nature of the difference 
between the proteins may be due to differences in the amino acid sequence, but 
apparently the differences in molecular weight do not alter the binding of natural 
autoantibodies to either of the carbonic anhydrase isoenzymes. Other post-translational
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modifications such as phosphorylation or sulphonation have not yet been reported for 
mouse carbonic anhydrase, but the fact that both bands in the doublet have the same pi 
would suggest that the nature of the modification is electrically neutral, and unlikely to 
alter the basic antigenic structures recognised by natural antibodies.
One study with human erythrocytes has attempted to provide two-dimensional 
maps of erythrocytemembrane and lysate proteins (Edwards et al. 1979 ). A different 
picture of the proteins emerges when compared to the two dimensional maps of purified 
erythrocyte membrane proteins (Fairbanks 1971). When whole erythrocytes are 
electrophoresed, haemoglobin and carbonic anhydrase are the two dominant proteins 
and membrane proteins are scarce. The pattern of glycosylated proteins is somewhat 
different when whole erythrocytes were examined rather than membrane proteins with a 
prominent band appearing at 26kD, the doublet bands of carbonic anhydrase occuring at 
29 and 31 kD ( Chapter 4, Figure 4.9).
During initial western blotting experiments, there was concern that the procedures 
involved in SDS-electrophoresis and W estern blotting may be quite harsh on the 
BrMRBC epitope. In this type of dot-blotting and immunoblotting system, the best 
result were obtained by employing the most sensitive system possible with biotinylated 
second antibody reagents and an alkaline-phosphatase detection system. Care needed to 
be taken with the second antibodies used and the preabsorbtion of second antibodies 
with the target RBC must be considered as mandatory with this autoantigen due to the 
likelihood of antibodies in the second antibody prepartions with specificity for carbonic 
anhydrase. With gut material, problems were encountered due to endogenous alkaline 
phosphatase. Endogenous alkaline phosphatase may be inhibited by preincubation of the 
gut sample with levisimole (Amersham notes), however, in the western blotting 
procedure, these bands may be accounted for by control blots that have not received first 
antibody. NBT/BCIP resulted in a better resolution of bands than earlier blots conducted 
with Fast Red, and the washing and blocking buffers need to be carefully chosen to 
eliminate background and enhance specific binding.
Previous experience in ELISA assays for BrMRBC and NMRBC showed that 
NMRBC could be recognised by IgM autoantibodies in LPS serum after cells were 
allowed to settle to plastic microtitre trays overnight or if cell fixatives such as poly-L- 
lysine or glutaraldehyde had been used (Jonusys and Steele 1988). Thus, to exclude the
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creation of neo-antigens by fixing carbonic anhydrase to microtitre plates, competitive 
ELISA experiments were conducted with soluble carbonic anhydrase (Chapter 5, Figure 
5.2). In this experiment carbonic anhydrase was left untreated or pretreated with agents 
known to denature proteins, such as urea, acid, guanidine hydrochloride and SDS. 
Antibodies could bind to most of the denatured forms and intact carbonic anhydrase in 
these assays. In addition, native and denatured forms were capable of inhibiting FUB 1 
binding to plastic-bound native and denatured forms of carbonic anhydrase (Chapter 5, 
Figure 5.4), thus showing that the epitopes recognised were not due to the conformation 
of the molecule or the interaction between carbonic anhydrase and plastic microtitre 
trays. In a dot blot experiemnt, antibodies could also detect native or denatured carbonic 
anhydrase that was bound to nitrocellulose (Chapter 5, Figure 5.3). Thus, the epitopes 
on carbonic anhydrase recognised by LPS and FUB 1 in western blots are not due to the 
creation of neoantigens formed when the molecule binds to nitrocellulose or plastic 
substrates.
While inhibition of bound carbonic anhydrase with soluble carbonic anhydrase 
could be demonstrated ( Chapter 5, Figure 5.4.), inhibition experiments conducted to 
inhibit the binding between IgM autoantibodies and BrMRBC proved to be more 
difficult. Inhibition could not be demonstrated when large amount of soluble carbonic 
anhydrase were used for inhibition ( Chapter 5, Figure 5.5) or when carbonic anhydrase 
had been coupled to sepharose beads for use as inhibitory particles ( Chapter 5, Figure 
5.6.). This was attributed to the formation of lattices between carbonic anhydrase, IgM 
and BrMRBC, rather than carbonic anhydrase being capable of saturating all antigen 
combining sites on IgM molecules. Monomers were createdffom IgM with a number of 
different reducing agents to determine if the binding of the monomers rather than intact 
IgM could be inhibited by carbonic anhydrase (Chapter 5, Figures 5.7. and 5.8.). 
Inhibition could not be demonstrated with monomers, and in fact the binding of the 
uninhibited monomers was found to be drastically reduced, suggesting that each antigen 
combining site may have an intrinsic low "affininty" for BrMRBC, but that the binding 
seen is due to the avidity of IgM. This may be a unique feature of anti-BrMRBC 
antibodies and other natural autoantibodies, since it has been previously noted that there 
is a reduction in the binding of Fab '2 of multireactive natural autoantibodies was noted 
although binding specificity for a specific autoantigen was retained (Poncet et al. 1988).
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These results raise many questions on the strength of the antigen combining site 
o f these antibodies for BrMRBC. It would be interesting to determine the affinity of 
each o f the antigen com bining sites for carbonic anhydrase as well as 
phosphatidylcholine, in an effort to determine the relative strength of the interaction 
between natural autoantibodies and autoantigens . It is possible that phosphatidylcholine 
may be bound in one antigen combining site leaving other antigen combining sites free 
to bind to carbonic anhydrase if  these antibodies behaved as bifunctional antibodies 
(Richards and Königsberg 1973, Varga et al. 1973), or conversely phosphatidylcholine 
may be able to form a complex with carbonic anhydrase that could be recognised by one 
antigen combining site. Experiments using liposomes or resealed erythrocyte ghosts 
loaded with carbonic anhydrase may provide an answer as to the possible interactions 
between phosphatidylcholine and carbonic anhydrase.
It is also interesting to recall at this point a precedent for a complex antigen 
involving both a phosphatidylcholine and unidentified 28.5 kD protein antigen, viz the 
human Rh (D) antigen (Moore et al. 1982). The BrMRBC antigen is not likely to be 
the mouse analogue of the human Rh (D) antigen because to reveal the BrMRBC 
autoantigen Band 3 has been removed from the membrane whereas Rh (D) would 
presumably be a cell surface antigen. However, it is feasible that a complex antigen 
consisting of glycoprotein and lipid may be bound by a single type of antibody.
Lipid immunoblotting was approached briefly as a method to examine the 
endogenous lipids and try to demonstrate whether lipids isolated from murine 
erythrocytes were indeed recognised as antigenic. These methods were not pursued 
vigorously due to the lack of specifc control lipids and anti-lipid antibodies required to 
establish if the method could be feasibly applied to erythrocyte lipids. There is no doubt 
that phosphatidylcholine is involved in the BrMRBC epitope, but the existence of 
phosphatidylcholine does not exclude other molecules interacting in a complex of lipid, 
protein and /or carbohydrate. Therefore, once the epitopes on carbonic anhydrase have 
been elucidated, then the possible interactions of phosphatidylcholine and carbonic 
anhydrase should be examined i.e. if hydrophobic portions of carbonic anhydrase were 
found to be recognised by natural autoantibodies then it may be possible to examine if 
hydrophobic regions in the protein are complexed to phosphatidylcholine. One way to 
do this would be to construct 7-10 |im  micelles containing phosphatidylcholine and 
carbonic anhydrase to see if these particles were either recognised or capable of
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inhibition. Another experiment could involve the construction of protein-free ghosts or 
protein-containing ghosts, to which carbonic anhydrase was added back at different 
concentrations and incubated in buffers so that they reseal. These particles could 
perhaps be bromelain treated and the fate of carbonic anhydrase and phosphatidylcholine 
followed to determine if natural autoantibodies bind to these particles in vitro and in 
vivo .
Other studies with phosphatidylcholine have used commercial supplies derived 
from sources apart from MRBC. Studies on the actual lipid content of mouse and sheep 
RBC have shown that phosphatidylcholine is present on the inner side of MRBC but 
not present at all on sheep RBC (Nelson 1967, Saito et al. 1983). Thus, this places the 
relationship between BrMRBC and SRBC in a quandry if phosphatidylcholine alone is 
involved in this epitopeas it had been supposed that the epitopes were cross-reactive or 
at least closely related structures. A more likely candidate for the crossreactive epitope 
shared between BrMRBC and sheep RBC is a water soluble substance isolated by 
Seman et al. (1970), which is of higher molecular weight than haemoglobin subunits 
and a protein . Further work would need to be done to establish that this immunogenic 
substance was in fact carbonic anhydase, but there is a strong evidence that the second 
most abundant protein in their antigenic extract from whole erythrocytes was indeed 
carbonic anhydrase. Clearly, this point o f the nature of the cross-reactive antigenic 
structure shared by BrMRBC and sheep RBC needs to be resolved by examination of 
the constituent protein and lipids of the respective red blood cells. If carbonic anhydrase 
was found to be this cross-reactive structure shared by sheep RBC and BrMRBC, then 
sheep carbonic anhydrase may be present in a more "exposed" way on erythrocytes than 
mouse carbonic anhydrase, perhaps due to the lack of phosphatidylcholine on the inner 
lipid bilayer of sheep erythrocytes to anchor the protein to the cytoplasmic side of the 
cell.
Recently, one group has examined the interaction on carbonic anhydrase and 
erythrocyte ghosts (Parkes and Coleman 1989). Carbonic anhydrase functions more 
efficiently when in association with a membrane and this is thought to be due to the 
carbonic anhydrase molecule being held in a certain orientation on the membrane to 
facilitate a more open structure of the active site of the enzyme. Other studies have been 
concerned with purifying membrane bound forms of carbonic anhydrase isoenzymes, 
but one comment that arises is that carbonic anhydrase cannot be purified free of lipid
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(Whitney and Briggle, 1982, Whitney 1984).
In histological studies on the distribution of carbonic anhydrase in rodent tissues, 
it has been found that carbonic anhydrase is abundant in stomach tissues, red blood 
cells, kidney , lungs, salivary glands and adipose tissue (Spicer et al 1979,1990). The 
fact that adipose tissue contains carbonic anhydrase is interesting, as it could be a site 
where carbonic anhydrase would be in close juxtaposition with lipids. The distribution 
of carbonic anhydrase is then similar to the distribution of the BrM-antigen which has 
been found in stomach, kidney, lungs and salivary glands (Cunningham 1974; 
Cunningham and Steele 1981; Garzelli et al 1987). It would be interesting to determine 
if  the distribution of carbonic anhydrase extended to the platelets as these have been 
shown to be recognised by anti-BrM antibodies (Kawaguchi 1989).
A partially purified blood-group-like substance was isolated from the gut that 
was capable of inhibiting haemolysis assays with BrMRBC (Cunningham and Steele 
1981). The stomach mucosae is a rich source of water soluble blood group substances 
attached to proteins, whereas blood group substances on red blood cells may be linked 
to lipids (Kabat 1956, Watkins 1974). Blood group substances were prepared and used 
in dot-blotting experiments (Figure 4.1.), but while some reactivity was noted with LPS 
serum, FUB 1 and FUB 3 did not bind to these preparations. Mouse blood groups are 
not strictly A-like or B-like because anti-A and anti-B typing reagents do not agglutinate 
either NMRBC or BrMRBC (Chapter 3). However, the Ii blood group has been 
demonstrated to occur on mouse red blood cells (Feizi and Childs 1985) and mouse red 
blood cells can also express stage-specific antigens (Solter and Knowles 1978 ). It was 
not possible to rule out these types of antigens at the present time, however, it may be 
more fruitful to further examine the carbohydrates attached to carbonic anhydrase since 
the binding of FUB 1 appears to depend upon the presence of O-linked sugars (Chapter 
5, Figure 5.15.).
In experiments with RBC and Bromelain-treated RBC from different species, the 
action of bromelain was found to be independent of the blood group expressed, as far as 
A- and B- blood group substances were concerned, i.e. B-blood group was still 
expressed on rabbit, rat and horse RBC whether they were bromelain- treated or not in 
serological experiments, but different levels of reactivity were noted in ELISA assays 
with the same cells depending upon whether they had been treated with bromelain or
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not. In experiments using AET or periodate to determine if blood group receptors 
destroying substances could reveal the BrMRBC antigen on NMRBC, target cell were 
lysed in protocols designed for use with preparing human RBC for agglutination 
assays.These agents may be better suited for use with NMRBC ghosts, if blood group 
receptors are still present after haemolysis, and these treated ghosts may be useful as 
inhibitors of the BrMRBC-autoantibody interaction. There is some evidence, at least for 
FUB 1, that O-linked carbohydrates present on CA may be involved in the formation of 
the BrMRBC autoantigen, so this may not be a productive exercise considering that 
carbonic anhydrase is rem oved from the cell in the production of ghosts. The 
experiments with AET and periodate and whole mouse red blood cells may require 
different assay conditons than those suitable for human red blood cells.
Studies on the epitopes recognised by carbonic anhydrase were at a preliminary 
stage when time became short. However, there are indications that O-linked 
carbohydrates are involved in the epitope that FUB 1 binds to on carbonic anhydrase 
(Chapter 5, Figure 5.15). The result with LPS serum was not clearcut because 
polyclonal serum may recognise more than a single site on the protein, thus different 
natural antibodies specific for carbonic anhydrase may recognise protein and/or 
carbohydrate epitopes of the molecule.
Of all the proteins used in this study, including all of the marker proteins, all of 
the other erythocyte proteins and proteins from the mouse stomach, LPS serum and 
FUB 1 predominantly recognised carbonic anhydrase from RBC and the stomach. It 
was thus surprising that endoproteinase Arg-C purified from mouse submaxillary 
glands should also be detected by LPS serum and FUB 1, although it must be borne in 
mind that the enzyme is present on the gel in supraphysiological concentrations . The 
relationship between endoproteinase Arg-C and carbonic anhydrase is not known apart 
from the fact that both enzymes occur in the salivary glands (Levy et al. 1970; Spicer et 
a l  1990).
How might bromelain-treatment expose antigenic sites that are normally hidden 
on red blood cells ? Coating the red blood cell is a layer of erythroglycan, consisting of 
carbohydrate chains attached to membrane proteins and principally Band 3, that is 
thought to be responsible for the mechanical resilience of the cells during circulation 
(Jamefelt et al 1978, 1982). This layer of carbohydrates is presumably why NMRBC
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are not normally recognised by natural antibodies and also why in effect even the outer 
layer of the lipid bilayer may be considered to be "hidden” from the immune system 
under a layer of erythroglycan. In the removal of Band 3, some erythroglycan must also 
be removed leaving an "intact" BrMRBC that does not spontaneously lyse, but with 
exposed phosphatidylcholine sites and exposed components of the anion channel that 
would have otherwise physically interacted with Band 3. In human red blood cells, 
phospahtidylcholine accounts for 30% of the total phospholipid content of the 
membrane, with about 76% present in the outer lipid bilayer and the remaining 24% 
present in the inner lipid bilayer (Op den Kamp et al. 1985). Similar studies also need to 
be conducted as to the disposition of phosphatidylcholine in mouse erythrocyte 
mem branes, however, assuming that they are similar, the phospholipids in the 
membrane m ust reorganise to seal cytoplasmic proteins inside the membrane. To 
continue as a functioning cell capable of transporting oxygen and carbon dioxide, 
carbonic anhydrase , that must be functionally associated with the anion channel, may 
find itself inserted in the membrane albeit in a more exposed position. In this model of 
the action of brom elain on the topology of the membrane, it is feasible that 
phosphatidylcholine and carbonic anhydrase may both become accessible targets for 
natural autoantibodies. A more subtle mechanism is thought to allow this process in 
vivo .
What is the possible relevance of carbonic anhydrase to autoimmunity ? How can 
this protein become recognised by natural autoantibodies in vivo ? Although arguments 
have been put forward as to the relevance of the epitope revealed by bromelain when 
there is no analogous process known to occur in vivo, it may only take a subtle process 
such as the inactivation of the anion channel to render a red cell nonfunctional, or some 
pathway in the process of the red blood cell binding onto oxygen to break down before 
the cell becomes nonfunctional and "autoantigenic". Carbonic anhydrase plays a central 
role in the function of the erythrocyte, given that the function of the enzyme in the 
erythrocyte to provide hydrogen ions to protonate haemoglobin to an activated form 
where it can bind to oxygen. Carbonic anhydrase may be the perfect target for signalling 
that the red blood cell can no longer function in its major capacity of oxygen and carbon 
dioxide transport since it must play a central role in interacting between the anion 
channel and haemoglobin (Silverman et al. 1978,1979). In addition, it may be recalled 
that different isoenzymes of carbonic anhydrase are located at numerous sites, such as 
the stomach, kidney, the liver, muscle and could potentially act as autoantigens helping
CHAPTER SIX 191
to signal senesence if the cells containing the enzyme became damaged or unfunctional.
In normal animals this may be a subtle physiological process, however, at 
present erythrocyte senesence has not been investigated from this perspective. One 
experimental approach could be to examine the interactions of carbonic anhydrase and 
natural autoantibodies at the numerous anatomical sites where carbonic anhydrase 
resides, and widen the perspective of this interaction from the red blood cell to the other 
tissues and organs containing carbonic anhydrase.
Carbonic anhydrase has been demonstrated to be specifically involved with the 
serological determinant revealed when mouse erythrocytes have been treated with the 
proteolytic enzyme bromelain. This is a novel and unexpected finding, as previous 
studies have demonstrated a role for phosphatidylcholine in this autoantigenic 
determinant. Further studies need to be undertaken to establish the relationship between 
phospahtidylcholine and carbonic anhydrase and to determine the immunological and 
physiological functions of natural autoantibodies binding to carbonic anhydrase. 
Carbonic anhydrase, as a target for natural autoantibodies may be of importance as a 
marker o f erythocyte senescence, and thus play a vital physiological role in the 
mammalian body to signal to the immune system that an erythrocyte no longer has the 
full capacity to carry oxygen.
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Abstract—The aim was to develop a cellular-ELISA assay to detect natural autoantibodies specific for 
bromelain-treated mouse red blood cells (BrMRBC). High, unexpected IgM titres against normal mouse 
red blood cells (NMRBC) were detected in day 7-14 sera of CBA mice treated with E. coli lipo­
polysaccharide (LPS). These “autoantibodies” bound to normal mouse red blood cells in the presence or 
absence of commonly used c-ELISA adhering agents. Such high reactivity to NMRBC was never detected 
using complement dependent haemolytic assays in earlier work in this system. The question whether these 
IgM a-NMRBC molecules were binding nonspecifically (via Fc) or specifically (via Fab) was answered 
indirectly by comparing the binding titres of LPS-stimulated serum and several purified IgM antibody 
preparations (a-PC, a-KLH, MOPC 104E) on the same antigen coated plates. The observed binding 
ratios (titre on antigen X: titre on NMRBC) varied widely between different antibody sources, indicative 
of specific binding. In addition no significant unequivocal binding against NMRBC could be detected in 
vivo (LPS-stimulated mice) nor could bound IgM antibody be detected in a suspension-c-ELISA assay 
(high binding titres to BrMRBC could be detected in the latter test system). In conventional c-ELISA 
assays, modification of normal erythrocyte by adhesion to plastic microtitre plates appears to expose or 
create “neoantigens” on NMRBC which are not encountered in suspension-type c-ELISA, nor in lytic 
or agglutination assays where the erythrocyte targets are in suspension at physiological pH and isotonicity.
INTRODUCTION
It is clear that significant levels o f  IgM  autoantibodies 
specific for m any buried cellular and soluble auto­
antigens exist in norm al animals (13th Forum  in 
Im m unology, 1986). For exam ple, in strains o f  nor­
mal, inbred C BA  m ice which do not spontaneously  
develop autoim m une diseases, a large fraction o f  the 
potential Ig secreting repertoire (2% in spleen, 
50-90%  in peritoneum , 10% in bone marrow) has 
been shown to contain natural autoantibodies specific 
for brom elain-treated autologous erythrocytes (Steele 
and Cunningham , 1978, 1981). A nti-BrM R BC  IgM  
antibodies appear to  belong to a family o f  restricted 
V-regions (Poncet et al., 1985; Kaushik et al., 1986) 
and they arise from  the L y-1+ class o f  B-cells (Hay- 
akawa et al., 1983, 1984, 1986).
N atural autoantibodies to BrM RBC antigens are 
cross-reactive with determinants on sheep RBC  
(Pages and Bussard, 1975), p igeon RBC and human
♦This work was supported in part by a University of 
Wollongong research grant. 
fAddress for correspondence.
Abbreviations: BrMRBC, bromelain-treated mouse red 
blood cells; NMRBC, normal mouse red blood cells; 
c-ELISA, cellular-enzyme-linked immunosorbent assay; 
LPS, lipopolysaccharide; PBS, phosphate buffered 
saline; PLL, poly-L-lysine; GA, glutaraldehyde; i.p., 
intraperitoneal; BSA, bovine serum albumin; PC, phos- 
phorylcholine; KLH, keyhole limpet haemocyanm.
RBC (Pages and Arnaud, 1980) and isologous mouse 
IgG  (Fc) (Cunliffe and Cox, 1980). Immunochemical 
studies have shown that trimethylammonium- 
containing com pounds are capable o f  inhibiting IgM  
mediated complement-dependent lysis o f  BrMRBC  
(Serban et al., 1981; Pages et al., 1982; Cox and 
Hardy, 1985). In addition, Ly-1+ B-cells recognize 
phosphatidylcholine (M ercolino et al., 1986) as well 
as BrM RBC (Hayakawa et al., 1984, 1986).
There is good evidence, therefore, that a com m on  
membrane phospholipid headgroup may be one pos­
sible natural ligand for the bromelain-specific family 
o f  natural antibodies. The exact identity in vivo 
however o f  the responsible endogenous stimulating 
determinants is unknown. In earlier studies using 
antigen inhibition o f the complement mediated lytic 
assay, BrM RBC antigens were found in the gastro­
intestinal tracts o f  normal inbred CBA/J mice (Cun­
ningham and Steele, 1981) and germ-free outbred 
Swiss mice (Steele and Cunningham, 1979). In addi­
tion, complement-dependent lysis o f  antibody- 
sensitized BrM RBC could be specifically inhibited 
with a “blood-group-like” substance extracted from  
m ouse stomachs (Cunningham and Steele, 1981) fol­
lowing the m ethods o f  K abat (1956). The gastro­
intestinal distribution and emergence o f  the 
BrM RBC antigen early in ontogeny and the sub­
sequent appearance o f  specific natural autoantibodies 
in 1-week-old mice, suggest that the BrM RBC anti­
gen may act as an important stimulator o f  large
535
536 A. M. Jonusys and E. J. Steele
numbers o f  potential autoantibody-secreting B-cells 
(Steele and Cunningham , 1979; Cunningham  and  
Steele, 1981).
The initial aim here was to develop c-ELISA  
techniques to detect natural IgM  autoantibodies 
against buried determinants on m ouse erythrocytes to 
aid in the isolation o f  the gut associated BrM RBC  
antigen. The advantages o f  ELISA techniques are 
that they provide a non-com plem ent-dependent, 
sem i-quantitative endpoint based on optical density. 
However, we encountered an obstacle in achieving  
this simple goal. Thus, in LPS-stim ulated m ouse 
serum (a convenient source o f  high titre BrM RBC- 
specific IgM ) we detected, using a straightforward  
c-ELISA assay where the cells were attached to wells 
o f  plastic microtitre plates, high levels o f  antibody  
binding against both brom elain-treated and normal 
m ouse erythrocytes. If, however, the initial antibody  
binding was carried out using target erythrocytes in 
suspension specific IgM  binding was found only  
against brom elain-treated m ouse erythrocytes.
MATERIALS AND METHODS
Mice
C B A /H Can mice (10-19 weeks old) were obtained  
from the Anim al Breeding Establishm ent o f  the John  
Curtin School o f  M edical Research, Canberra, 
Australia.
Antibodies
M ale C B A /H  mice received lipopolysaccharide 
(LPS) from Escherichia coli strain 0127: B8 (Phenol 
extract, Sigma N o . L-3129, Sigma Chem ical Co. St. 
Louis, M O, U .S .A .) 500 /ig /m l intraperitoneally (i.p.) 
in 0 .1m l o f  sterile physiological saline. LPS- 
stimulated serum from a group o f  5 m ice was col­
lected and pooled 7 days or 14 days after injection  
and diluted 1:10 or stored neat in small lots at — 20°C  
until use. Serum from normal mice was collected in 
the same manner.
In the determination o f  the antigen binding 
specificity o f  IgM antibody preparations for 
N M R B C , one IgM m yelom a, M O PC 104E specific 
for the hapten alpha 1 —► 3 linked glucose residues 
(Litton Bionetics, K ensington, M A , U .S .A . Cat. N o . 
8402-29) was used at 500/^g/m l, and two affinity 
purified preparations, IgM  anti-phosphorylcholine 
(IgM  a-PC ) at 5 //g/rnl and IgM  anti-keyhole limpet 
haem ocyanin (IgM a-K L H ) at 5 0 /ig /m l were used. 
The affinity purified IgM  antibodies were isolated  
from ascitic fluid o f  B A L B /c m ales hyperim munized  
with PC -K LH  (by the procedure o f  Tung et al., 1976) 
by binding and elution (in 3 M  N aSC N ) from PC- 
BSA-Sepharose 4B or K L H -Sepharose 4B. C on­
tam inating IgG  was rem oved by passage through  
Sephadex G-200. The purified IgM  preparations were 
stored at 4°C in the presence o f  1% BSA in p hos­
phate buffered saline (PBS) containing 0.1%  (w/v) 
sodium  azide.
Erythrocytes
Red b lood  cells were collected  under ether ana­
esthesia from  adult m ale and fem ale CBA/H mice 
into A lsever’s solution. R ed b lood  cells were used 
either on the day o f  co llection  or stored at 4°C and 
used 1-2  days after co llection . Erythrocytes were 
washed three times in phosphate-buffered saline 
(PBS, pH  7.4) before use, carefully removing the 
buffy coat after each centrifugation  step. Bromelain- 
treated m ouse RBC (B rM R B C ) were prepared by the 
sam e procedure as C unningham  (1974). Briefly, one 
volum e o f  packed R B C  w as treated with one volume 
o f  lO m g/m l brom elain (Sigm a N o . B-2252) in PBS 
for 30 min at 37°C. B rM R B C  were washed an addi­
tional three tim es in PBS before use. Red blood cells 
were diluted in PBS, counted  under the microscope 
with a haem ocytom eter and applied to the wells of 
the ELISA plates at cell densities between 103 and 106 
cells per well.
Other antigens
K eyhole lim pet haem ocyanin  (K L H ) was obtained 
from C albiochem  (Cat. N o . 374805). p-Nitrophenyl- 
phosphorylcholine (Sigm a N o . N -5879) was con­
verted to the reactive p -d iazon iu m  intermediate, 
D PPC , fo llow ing the m ethod o f  Chesebro and 
M etzger (1972). (W e are grateful for the expert 
assistance at this step o f  Dr. W . C ow den, Department 
o f  M edical Chem istry, John Curtin School o f  Medi­
cal Research.) A liquots o f  D P PC  were stored at 
— 20°C. T o prepare conjugated proteins, the DPPC 
was reacted with BSA  or K L H  follow ing the methods 
outlined by G earhart et al. (1975) and Quintans and 
C osaenza (1976). The m olar conjugation  ratios were 
two m oles o f  PC per m ole o f  BSA  and approximately 
one m ole o f  PC per 100,000 m ol. wt subunit o f  KLH.
c -E L IS A  with cell fixa tives
W ells o f  activated, flat-bottom ed, 96-well poly- 
vinylcholoride im m unoassay plates (Titertek, Cat. 
N o . 77-173-05, F low  Labs) were coated with 50 //I of 
poly-L-lysine (PLL) hydrobrom ide (Sigm a N o. P­
2636; 1 0 //g /m l in PBS) for 30 m in at room  tem­
perature. W ells were aspirated and 50 /¿I o f  NM RBC  
and BrM R BC  suspensions were added to the wells at 
various cell densities and left to settle under gravity 
for 6 0 -90  m in. The cells were fixed for a further 
30 min with 50 /¿I o f  a 0.2%  solution  o f  glu- 
taraldehyde (G A ) in PBS, freshly prepared from a 
25% aqueous stock solution  o f  glutaraldehyde 
(Sigm a N o . G -6457) per well. Excess glutaraldehyde 
was aspirated, the wells washed twice with PBS and 
blocked with 1 0 0 /¿I o f  1% BSA  in PBS (w /v) with 
0.1%  sodium  azide for 6 0 -90  min.
Excess BSA  solution  was aspirated, and the pri­
mary (first) antibodies were titrated in 1 %  BSA  in 
PBS, and left to incubate at room  tem perature for 
60 m in. U nbound first antibody was rem oved by 
three washes with G T S [0.5% gelatin (w /v) Tw een 20
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(v/v) (Sigma No. P-1379), 0.9% saline (v/v) 
pH 6.5-7.0]. The second antibody, alkaline phos­
phatase conjugated goat anti-mouse IgM (/z-chain 
specific) (Sigma No. A-7784), was used at 1:500 
dilution in 1% BSA in PBS and 50 /tl of the dilution 
used per well for 1 hr at room temp. The second 
antibody was removed from the wells by three washes 
with GTS. The phosphatase substrate solution was 
prepared by dissolving 1 mg of disodium p- 
nitrophenyl phosphate (Sigma No. 104-0) per ml of 
diethanolamine buffer (0.5 mM  MgCl2 (AR) in 1 M  
diethanolamine (BDH 10393), pH adjusted to 9.2 
with 3 M  HC1) and 100 ûl delivered to all wells on the 
microtitre plates. Optical density was measured at 30 
and 60 min after the addition of substrate using a 
Dynatech MR 600 microplate reader set at 410 nm. 
Endpoint titres were determined at either 30 or 
60 min by taking the titre (x-value) at an optical 
density (OD410nm) =  0.2 cutoff point (y-value) as the 
endpoint. The replicate error of the endpoints is the 
difference about the duplicate mean expressed as a 
percentage.
Only the inner sixty wells of the immunoassay 
plates were used in all experiments due to thermal 
effects at the plate perimeter—“the edge effect” (Burt 
et al., 1979). The outer wells on the immunoassasy 
plates were blocked with 1% BSA in PBS from the 
first antibody step onwards, and all wells contained 
substrate in the final step to minimize the thermal 
effect.
c-ELISA without cell fixatives
Red blood cells at densities ranging from 2 x 105 to 
1.25 x 106 cells per well were placed in the inner sixty 
wells of the standard immunoassay plate and allowed 
to settle under gravity overnight at room temperature 
(20-25°C). The assay was completed the next day by 
following the procedure from the first antibody incu­
bation onwards in the standard c-ELISA (above).
Suspension - transfer c-ELISA
Suspension c-ELISA techniques have been used to 
detect human anti-HLA antibodies (Morris et al., 
1983; Morris, 1983) and human anti-platelet anti­
bodies (Gudino and Miller, 1981). These methods 
were modified in this work by including a cell-transfer 
step prior to the addition of second antibody and 
substrate to circumvent the significant background 
optical density generated following the centrifugation 
and washing of erythrocytes in microtitre trays. 
Rigid, V-bottomed, 96-well plates (Linbro/Titertek, 
Cat. No. 76-321-05, Flow Labs) were blocked with 
100 /H of 1% BSA in PBS per well and left overnight 
at room temp. Plates were aspirated before use, and 
first antibodies titrated in three-fold steps. Fifty 
microlitres of a 1% suspension of erythrocytes was 
added to each well, and left at room temperature for 
60-90 min. Each plate was centrifuged at 1000 rpm 
for 2 min at room temp on plate carriers in the 
Beckman TJ6 bench centrifuge to pellet the RBC.
The supernatant was carefully aspirated from around 
the pellet to minimize cell loss. The RBC pellet was 
resuspended in 100 p\ of 1 % BSA in PBS and centri­
fuged at 1000 rpm for 2 min. The pellet then received 
two further washes in 1% BSA in PBS. After wash­
ing, the pellet was resuspended in 100/H of 1% BSA 
in PBS and transferred to another freshly aspirated 
V-bottomed plate that had been blocked overnight 
with 1% BSA in PBS.
The second antibody and substrate steps were the 
same as above, however, at 20 min the plates were 
centrifuged at 1000 rpm for 2 min and 75/d of the 
supernatant was removed and transferred into stan­
dard flat-bottomed wells of 96-well immunoassay 
plates for optical density measurement at 30 and 
60 min.
Serum absorptions
For serum absorptions, 400 p\ of packed, washed 
RBC were incubated for 30 min at room temp, and 
30 min on ice with 400 /zl of serum. After the first 
absorption, the red blood cells were centrifuged and 
the serum transferred to a freshly packed pellet of 
RBC. Slight haemolysis was noted in the absorbed 
serum samples.
RESULTS
High autoantibody activity against red blood cells 
detected by c-ELISA with and without cell adhering 
agents
In initial experiments designed to establish the 
c-ELISA assay parameters for the BrMRBC 
specificity, a high level of IgM binding against 
NMRBC was detected in the presence of cell adher­
ing agents (Fig. 1). IgM (but not IgG) was then found 
to bind NMRBC at high titres, with no prozones, 
whether fixatives were present or absent (Fig. 2a,c). 
The effects of combinations of the adhering agent
Fig. 1. Binding of a batch of day 7 LPS-stimulated serum 
and normal mouse serum (1:50 dilutions) on wells contain­
ing no cells, or coated by adding 2.5 x 105 red blood cells 
per well. c-ELISA technique with cell adhering agents was 
followed and OD410nm was measured 15 min after the addi­
tion of substrate. Each column represents the mean of 
duplicate wells with the blank subtracted (50^1 of PBS 
substituted for first antibody). The error around the dupli­
cate mean was between 0.8% and 7.0%.
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Fig. 2. The effects of different combinations of cell adhering agents, poly-L-lysine and glutaraldehyde, on 
the binding of day 7 LPS-stimulated serum to plates where the wells were coated by adding 1.25 x 106 
red blood cells per well. IgM autoantibodies against NMRBC (O), BrMRBC (■ ) , and empty wells (# )  
were detected by c-ELISA at 30 min after the addition of substrate. Prozones were not observed. On 
immunoassay plates where PLL was absent (c, d), wells were coaled with RBC overnight at room temp. 
Similar results were obtained at a range of RBC coating densities from 1 x 10J to 1.25 x iO6 cells per well.
Along the T-axis is the reciprocal of the serum dilution.
poly-L-lysine (PLL) and the fixative glutaraldehyde 
(GA) were tested (Fig. 2, Table 1). Whilst it has been 
suggested that glutaraldehyde may cause non­
immunological adsorption of protein onto human red 
blood cells by the formation of Schiff’s bases (Jamin 
et al., 1986) we found that although fixatives do have 
a marked effect on improving the titres of antibodies 
in this system, respectable titres to the same level on 
BrMRBC and NMRBC were nevertheless observed 
when fixatives were absent (target cells left to bind to 
plastic overnight at room temp.).
Table 1. Titres of LPS-stimulated serum in uncoated wells 
and wells coated with NMRBC and BrMRBC (see Fig. 2) 
with different combinations of cell adhering agents
Reciprocal endpoint titre 
Uncoated
Fixative wells NMRBC BrMRBC
+ PLL + GA 125 2400 3150
+  P L L -G A 22 56 60
— PLL + GA 11 5000 4900
— PLL — GA 9 190 235
Specificity o f autoantibodies to antigens on NMRBC
Since high anti-NMRBC activity could be demon­
strated when fixatives were absent, the most im­
portant consideration was whether these IgM anti­
bodies were binding specifically (via Fab) or 
non-specifically (via Fc). Since this point is difficult to 
establish directly we tested it indirectly by looking for 
possible Fc binding of affinity purified IgM antibody 
preparations on erythrocytes and by comparing the 
binding ratios of these pure IgM antibodies with their 
corresponding specificities represented in LPS- 
stimulated serum (Table 2). The mouse myeloma, 
MOPC 104E, which is not crossreactive with the 
BrMRBC determinant (Serban et al., 1981) was used 
at 500 ¿tg/ml and gave low titres against all antigens. 
In contrast the purified a-PC and a-KLH IgM anti­
bodies gave relatively high titres against their specific 
determinants compared with their titres on NMRBC 
and BrMRBC (approximately 30-60-fold higher 
specific titres). These data taken together, strongly 
suggest that purified IgM molecules are unlikely to
Table 2. Reciprocal endpoint titres and antigen binding ratios of LPS-stimulated serum, IgM a-PC, IgM a-KLH and 
_________________ _ ____MOPC1Q4E against a panel of antigens (absence of fixatives)
Reciprocal titre against Ratio of titres
NMRBC BrMRBC PC KLH PC: NMRBC KLH: NMRBC
LPS-stimulated
serum
67.0 240.0 1.0 3200.0 0.015 47.8
IgMa-PC 0.6 0.2 38.0 N.D. 63.3
IgMa-KLH 1.0 1.0 N.D. 35.0 35.0
MOPC 104E 3.0 7.4 0.5 1.7 0.2 0.6
N.D. = not done.
IgM a-PC at 5/ig/ml, IgM a-KLH at 50/rg/ml and MOPC 104E at 500/ig/ml.
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bind nonspecifically (via Fc?) to either norm al or 
bromelain-treated erythrocyte m em branes. This is 
supported by the very different binding ratio on PC  
versus N M R B C  for LPS-stim ulated serum (0.015) as 
opposed to Ig M a -P C  (63.3).
Attempts to detect autoantibodies binding against 
NMBRC  in vivo
v The above results suggest that IgM  in LPS- 
stimulated serum binds in an im m unologically  
specific way to N M R B C . A ttem pts to dem onstrate 
direct c-EL ISA  binding o f  such putative anti­
erythrocyte antibodies to erythrocytes in vivo in mice 
injected 2 -6  days previously with LPS gave negative 
results. In addition, in vivo bound IgM  could not be 
detected using a direct C oom b ’s antiglobulin test 
(data not shown). These unsuccessful direct attempts 
to dem onstrate in vivo binding o f  IgM  to N M R B C  in 
suspension-type assays suggests that the con­
formation o f  the N M R B C  m ay be altered in the 
c-ELISA assay due to the attachm ent o f  the cells to 
plastic m icrotitre plates.
Comparison o f  anti-N M RBC  and anti-BrM RBC ti­
tres in a suspension c-ELISA  assay to those in a 
conventional c-ELISA  assay and the effect o f antigen 
absorption
Physical changes to the red b lood cell membrane 
during adhesion to plastic microtitre plates (either 
with or w ithout fixative) m ay create “neoantigens” or 
expose “buried” antigens. W e tested this possibility 
by com paring binding titres in the c-ELISA assay 
with those obtained in a “ suspension” c-ELISA  
assay. In addition we tested the specificity o f  binding 
by absorbing the serum with packed washed erythro­
cytes. Typical data from  such experiments are shown  
in Table 3 and Fig. 3. It is clear that absorbing with 
erythrocytes (in suspension) will not rem ove IgM  
antibodies w hich bind to plastic adhering N M R B C  
and BrM R BC  (conventional c-ELISA assay in Table 
3; Fig. 3b ,d ,f). This indicates that the antigenic 
determinants detected in this assay are not displayed  
on the absorbing erythrocytes’ surface. In contrast, a 
different binding and absorption pattern is obtained  
if  the erythrocyte targets are kept in suspension  
(suspension c-EL ISA  assay in Table 3, Fig. 3a,c,e). 
Here we note a high binding titre on BrM RBC an 
a very low  (and probably insignificant) titre against
N M R B C . Further, the high anti-BrM RBC titre is 
com pletely rem oved by absorbing with bromelain- 
treated erythrocytes, yet only slightly affected (if at 
all) by absorption with N M R B C .
It is possible, however, that the autoantibodies 
detected in the conventional c-ELISA recognize hid­
den antigens exposed by treatment o f  the cells with 
the G TS washing buffer which contains the detergent 
Tween-20. The Tween-20 in the GTS washing buffer 
m ay alter the lipid structure o f  the cell membrane 
whereas this problem  would not arise for the sus­
pension assay where 1 % BSA was used as the wash­
ing buffer. This was tested by examining whether 
significant IgM  binding occurred in a conventional 
c-ELISA when 1 % BSA-PBS was used as a washing 
buffer. In addition, we examined the effect o f  prior 
absorption with erythrocyte antigens. These data, 
collected at the same time as the results in Table 3 and 
Fig. 3, are displayed in Table 4. The pattern o f  titres 
is the same as Table 3, i.e. the absorbing erythrocytes 
do not remove IgM  antibodies which bind to 
N M R B C  and BrM RBC adhering to plastic. This is 
consistent with the proposition that the altered anti­
genicity is due to the adherence o f  the cells to the 
plastic microtitre tray. It is also clear that the abso­
lute titres in Table 4 are 5-10-fold  greater than the 
corresponding ones in Table 3.
Before closing this section a com m ent can be made 
about the suspension c-ELISA. In establishing the 
protocol, haem olysis often occurred and interfered 
with optical density measurements if  GTS was used 
as a washing buffer or if. high or prolonged centrifu­
gation was employed. Further, more LPS-stimulated 
serum was found to bind against N M R B C  if  the 
transfer step was omitted, and this is probably due to 
the form ation o f  antibody com plexes or antibodies 
binding to cell fragments caused by lysis during the 
first centrifugation step.
DISCUSSION
Em ploying c-ELISA techniques where cells are 
attached to plastic, either with or without cell adher­
ing agents, we have shown that IgM autoantibodies 
found in LPS-stimlated serum bind to similar levels 
on both BrM RBC and N M R B C , and further, that 
the binding detected is im m unologically specific. 
However, by using a suspension c-ELISA technique,
Table 1 Comparison of anti-NMRBC and anti-BrMRBC titres in a suspension c-ELISA assay to those 









Suspension c -E L IS A “ 8 5 0.7 0.8NMRBC
BrMRBC 160
0 98.5
Conventional c-E L ISA 287 415 260NMRBC
BrMRBC . 173
570 385
“Washing buffer—1 % BSA in PBS. 
^Washing buffer—GTS.
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Conventional c-ELISA
Reciprocal of Scrum Dilution Reciprocal of Scrum Dilution
Fig. 3. Comparison of day 7 LPS-stimulated serum on 5 x 105 NMRBC ( # )  and BrMRBC (O) in either 
(a) titration curves of the suspension-transfer c-ELISA assay and (b) the c-ELISA assay with no adhering 
agents. In the suspension-transfer c-ELISA, OD410nm was measured at 60 min after substrate addition and 
after 30 min for the conventional c-ELISA. Titration curves for LPS-stimulated-serum that has been 
absorbed with NMRBC for (c) the suspension-transfer c-ELISA and (d) the conventional c-ELISA; can 
be compared to LPS-stimulated serum that has been absorbed with BrMRBC for (e) the suspension assay
and (f) the conventional c-ELISA.
we were able to detect specific IgM antibody binding 
exclusively to BrMRBC. These experiments suggest 
that neoantigenic sites may be uncovered on 
NMRBC if cells bind to plastic (with or without 
fixatives), and may provide a possible explanation for 
the action of anti-erythrocyte autoantibodies in vivo 
(below).
From preliminary experiments (Fig. 1), it was 
thought that the autoantibody binding to erythro­
cytes was due either to the effects of cell adhering 
agents creating neo-determinants on normal mouse
erythrocytes or to the detection of a a non­
complement fixing class of IgM anti-mouse erythro­
cyte antibodies [akin to those detected by Salama and 
Mueller-Eckhardt (1987) in human autoimmune hae­
molytic anaemia]. Fixatives appear to have a marked 
effect on the binding properties of anti-erythrocyte 
antibodies (Fig. 2) and there is evidence that murine 
natural antibodies may recognize a number of intra­
cellular antigens created cell fixation procedures us­
ing glutaraldehyde (Perrot et al., 1986). Others, how­
ever, have successfully used c-ELISA with
Table 4. Anti-NMRBC and anti-BrMRBC titres in conventional c-ELISA assay 
using 1 % BSA in PBS as the washing buffer and the effect of antigen absorption
Unabsorbed
Reciprocal titre against 
BrMRBC absorbed NMRBC absorbed
LPS-stimulated LPS-stimulated LPS-stimulated
serum serum serum
NMRBC 2200 2600 2250
BrMRBC 2300 1100 2150
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poly-L-lysine and glutaraldehyde to dem onstrate 
complement receptors on  hum an erythrocytes 
(Thomsen et a l,  1985) and hum an blood group 
antigens (Sharon et al., 1986). In other experiments 
using G A  to im m obilize cells to im m unoassay plates, 
a slight reduction in antigenicity has been reported in 
some cases (Thom sen et al., 1985) but not in others 
(Douillard and H offm an, 1983). Higher titres were 
observed here against m ouse erythrocytes when glu­
taraldehyde was present and this may be due to a 
reduction o f  cell loss during washing procedures or 
the creation o f  new antigenic determinants. By using 
PLL alone, however, the opposite effect was noted  
and this reduction in titre m ay be attributed to the 
formation o f  clum ps by RBC agglutination (Mari- 
kovsky et al., 1966) that could be dislodged during 
washing procedures. M ethods using adhering agents 
to bind erythrocytes to plastic or glass, such as the 
Kennedy and Axelrad (1971) haem olytic plaque­
forming cell assay and procedures based on this 
assay, may reveal neodeterm inants on normal eryth­
rocytes. Regardless o f  the effects o f  cell adhering 
agents, we find that IgM  autoantibodies bind to 
“normal” m ouse RBC  even when cells are allowed  
to settle onto  plastic overnight with no fixatives 
(Fig. 2c).
In experiments designed to determine whether the 
binding o f  IgM  autoantibodies against normal mouse 
erythrocytes in c-EL ISA  was specific, we compared a 
group o f  purified IgM  preparations and LPS- 
stimulated serum and showed that binding is not 
taking place via Fc regions either with fixatives (data 
not shown) or w ithout (Table 2). The wide variation 
noted in the binding ratios o f  the IgM  antibodies 
(Table 2) indicates that the binding observed against 
normal m ouse red b lood cells is specific. Thus, in 
contrast to the report o f  “ non-im m unological” bind­
ing o f  serum proteins to hum an red blood cells by the 
formation o f  Schiff’s bases in the presence o f  al­
dehyde derivatives (Jamin et al., 1986), the auto­
antibodies detected here in the c-ELISA appear to be 
binding specifically to undefined determinants on 
mouse erythrocyte membranes.
Direct in vivo binding o f  autoantibodies to RBC  
could not be dem onstrated in LPS-stimulated ani­
mals by c-EL ISA  and direct antiglobulin tests; how ­
ever, this m ay be difficult to detect due perhaps to the 
rapid clearance o f  autoantibody-coated RBC by 
“m acrophage-like” cells (Bussard and Pages, 1976) o f  
the reticuloendothelial system. Cox and Keast (1974) 
also could n ot detect autoantibodies using direct 
antiglobulin tests after injection o f  LPS-coated syn-
genic erythrocytes. , ,  , A ,
U sing a suspension c-ELISA, we could detect a 
difference between antibodies binding to r 
and N M R B C  (Fig. 3a) which resembled previous 
results obtained with lytic assays (Cunningham and 
Steele, 1981), i.e. very little if  any antibody^ against 
normal m ouse erythrocytes, yet sigmfican y g 
titres against brom elain-treated erythrocy es.
difference is not demonstrable with plastic im mo­
bilized cell targets in the conventional c-ELISA assay 
(Fig. 3b). Further, the suspension c-ELISA assay 
allows detection o f  a total reduction o f  antibody 
activity when LPS-stimulated serum is absorbed with 
BrM RBC (Table 3), whereas no significant reduction 
in titre can be demonstrated by the absorptions using 
the conventional c-ELISA and no difference can be 
shown between activity on N M R B C  and BrMRBC. 
This result was obtained whether GTS, containing 
the detergent Tween-20 (Table 3) or 1% BSA in PBS 
(Table 4) are used as the washing buffers (although 
the later buffer allows the detection o f higher absolute 
titres). The suspension c-ELISA technique therefore 
allows us to conclude that the BrMRBC antigen can 
be distinguished only when the cell retains its shape 
in suspension and not when immobilized on plastic.
Our experiments with LPS-stimulated serum in 
conventional c-ELISA assays, where IgM antibodies 
were found to bind specifically to “normal mouse 
erythrocytes” (neoantigens), support a possible in 
vivo role for these autoantibodies at local sites o f  
erythrocyte damage. It is feasible that distortion o f  
the erythrocyte membrane (akin to the type caused by 
plastic adherence) could occur during coagulation o f  
blood cells at wound sites or at sites o f local 
inflammation. The subseqeunt distortion o f  the mem­
brane and exposure o f neoantigens would allow  
access o f  a-N M R B C  autoantibodies which may facil­
itate erythrocyte clearance.
The present results suggest that it may not be 
possible to look at all cellular antigens with con­
ventional c-ELISA assays if it is uncertain whether 
the epitope(s) in question are subject to the easy 
creation o f  “neoantigens” . In another ELISA system  
in our laboratory to detect m onoclonal antibodies 
against immunogenic peptides coupled to BSA we 
have consistently found a significant number o f anti- 
“neoantigen” clones, i.e. antibodies specific for BSA  
determinants once BSA has adhered to plastic 
(Tholen A .-S., Honours Thesis, 1987, University o f  
W ollongong). The creation o f  neoantigens does not 
apparently affect all c-ELISA systems, for example, 
Bishara et al. (1983) could detect H LA antigens using 
glutaraldehyde to immobilize freshly prepared and 
dried peripheral blood mononuclear cells to micro­
titre plates, and Thomsen et al. (1985) readily mea­
sured complement receptors on human RBC with 
adhering agents without neoantigen interference.
One recent concern has been the existence o f  
antibodies (and autoantibodies) recognizing arti- 
factually created antigens, especially with glutaralde- 
hyde-fixed cells (Perrot et al., 1986; Wasik et al., 
1986). Cohn (1986) and Langman and Cohn (1986) 
have stressed, in the context o f  self versus non-self 
discrimination as it applies to the viability o f  the 
idiotype network theory, that physical and chemical 
changes may readily occur to antibodies and antigens 
removed from their normal physiological environ­
ments and questions have been raised as to the
542 A. M. Jonusys and E. J. Steele
validity o f detecting true autoantibodies in ELISA  
systems (Schwarz, 1986). Our results are consistent 
with these concerns. Our experiments show that the 
suspension-transfer c-ELISA is a valid technique for 
the selective detection o f  BrM RBC antigens, but that 
these BrMRBC determinants cannot be distinguished 
from the neoantigens revealed on N M R BC  using 
c-ELISA techniques when the target cells are im m o­
bilized on plastic.
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Carbonic anhydrite (C A ) from mouse erythrocyte membranes is recognised as an autoandgen in Western 
blotting experiments with FUB 1, a murine IgM monoclonal antibody that binds both phosphatidylcholine 
and bromelain-treated mouse red Mood cells (BrM RBC). Serum from mice stimulated with lipopolysacchar- 
ide (LPS-tetum ) also recognises C A . From SDS-PAGE, and blotting experiments with whole mouse erythro­
cytes. w e found tw o closely spaced glycoprotein bands in the 30 kD  region that reacted with both FUB 1 and 
LPS-terum. One o f the molecular weight markers, bovine carbonic anhydrase which is o f a m olecular weight 
o f about 30 kD, electrophoresed in the same 30 kD region also reacted with these antibodies. Carbonic 
anhydrites from a range o f mammalian species were found to be crossreactive with FUB 1 and LPS-terum 
by W estern blotting, whereas human glycophorin A  and human asialoglycophorin were not recognised by the 
antibodies. FUB 1 specifically recognises both native and denatured bovine carbonic anhydrase in ELISA 
assays. The serological identity o f the determinants on C A  and B rM R BC was confirmed by specific absorp­
tion o f both FUB 1 and LPS-terum with BrM RBC and normal mouse erythrocytes. W e propose that a native 
autoantigenic epitope on erythrocytes may be revealed by the proteop .  .ction o f bromelain and that this 
determinant it associated, at least in pan, with carbonic anhydrase. >
K E Y  W ORDS: Bromelain-treated red blood cells, carbonic anhydrase, natural autoantibodies, western blot­
ting, ELISA.
ABBREVIATION S: C A , carbonic anhydrase; BrM RBC, bromelain-treated mouse red blood cells; N M RBC, 
normal mouse red blood cells; c-ELISA, cellular-enzyme-linked immunosorbent assay;
PBS, phosphate buffered saline; i.p. mlrapetilaneal; B SA, bovine serum albumin; L °S , 
lipopolytaccharide.
INTRODUCTION
Normal and germ-free mice from many strains display 
high natural levels of IgM autoantibodies specific for 
bromelain-treated erythrocytes, either autologous or 
allogeneic1’2 (BrMRBC). These levels can be aug­
mented by B cell mitogens such as lipopolysacchar­
ide3, (UPS) or by procedures such as treatment with 
antilymphocyte serum4 which interfere with homeos­
tatic regulatory mechanisms or injections of bromel­
ain-treated rat red blood cells3. An investigation of the 
autoimmune response measuring serum antibody 
levels, specific plaque forming cell capacity and the 
appearance of the normal in vivo form of the BrMRBC 
antigen established that both the capacity to synthesise 
BrMRBC specific IgM antibody and the natural form 
of the BrMRBC antigen appeared by the end of the 
first week of life and reached adult levels by the third 
week*. Tissues from the stomach and upper small
g A d d ie u  for concspondence.
intestine were a rich source of antigenic material, cap­
able of specifically absorbing the IgM anti-BrMRBC 
antibody.
In recent years a number of groups have attempted 
to identify the epitope(s) recognised by BrMRBC-spe- 
cific IgM. In earlier experiments with serum from LPS- 
stimulated mice (LPS-serum), Cunliffe and Cox5 
showed a crossreaction with determinants located 
within the Fc fragment of mouse IgG and BrMRBC. 
Bussard and colleagues using anti-BrMRBC IgM mon­
oclonal antibodies derived from peritoneal B-cells 
from NZB mice found that they recognised trimethyl- 
ammonium compounds (choline)1"10. Cox and Hardy" 
further showed that anti-BrMRBC antibodies displayed 
strong crossreactivity with the ubiquitous membrane 
phospholipid, phosphatidylcholine but did not react 
with very closely related phospholipids. Kawaguchi12 
has demonstrated that anti-BrMRBC antibodies, in 
addition to recognising phosphatidylcholine, bound to 
low density lipoproteins of humans and chickens, but 
not to mouse or rat low density lipoproteins. In more
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recent work. Haughton and coworkers” -14 have 
employed liposomal probes of phosphatidylcholine 
impregnated with fluorocien conjugates to allow detec­
tion and isolation of BrMRBC specific peritoneal B 
cells using the fluorescence activated cell sorter.
X The aim of our work has been to identify th£) 
X  molecular form of the BrMRBC antigen normal 10 
X found in vivo either on bromelain-treated mouse eryty 
X rocytes or in its natural antigenically detectable form£h 
the mouse gastrointestinal tract6. In this paper we show 
that one possible natural ligand (autoantigen) on mouse 
red blood cells is carbonic anhydrase.
(0.5-1.0 ml) of packed RBC was treated with one vol­
ume of 10 mg/ml bromelain (Sigma no. B-2252) in 
PBS for 30 minutes at 37°C. BrMRBC were washed an 
additional three times in 10 ml volumes of PBS before 
use.
Purified Antigens and Chemicals
Glycophorin A (G 5017), human asiaologlycophorin 
(A 9791), carbonic anhydrase from bovine (C 7500), 
human (C 6892), rabbit (C 1266) and dog (C 3513) 
erythrocytes were purchased from Sigma Chemical Co.
METHODS
Mice
Retired female breeder CBA/Hr- mice (10-19 weeks 
old) were obtained from the Animal Breeding Estab­
lishment of the John Curtin School of Medical 
X  Research, Canbqffja, Australia.
Antibodies
Erythrocytes
Red blood cells were collected, under ether anaesthesia 
from adult female CBA/H mice into Alsever's solution 
and used on the day of collection. Erythrocytes were 
washed three times in phosphate-buffered saline (PBS, 
pH 7.4) before use, carefully removing the buffy coat 
after each centrifugation step. Bromelain-treated 
mouse red blood cells (BrMRBC) were prepared as 
described by Cunningham (1974). Briefly, one volume
SDS PAGE and immunoblotting
The discontinuous SDS-PAGE method of Laemmli16 
with 4%T stacking gel and 15%T separating gel was 
used in a minigel system (Biorad Mini Protean II) at 
200 V constant for 55 min. Low molecular weight 
markers were purchased from Biorad (161 0304). Gels 
were stained for protein with Coomassie Blue R250 
using NeuhofPs method for detecting nanopram 
amounts of proteins in gels17. The alcian bluei r and 
periodic acid-Schiff methods1* were used to stain gels 
for glycoproteins.
Western blotting was performed according to the 
methods of Towbin*. Western transfer was conducted 
using a mini-transfer system (Biorad Mini Trans-blot) 
and a 25 mM Tris-192 mM glycine, 20% (v/v) meth­
anol buffer, pH 8.3 for 1 hour at 100 V constant. Blots 
were blocked with 3% BSA in PBS overnight at room 
temperature on a rocker, and washed extensively with 
20 ml PBS containing 0.1% Tween 20 during all wash­
ing steps.
The biotinylated goat anti-mouse IgM antibodies 
(Sigma B 9265) used at 1:2500 or 1:5000 to develop 
the blots, were routinely preabsorbed with NMRBC 
and BrMRBC to remove antibodies that were capable 
of directly binding to carbonic anhydrase-associated 
determinants on mouse erythrocytes. An alkaline phos­
phatase detection system21 involving 1:2000 or 1:2500 
Streptavidin-Alkaline Phosphatase (Dakopattsfc>396) 
and Nitroblue Tetrazolium (Sigma N6876)/5-bromo-4- 
chloro-3-indolyl phosphate, p-toluidine salt (B 8503 
Sigma) (NBT/BCIP) in diethanolamine/HCl, pH 9.2 
was used.
Enzyme-linked immunoassays for carbonic anhydrase
For the measurement of antibody titres against car­
bonic anhydrase, the inner 60 wells of a plastic microt- 
itre plate were coated overnight at room temperature 
with 50/d of a 2.5 mg/ml solution of bovine carbonic 
anhydrase that had been either left untreated (dissolved 
in phosphate-buffered saline) or denatured in various 
ways. Carbonic anhydrase was denatured by the fol-
CBA/H mice, received lipopolysacchande (LPS) from 
Escherichia coli strain 0127:B8 (Phenol extract, Sigma 
no L-3129, Sigma Chemical Co. St. Louis, MO, USA) 
50 intraperitoneally (i.p.) in 0.1ml of sterile 
physiological saline. LPS-stimulated serum from a 
group of 90 mice was collected and pooled 7 days after 
injection stored in small lots at -20°C until use.
FUB 1 is an IgM monoclonal antibody produced by 
fusion of an LPS stimulated C3H mouse spleen with 
P3.653. The monoclonal was selected for its ability to 
specifically lyse BrMRBC and not NMRBC in stand- 
aid haemolysis assays (Kenny et al., in preparation).
Antibody titres against normal and bromelain- 
treated mouse erythrocytes were determined by a sus­
pension c-ELISA method11. The concentration of IgM 
in the FUB 1 preparation was determined to be 
65 Mg/ml, using the single radial immunodiffusion kit 
from The Binding Site (University of Birmingham 
Research Institute, Medical Diagnostics Sydney RN 
278). MOPC 104E for use as a negative control was 
obtained from Sigma (M 3273).
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lowing treatments; acid treatment -  |  mM HC1. pH 2.4; 
heat -  60°C  for IS min in phosphate-buffered saline; 
SDS+heat — heat in 10% SDS for 15 min at 60*G; urea 
-  10 M urea; Gu-HCl -  8 M guanidine-HCl. Concen- 
X  trations o f urea and guanidine-HCl used here a£b 
X  greater than the concentrations known to produce ran­
dom coils of purified human carbonic anhydrase22.
Wells were aspirated and then blocked with 100 fA  
of 1% bovine serum albumin for 90 min at room tem­
perature. FUB 1 was titrated in three-fold steps and 
allowed to incubate for 90 min. Plates were washed 
three times with 100/d/well of 1% BSA and then 
coated with 50 fA  of 1:5000 Biotinylated goat anti­
mouse IgM for 3 hours. Plates were aspirated and 50 fA  
of 1:2000 Streptavidin-alkaline phosphatase allowed to 
bind for 1 hour. After three more washes. 100 fA of p -  
nitrophenylphosphate substrate in diethanolamine/HCl 
buffer, pH 9.2, was applied to each well and 
absorbance read at 410 nm at 30 and 60 min. Endpoint 
titres were defined as the reciprocal of the dilution of 
FUB 1 at an OD cutoff point of 0.2 at 30 min.
In competitive inhibition assays with carbonic anhy­
drase, plates were coated overnight with 50 fA of 
500 ¿¡g/ml bovine carbonic anhydrase. Wells were 
blocked for 90 min with 100 fA  of 1% BSA in PBS. 
FUB 1 was titrated in the presence of 200 f ig/ml car­
bonic anhydrase with the remainder of the procedure 
the same as a standard ELISA from the second anti­
body step onward.
S u s p e n s io n  c e l lu la r  e n z y m e -lin k e d  im m u n o a ssa y s  f o r  
e r y th r o c y te s
A suspension c-ELISA was used to detect BrMRBC- 
specific antibodies15. Alkaline phosphatase conjugated 
goat anti-mouse IgM second antibodies were replaced 
with 50 /A  of 1:5000 biotinylated goat anti-mouse IgM 
second antibody added to each well and left for 3 
hours. Plates were centrifuged and aspirated, then 50 fA  
of 1:2000 streptavidin-alkaline phosphatase added and 
left for 1 hour.
The replicate error of the mean between duplicate 
titrations in ELISA assays expressed as a percentage 
varied between 2 and 10%.
P r e -a b s o r p tio n  o f  p r im a r y  a n d  s e c o n d a r y  a n tib o d ie s  
w ith  e r y th r o c y te s
Commercial second antibody preparations used for 
immunoblotting and ELISA were routinely absorbed to 
remove anti-carbonic anhydrase and anti-BrMRBC and 
NMRBC antibodies: 20 fA diluted 10-fold to 200 fA in 
\  1% BSA in PBS was absorbed on ice three times witij)
500 fA of packed NMRBC and then an additional three 
times with 500 fA of packed BrMRBC.
For the pre-absorption of FUB 1 and LPS-serum, a
20% (v/v) packed pellet of either BrMRBC or NMRBC 
was added for 60 min on ice for the three absorptions.
RESULTS
I m m u n o b lo ts  o f  m o u se  e r y th r o c y te s
The primary aim was to examine mouse erythrocytes 
by immunoblotting with FUB 1 and LPS-stimulated 
serum to ascertain if any RBC proteins would allow 
binding of the antibodies and thus behave as potential 
autoantigens. Whole normal mouse red blood cells, 
bromelain-treated mouse red blood cells and low 
molecular weight markers were electrophoresed on dis­
continuous SDS-PAGE gels and electroblotted onto 
nitrocellulose (Figure 1). It can be seen that two bands 
from the 30 kD region (29 kD, 31 kD) of both NMRBC 
and BrMRBC, and bovine carbonic anhydrase from the 
marker lane, were specifically recognised by the mono­
clonal FUB 1 and polyclonal LPS-serum. The doublet 
bands have been detected on SDS-PAGE and Western 
blots from mouse, rat and rabbit erythrocytes, whereas 
only a single band is detected with bovine CA and 
sheep, horse and human erythrocytes (A.M. Jonusys, 
unpublished). FUB 1 specifically detected carbonic 
anhydrase from human, dog and rabbit erythrocytes but 
not human glycophorin A or asialoglycophorin on 
Western blots (result  ̂ not shown). In further control 
experiments no bands developed if blotted membranes 
were first exposed to the myeloma protein, MOPC 
104E, at concentrations comparable to those used for 
FUB 1 at 1:10 dilution (viz. 6.5/rg/ml). From alcian 
blue and periodic acid-Schiff base staining, these 
30 kD mouse erythrocyte bands are glycoproteins 
(result not shown).
F U B  1 A c t iv i ty  a g a in s t n a tiv e  a n d  d e n a tu r e d  f o r m s  o f  
c a r b o n ic  a n h y d ra s e
From these initial results, it was not clear if FUB 1 was 
recognising a native or denatured form of the auto­
antigen because of the possible denaturating steps dur­
ing the electrophoretic and blotting procedures. In 
order to investigate this question, a direct ELISA was 
performed where FUB 1 was used to detect either 
untreated carbonic anhydrase or carbonic anhydrase 
that had êen allowed to bind overnight to plastic mic- 
rotitre plates in the presence of various denaturating 
agents (acid, urea, guanidine-HCl, SDS) (Figure 2). 
The results show that FUB 1 can recognise native and 
unfolded forms of bovine carbonic anhydrase, but that 
microtitre wells coated with heated or SDS-heated CA 
lead to a substantial loss of FUB 1 binding. This could 
be due to a destruction of the antigenic portion of car­
bonic anhydrase and/or to a reduced ability of heat 
denatured CA to adhere firmly to plastic.
In dot blot experiments using the same samples at 
various concentrations, FUB 1 could detect down to 
1 /rg of untreated CA, acid-treated, urea-treated and 
Gu-HCl-treated CA, but only down to 100/tg of 
SDS/heat and heat-treated CA (result not shown).
In competitive inhibition ELISAs, where different
forms of carbonic anhydrase were used to inhibit 
increasing dilutions of FUB 1 binding to carbonic 
anhydrase associated with plastic microtitre wells, we 
found that native carbonic anhydrase, as well as the 
denatured forms (acid-treated, SDS/heat treated) of 
carbonic anhydrase, were specifically recognised by
Mwt.
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Figure 1 SDS-PAGE and Western 
blotting of mouse red blood cells and 
carbonic anhydrase. Lane 1: Biorad low 
molecular weight markers (10 /d of 
1:20 dilution containing: rabbit muscle 
phosphorylase B, 97.4 ld>, bovine 
serum albumin, 66.2 kD; ovalbumin, 
45 kD; bovine carbonic anhydrase, 
31 kD; soybean trypsin inhibitor, 
21.5 kD; and lysozyme, 14.4 kD). The 
position of bovine carbonic anhydrase 
is indicated by an arrow. Lane 2: Nor­
mal mouse red blood cells from CBA/H 
retired female breeders (10 /A of 2% 
RBC in reducing sample buffer). Lane 
3: Bromelain-treated mouse ted blood 
cells. Lane 4: Bovine carbonic anhyd­
rite (5 /rg). Lane 5: Molecular weight 
markers. FUB 1 and LPS-serum were 
applied at a concentration of 1:10 to 
one half of a nitrocellulose sheet that 
had been blotted from the same gel. 
Control blots treated with PBS instead 
of first antibody were negative. 
Biotinylated Goal anti-mouse IgM was 
used at 1:2500 and strepiavidin-alkaline 
phosphatase at 1:2000.
FUB 1 (1:10) LPS-serum(1:l0)
1 2 3 , 4 5  1 2 3 4 5
Reciprocal of FUB 1 Dilution
F igure 2 Tumi on curvet for FUB 1 in in ELISA wilh nitive and denatured forms of bovine carbonic anhydrite. The wells of a plastic 
microcitre plate were coated overnight with 50 /d of a 2.5 mg/ml solution of bovine carbonic anhydrite that had been either left untreated 
/ \  (OO), i-e. dissolved in phosphate-buffered saline, or denatured in various ways. The following denaturauon treatments were used: Add treat­
ment -  1 mM HQ, pH 2.4 (•>, Heal -  heat in phosphate-buffered saline at 60°C for 15 min (■); SDS+Heat -  heal in \Q% SDS for 15 min at 
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Figure 3 Competitive inhibition EUSA with untreated or denatured carbonic anhydrase. In control wells (O), FUB 1 was titrated in three­
fold ateps tuning at 1 in 3 in 1% BSA and allowed to incubate at room temperature for 90 min, while in test wells FUB was titrated in the 
presence of 200/rg/ml carbonic anhydrase in I % BSA (either untreated carbonic anhydrase (•) , add-treated carbonic anhydrase (■) or SDS- 
ueated carbonic anhydrase (■)).
n
Figure 4 A suspension-transfer c-ELISA was used to delect specific inhibition of binding of antibodies against BrMRBC using 500/ig/ml 
bovine carbonic anhydrase. FUB 1 did not bind to NMRBC (not shown). Inhibition of FUB 1 binding to BrMRBC could not be demonstrated 
when FUB 1 was preincubaied with 500 /¿g/ml bovine carbonic anhydrase ( • )  for 2 hours at room temperature when compared to control 
titrations (O) where bovine carbonic anhydrase was not present.
Blots 1 2
F igu re 5 Western blot of carbonic anhydrase and normal mouse red blood cells and FUB 1. Conditions for electrophoresis and electroblot- 
ling were the tame as for Figure 1 except carbonic anhydrase (lane a) and NMRBC (l»ne b) were blotted side-by-tide and the nitrocellulose 
wat stored dry before ute. FUB 1 wat preabsorbed extensively by either 20% packed BrMRBC (Blot 1), 20% packed NMRBC (Blot 2) or 
unabsorbed (Blot 3) before application to the blots. Preabsorption of FUB 1 with BrMRBC lowers the intensity of binding to carbonic anhyd­
rase and the 30 kD bands from mouse erythrocytes, whereas prcabtorbing with NMRBC does not.
Blots 1 2 3 4
Lane a b a b a b a b
F igu re  o Western blot of carbonic anhydrase and normal mouse red blood cells and LPS-serum. In a separate Western blot experiment with 
LPS-terum used at 1:500 against NMRBC (lane a) and carbonic anhydrase (lane b), a similar result to Figure 5 was obtained. LPS-serum was 
preabsorbed extensively by either 40% packed BrMRBC (Blot 2), 40% packed NMRBC (Blot 3) or left unabsorbed (Blot 1) before applica­
tion to the blots. Blot 4 is the PBS control. Similar results were obtained with LPS-serum at 1:1000 and 1:5000 (not shown).
Laing and co-workers“  have recently demonstrated 
with Western blotting experiments that mouse anti-rat 
RBC serum, but not mouse anti-BrRat RBC serum, is 
capable of detecting rat erythrocyte glycophorins. In 
contrast, we have shown here that both LPS-serum and 
the monoclonal anti-BrMRBC antibody, FUB 1, used 
in Western blotting experiments (Figures 1, 5 and 61 
X  specifically recognises carbonic anhydrase from mousg) 
erythrocytes and bovine carbonic anhydrase. This 
apparent difference between mouse and rat RBC West­
ern blotting experiments may be due to the fact that 
Laing’s study concentrated on the mouse response to 
rat erythrocyte ghosts whereas we are concerned prim- 
x  arily with mouse natural autoantibodies that recogri^e 
the antigen revealed when whole mouse erythrocytes 
a: have been pretreated with bromelain. Although <£hr- 
bonic anhydrase is a transmembrane protein and the 
a  second most abundant erythrocyte protein after haemo­
globin, levels of carbonic anhydrase are diminished in 
\  erythrocyte ghost preparations (A.M. Jonusys, un îQ- 
A fished). This apparent difference between rat ajid) 
mouse erythrocytes warrants further investigation.
In immunoblotting experiments (Figures 5 and 6) 
where FUB 1 and LPS-stimulated serum have been 
\  preabsorbed extensively with BrMRBC, we have cl(T> 
arly demonstrated that carbonic anhydrase bands in the 
blots have been substantially reduced in staining 
A intensity, suggesting that carbonic anhydrase is part/gf 
the set of BrM-epitopes.
Some IgM antibodies in unabsorbed LPS-stimulated 
serum also recognise haemoglobin subunits on blots 
suggesting that some other BrM-specific epitopes, 
recognized by other serum IgM antibodies, may be loc­
ated on haemoglobin (the faint band in the 12-14 kD 
region, Blot 1 lane a Figure 6). This faint 12-14 kD 
band has been augmented in intensity following 
absorption of LPS-serum with NMRBC (Blot 3 lane a 
Figure 6), which may be due to IgM-haemoglobin 
complexes binding to the band.
In a tissue distribution and ontogeny study of the 
BrM antigen, Cunningham and Steele6 found a form of 
the BrM-antigen at high levels in the stomach and 
upper small intestine with some BrM activity present 
in the kidney, liver and salivary glands. Garzelli e t a l 26 
have confirmed the distribution of the BrM-antigen in 
cells of the lamina propria of mouse gastric mucosae, 
x the cytoplasm of cells in the salivary glands and tl(e) 
lumen of the seminiferous tubules of the testis with an 
immunofluorescence study of frozen tissue sections 
and anti-BrMRBC monoclonal autoantibodies.
The tissue distribution of the in  v iv o  form of the 
BrM-antigen is similar to the distribution of carbonic 
anhydrase II. Carbonic anhydrase (E.C. 4.2.1.1.), a 
30 kD glycoprotein isoenzyme responsible for the 
reversible hydration of carbon dioxide required for 
acid-base balance in mammals, is primarily located in
the gastrointestinal tract, erythrocytes, the lungs and 
the kidneys17. Carbonic anhydrase has been found in 
follicle-associated epithelial cells in ileal Peyer s 
patches of lambs and goat kids21 and in the gastric pari­
etal cells, brush border of the small intestine 
enterocytes, nephron, glial cells, erythrocytes and adip­
ose cells of rodents29. The biochemistry and^enetics of 
CA has been studied for mouse CA II30" . The two 
electrophoretic types of CA II that may be distingu­
ished on cellulose acetate gels (and also found here on 
polyacrylamide gels, Figure 1) are thought to be due to 
a single nucleotide and subsequent amino acid substitu­
tion . A number of different isoenzymes of carbonic 
anhydrase have been characterised in a range of spe­
cies’4 and the protein sequence is highly conserved 
with CA IH displaying some sequence homology to 
ubiquitin, a marker of protein senescence.
The question arose as to whether carbonic anhydrase 
was recognised in its native form or had undergone 
partial unfolding in the interaction with nitrocellulose. 
ELISA experiments with bovine carbonic anhydrase 
coated plates, together with CA present as a soluble 
competitive inhibitor, showed specific binding of FUB 
1 to both “native” and denatured carbonic anhydrase 
(Figures 2 and 3). Thus, this ELISA data suggests that 
FUB 1 is binding to an epitope that is present on the 
surface of the CA protein and would suggest a linear 
epitope rather than a conformational epitope. Further 
work is in progress to determine the identity of this 
epitope.
A suspension-type ELISA experiment (Figure 4) was 
conducted to test if a native or denatured form of car­
bonic anhydrase could inhibit the binding of FUB 1 to 
BrMRBC, but this could not be demonstrated at the 
levels of bovine carbonic anhydrase used. Thus inhibi­
tion of binding of FUB 1 to antigen coated plates by 
ELISA can be clearly demonstrated (Figure 2) but not 
by cellular ELISA using BrM erythrocytes in suspen­
sion as antigenic targets (Figure 3). This could be due 
to an effect of intrinsic low affinity of each antigen 
combining site in IgM as well as an effect of avidity 
due to the binding of the IgM to a multivalent array of 
different epitopes on the BrM erythrocyte surface i.e. 
FUB 1 preferentially recognising murine carbonic 
anhydrase in the membrane in association with phos­
phatidylcholine and other membrane proteins. The 
likelihood of multipoint binding may indicate it is dif­
ficult to achieve inhibition in this system using soluble 
bovine carbonic anhydrase.
In other experiments we have reduced and alkylated 
FUB 1 and shown a greater than 99% loss in binding 
activity, both for CA in the direct ELISA assay (using 
CA-coated plates), and for BrM erythrocytes in the cel- 
lular-ELISA assay. This indicates that the individual 
combining sites are of very low affinity and that the 
binding avidity of the intact antibody is due entirely to
>  che increased vale n cy (A .M . Jonusys, unpubli^jkd
data).
It has already been clearly demonstrated by a num- 
X ber of groups that phosphatidylcholine is recognised @  
y. part of the anti-BrMRBC response in mice. Howevt© it 
is apparent from the work presented here that the 
autoantibodies also specifically recognize murine 
X erythrocyte carbonic anhydrase. Therefore, it app0rs 
that natural autoantibodies specific for anu-BrMRBC 
may be capable of simultaneously binding diverse epi­
topes such as phosphatidylcholine and carbonic anhyd- 
xrase akin to the bi-functional antibodies described^' 
Varga, Königsberg and Richards” .
In conclusion we have provided strong immuno- 
vchemical evidence showing that murine monocla^l 
v and serum lgM autoantibodies which recognisg) 
BrMRBC also bind the ubiquitous and abundant 
enzyme catalysing the reversible hydration of carbon 
v dioxide, carbonic anhydrase. The prominent tissue@s- 
\  tribution of carbonic anhydrase in erythrocytes £hd 
v gastrointestinal tissue parallels that of the previously 
v established tissue distribution of the in vivo form of(3*e 
BrM autoantigen*.
An additional proof that these anti-BrMRBC anti­
bodies also recognise carbonic anhydrase could 
v involve immuno-affinity purification of the 30(k)D 
v bands from erythrocytes followed by amino acid s0p- 
\  encing to establish identity with carbonic anhyd^e. 
The immunochemical evidence however showing this 
serological identity is persuasive. Western blots of 
X SDS-PAGE separated membrane glycoproteins derogi- 
X  sirate that the prominent reactivity of FUB 1 and 
stimulated serum is against a doublet band running in 
the 30 kD region which other, independent evidence 
equates with the two known isozymes of murine car­
bonic anhydrase which appear in these positions when 
membrane glycoproteins of mouse erythrocytes are 
analysed by electrophoretic techniques” . Moreover, 
the reactivity against this doublet band is removed or 
substantially reduced by prior immunoabsorption with 
bromelain treated erythrocytes and not normal mouse 
verythrocytes. Finally, we interpret the discrepancy)in 
the antigen inhibition results between the EuSA 
assays involving antigen (bovine carbonic anhydrase) 
coated plates versus BrMRBC targets in suspension as 
evidence that the carbonic anhydrase associated BrM 
epitope is only one of several ligands that can be 
accommodated within the antigen combining site of 
these naturally occurring murine IgM anti-BrM anti­
bodies. Thus failure of soluble bovine carbonic anhyd­
rase to inhibit the binding to BrM erythrocytes is inter­
preted to be mainly due to an increase in binding 
avidity contributed by the multipoint array of several 
different epitopes on the surface of BrMRBC. This 
situation does not apply when soluble carbonic anhyd­
rase competitively inhibits binding to carbonic anhyd­
rase coated ELISA plates.
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Appendix I
Answers to queries raised by Dr. P.L. Ey
Query 1.
Emphasis on one particular antigen (p 37). Possibility o f several?
An erythrocyte may have a large number of potentially antigenic structures, (e.g. blood 
group substances, cytoskeletal elements, glycoproteins or glycolipids) that may act as antigens 
when injected into different species. However, this thesis specifically deals with one putative 
mouse autoantigen, the BrMRBC autoantigen, that has been defined in terms of a structure that 
is revealed after proteolytic digestion with bromelain (Cunningham 1974). The exact biological 
structure of all of the components of this autoantigen had remained undefined for almost 15 
years until carbonic anhydrase was shown to be an in vivo component of the BrMRBC 
autoantigen (Jonusys et al. 1991). Some knowledge on the possible natural autoantigenic 
ligands has been gained from using a wide variety of compounds, such as phosphatidylcholine 
and low density lipoproteins from egg yolk, to inhibit the binding of BrMRBC and specific 
IgM natural autoantibodies that bind to BrMRBC (Table 1.3, p.9). Also, anti-BrMRBC 
autoantibodies do not bind to normal mouse red blood cells (Chapter 1, 1.4.2), which shows 
that potentially autoantigenic structures on the surface of intact red blood cells, such as 
cytoskeletal elements or blood group antigens, do not normally act as autoantigens.
In contrast to the lack of specific knowledge on the structure of the BrMRBC 
autoantigen, a great deal is known about the structure and genetics of the antibodies that 
recognise the BrMRBC autoantigen (Chapter 1, 1.3). For this reason alone it was important to 
place emphasis on one particular "antigen" as it is difficult to advance this field of study when 
one of the principal components, the target BrMRBC autoantigen, has been so poorly defined 
in vivo. This thesis has revealed a previously unrecognised mouse erythrocyte autoantigen, viz. 
carbonic anhydrase, and will stimulate further research into the interactions of carbonic 
anhydrase and the other main candidate autoantigen, phosphatidylcholine.
Query 2
Seem to assume that all hybridoma-derived anti-BrMRBC antibodies are directed 
against the same antigen (eg. p. 38). Evidence that this is so?
In the studies of Pages and Arnaud (1980) and Kawaguchi (1986), in which the 
reactivity of anti-BrMRBC antibodies were tested against bromelain-treated RBC and normal red 
blood cells from a wide variety of different species, the authors in both papers have attempted to 
measure the relative binding hierarchy of anti-BrMRBC antibodies by inhibition of RBC lysis 
assays. In these studies it has been assumed that bromelain would have a common action on 
RBC, whether they came from a mouse or a frog, and thus reveal a common antigen on all of
these target cells. The exact in vivo identity of the target autoantigen or antigen could not be 
defined in these studies, but would have been assumed to be the same for different species' 
erythrocytes.
In experiments conducted in this thesis, this problem of what anti-BrMRBC antibodies 
bind to on the RBC of different species and whether this antigen was common to a range of 
different species was addressed in Western blot and c-ELIS A experiments (Chapter Five, Section
5.5 pl60-166). I found that anti-BrMRBC antibodies recognise carbonic anhydrase from a range 
of different species, and the different binding hierarchies found by other authors may perhaps be 
explained by the different local topology of different species' erythrocytes after bromelain 
treatment in their assay systems. The western blot results obtained here indicate that the 
monoclonal antibody, FUB 1, recognises the same antigen, carbonic anhydrase, from the 
erthyrocytes of different species.
Query 3
Inhibition o f lysis o f antibody-sensitised BrMRBC (p 43). Any effect on lysis o f 
other cells in parallel asays ? (i.e. is inhibition specific fo r  antigen, or 
interference with c activation?).
These complement-dependent lysis assays, as conducted by Cunningham and Steele 
(1981), are specific for the antigen BrMRBC. The inhibition is specific for anti-BrMRBC 
antibodies and may not be explained as inhibition of complement components. The relevant 
controls were in place for these experiments, viz, erythrocytes and anti-erythrocyte antibodies 
from other species (Horse RBC) and anti-HorseRBC antibodies have been used to show that the 
lysis of BrMRBC with anti-BrMRBC is specific (Cunningham and Steele 1981).
In experiments where anti-BrM activity was absorbed out of the serum with various 
mouse tissues, there was a corresponding lack of absorption of IgM anti-Horse RBC serum 
with the same antigens. In different experiments designed to test a range of antigens that may 
inhibit the binding of anti-BrMRBC serum to BrMRBC, the same antigens did not inhibit the 
lysis of Horse RBC by anti-HRBC serum.Thus the inhibition of lysis described in this study 
was due to specific antigen and not interference of complement activation.
Query 4
Can one be certain that it is the protease activity in bromelain that exposes the 
BrMRBC antigen(s)? (p.55) Commercial stocks are rather crude and could 
contain other enzyme activities , e.g. glycosidases.
This is a valid concern that probably has not been looked at adequately by all researchers 
in this area. In a paper by Cunliffe and Cox (1979), the action of bromelain and pronase on
mouse erythocytes was examined, and bromelain, obtained from Sigma and used without further 
purification, was found to remove Bands I, II and III as well as some undefined glycoprotein 
and protein bands from the membranes of mouse red blood cells. This paper addressed only the 
action of bromelain and pronase on mouse RBC membranes and it should be noted that whole 
red blood cells, which are the common target cells used in other assay systems, were not 
examined.The possible glycosidase activity of bromelain was not examined in this paper nor 
was the purity of bromelain available commercially questioned or examined.
Sigma, which is the company that most researchers obtain bromelain from, sells 
bromelain on the basis of its proteolytic activity. It is of note that Sigma now markets a more 
highly purified product that was not available when I did the work described in this thesis. It 
would be of value to test the standard bromelain and the more purified product to determine if it 
could be responsible for the removal of carbohydrate.
However, in light of the results obtained with deglycosylated carbonic anhydrase 
(Chapter 5, 5.6, Figure 5.15), where it seems apparent that FUB 1 recognises the O-linked 
sugars on carbonic anhydrase, bromelain could not be responsible for removing sugars on red 
blood cell carbonic anhydrase in situ, otherwise these bands would not be detected on western 
blots.
Query 5
Assay volume (p. 57, paragraph 1): Was the final volume 75 or 100pi? It is not 
clear whether the 25pi o f rabbit c was included within the 50pl o f diluent, or 
added after sample dilution.
On page 57 the volume of the assay described is I O O jlxI ;  consisting of antibodies serially 
diluted in 50jil of buffer and 25jil of rabbit complement and 25jil of a 1% RBC suspension. 
The rabbit complement was added after the antibody dilution, so that a constant amount of 
complement would be present in all test wells of the assay.
Query 6
AET and periodate treatment (pp. 60, 75). The negative results emphasise the 
need to always include positive controls to ensure that the reagents are really 
working . Periodate only destroys cis-hydroxy sugars: it does not destroy 
carbohydrates generally, nor "deglycosylates"proteins (p.173).
AET and periodate where employed with whole RBC in an attempt to remove 
carbohydrates following standard human blood bank techniques (American Association of Blood 
Banks 1985) and standard methods to "destroy blood group substances" (Kabat, 1956). It was 
perhaps an oversight not to include a standard panel of human RBC, however problems were
encountered with mouse RBC and AET, such as the complete lysis of mouse red blood cells 
that are not commonly encountered with human red blood cells. As these experiments were 
conducted during the early, unfruitful stages of the project, it would probably be worthwhile to 
re-examine these experiments and make changes to the standard human blood protocols with 
regard to the concentrations of the reagents used and the times and temperatures of incubation, 
such that the assays would be applicable for mouse red blood cells.
Query 7
Coating concentration fo r  ELISA (p.73 & elsewhere). Was 2.5 mg/ml really 
used? This is a huge overdose and a waste o f purified protein; 5-10 pglml, the 
commonly used range, is essentially saturating.
The coating concentration for the carbonic anhydrase ELISA (p73, pl36) was in fact 
50jll1 of a 0.25mg/ml stock solution of carbonic anhydrase, which coats each microtitre plate 
well with 12.5 |ig of carbonic anhydrase. Any unbound carbonic anhydrase is removed upon 
aspiration at the next stage, leaving essentially a saturating level of carbonic anhydrase coating 
each well.
Query 8
Poor description o f methodology (p. 74). Was the RBC lysate centrifuged 
before treatment with ammonium sulphate? The latter was presumably used at a 
final saturation o f 45% (w/v?), not 45% o f the volume as described. Was the 
redissolved pellet dialysed prior to application to the DEAE column ? (this is not 
mentioned). Was a pH gradient employed fo r elution?
Perhaps this section could have been made clearer with a flow diagram, however if the 
method described on page 74 (Carter and Parsons 1970) is carefully followed the concerns 
raised by the examiner could have been answered. In preparing carbonic anhydrase from 
erythrocytes, haemoglobin is removed from the lysate by ammonium sulfate precipitation 
(45%w/v) and any membrane constituents are effectively removed by centrifugation at 10,000 
rpm for 1 hour. The supernatant (pH 7.2), which contains carbonic anhydrase, is applied to 
the DEAE column. The precipitate, containing haemoglobin and RBC membranes, is discarded 
and therefore does not have to redissolved or dialysed before being placed in the rubbish bin. A 
stepwise pH gradient was employed to elute carbonic anhydrase from the DEAE column.
